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1 Introduction 
 
 
 
This thesis is about the co-existence of depression with other health conditions 
or, to put it briefly, about comorbidity involving depression. It consists of two 
main parts. The first part presents three studies that concentrate on the 
occurrence of comorbidity involving depression. In the second part of the 
thesis, three studies are presented that deal with the health care 
consequences of the co-occurrence of depression with other health conditions. 
Before presenting the focus and content of the thesis in more detail the key 
concepts depression and comorbidity as well as the relevance of comorbidity 
involving depression will be described.  
 
 
1.1 Depression and comorbidity  
 
Defining depression  
Depressed mood and loss of interest or pleasure are commonly considered the 
most typical symptoms of depression. In addition, several other symptoms are 
indicative of depression, such as fatigue or lack of energy, weight change, 
disturbed sleep, feelings of excessive guilt, agitation, impaired concentration, 
and recurrent thoughts about death and suicide. In order to be diagnosed with 
depression (major depression) according to the criteria of the prevailing 
psychiatric classification system, the Diagnostic Statistical Manual of Mental 
Disorder (DSM), a person must have one or both of the core symptoms 
(depressed mood and loss of interest/ pleasure) together with at least four 
other symptoms for at least two weeks 
1
. In addition, the symptoms must 
cause clinically significant impairment in functioning or distress. A number of 
other depressive syndromes are distinguished in DSM-IV, among which is 
dysthymic disorder, a chronic but less severe form of depression. The 
classification system also includes provisional diagnostic criteria for minor 
depression, which correspond to the criteria for major depression, except that 
fewer symptoms are required. Various other criteria have been used to define 
depressive syndromes that fail to meet the diagnostic threshold for major 
depression 
2
. In the remainder of the introductory text these will be referred 
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to as subthreshold depression. 
Most studies presented in this thesis are based on morbidity data recorded by 
Dutch general practitioners (GPs). The International Classification of Primary 
Care 
3
 is the standard coding system for morbidity used in Dutch general 
practice, based on the criteria of the third edition of the International 
Classification of Health Problems in Primary Care 
4
. To be diagnosed with 
depression according to the ICHPPC-2-Defined, one must have at least three of 
the following six symptoms: (1) sadness or melancholy more than can be 
explained by psychosocial stress; (2) suicidal thoughts or attempt; (3) 
indecisiveness, decreased interest in usual activities or diminished ability to 
think; (4) feelings of worthlessness, self-reproach, or inappropriate/ excessive 
guilt; (5) early morning wakening, hypersomnia, or early morning fatigue, and 
(6) anxiety, hyperirritability, or agitation. As compared to the DSM-IV criteria 
for major depression, a lower number of symptoms is required, which in 
addition do not necessarily have to be present for a minimum duration of two 
weeks. Also, a clinical significance criterion is lacking. Accordingly, a broader 
definition of depression than the standard psychiatric diagnostic definition is 
being applied in this thesis. A proportion of the persons who are diagnosed 
with depression by their GP will suffer from dysthymic disorder or subthreshold 
depression 
5
.  
Since research on depression diagnosed by GPs is relatively scarce, drawing 
from the extensive literature on major depression, and, to a lesser extent, 
that on dysthymic disorder and substhreshold depression is essential to lay a 
foundation for the rationale of the thesis.  
 
Relevance of depression 
Major depression has often an early age of onset and a remitting and recurring 
nature. For instance, a nationally representative survey of psychiatric 
morbidity in the U.S. showed that in most cases major depression presents for 
the first time between the age of 19-44 years 
6
. Another U.S. study indicated 
that nearly three quarters of people aged 15-54 years who had ever fulfilled 
criteria for major depression had suffered from more than one episode 
7
. Using 
data from the only nationally representative psychiatric morbidity survey 
conducted in the Netherlands to date, the Netherlands Mental Health Survey 
and Incidence Study (NEMESIS), it has been estimated that Dutch adults 
meeting criteria for major depression will experience on average about seven 
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depressive episodes during their lifetime 
8
. The duration of  major depressive 
episodes varies widely and follows an asymmetric distribution that is skewed to 
the right 
9
. The NEMESIS study showed that half of affected Dutch adults aged 
18-64 years achieved remission within three months, while 20% were still 
depressed after two year of follow-up 
10
. Noteworthy, a substantial proportion 
does not reach full remission, but suffers from residual symptoms, thereby 
having an increased risk of relapse 
11-12
. 
It is well established that major depression is associated with substantial 
functional disability and loss of quality of life. The impact on functioning is 
wide-ranging, including occupational, social and physical areas of functioning 
13-14
. Functional status tends to be restored after remission from a major 
depressive episode 
15
, although improvement in functioning may lag behind 
clinical remission 
16
. Being an important correlate of functioning, it is not 
surprising that self-perceived quality of life is also decreased in major 
depression 
17. Depressed persons‟ appraisal of both mental and physical 
aspects of their current life is worse than that of their non-depressed 
counterparts, although mental aspects of quality of life have, understandably, 
been found to be affected to a greater extent 
18
. Overall, the degree of 
impaired functioning and quality of life associated with major depression 
appears similar to, if not greater than, the level of impairment associated with 
common chronic somatic disorders 
19
. Major depression also seems to shorten 
the lifespan 
20-21
. The increased risk of dying cannot solely be explained by the 
high rate of suicide among depressed persons 
22
, but also appears to be related 
to other factors such as the more unhealthy lifestyle behaviours of depressed 
persons, their increased risk for being non-adherent to medical treatment 
recommendations or the direct pathophysiologic effects of depression 
23
. 
The burden of major depression is not only significant at the individual level, 
but also at the societal level. First of all, major depression is very common. In 
the Netherlands, it is estimated that major depression afflicts approximately 
700,000 people aged 18 years and older every year 
24
. The NEMESIS study 
showed a one-year prevalence of major depression of 5.7% for adults aged 18-
64 years. It should be noted that about half of the persons affected annually in 
this age-group are first-ever cases of depression 
25
. Major depression is less 
prevalent among older persons 
26
. Its high prevalence, substantial impact on 
functioning and quality of life, early onset, relatively long average episode 
duration, and impact on premature mortality altogether result in major 
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depression being ranked as one of the most burdensome disorders worldwide in 
terms of disability-adjusted life years 
27
. The same is true when focusing on 
the Netherlands 
28
. Furthermore, it is evident that the economic burden of 
major depression is substantial 
29-30
. The high costs are primarily the result of 
the increased use of health care services by depressed persons and their 
greater risk of being absent from work and being less productive at work 
31
. 
The higher level of health care use associated with depression is pervasive, 
and includes a higher utilization of primary and specialized medical care, more 
emergency room visits and a greater number of (antidepressant and non-
antidepressant) drug prescriptions 
32
. 
All in all, the significance of major depression is clear. Although examined less 
frequently than major depression, studies point out that dysthymic disorder 
also is a condition associated with substantial clinical and societal burden 
19; 33-
38
. Indeed, dysthymic disorder and major depression frequently co-occur 
39
, a 
phenomenon referred to as “double depression”. Furthermore, evidence is 
accumulating that subthreshold depression is also clinically and economically 
relevant 
40
. Subthreshold depression is a highly prevalent condition and it has 
been indicated that a substantial proportion of affected persons experience an 
unfavourable course 
7; 41
. Some will develop major depression given that 
subthreshold depression has been shown to be a clear risk factor for 
subsequent major depressive episodes 
42
. In addition, subthreshold depression 
appears to be associated with impairments in functioning, including work 
impairment, and loss of quality of life 
43-45
, increased mortality 
20
, higher use of 
health care services 
46-47
, and considerable costs 
48
. 
 
Defining comorbidity  
Four decades ago, the term comorbidity was first coined by Feinstein and he 
defined it as “any distinct additional clinical entity that has existed or that 
may occur during the clinical course of a patient who has the index disease 
under study” 49-50. Since its introduction the concept of comorbidity has 
received increasing attention, not only in research on chronic somatic 
diseases, but also in psychiatry research, and has evolved in various directions 
51-53
. Consequently, numerous definitions of comorbidity have been presented 
in the literature through the years 
54-58
. Basically, all these definitions have in 
common that they are about patients with a certain index condition who have 
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or develop one or more other health conditions in a specific time span.
*
  This 
thesis deals with comorbidity involving depression: in all studies presented an 
index condition is being appointed, being either depression or a health 
condition that co-occurs with depression.  
In the course of time, several attempts have been made to classify 
comorbidity. A parsimonious classification is proposed by Van den Akker and 
colleagues, which is based on the more elaborate categorization of 
Schellevis
59
. Three categories of comorbidity are being distinguished in this 
classification
51; 60 
: 
1  concurrent (or simple) comorbidity:   
 The co-occurrence of an index condition with another health condition 
 whether coincidental or not; 
2 cluster (or associative) comorbidity: 
 The co-occurrence of an index condition with another health condition 
 at a significantly higher rate than expected by chance;  
3 causal comorbidity: 
 The causal mechanism underlying the co-occurrence of an index 
 condition and another health condition is known (e.g. ischaemic heart 
 disease and pheripheral disease). 
This is a hierarchical classification. Obviously, all instances of comorbidity 
fulfil the definition of concurrent comorbidity. Some of these comorbidities 
will occur in numbers greater than expected by chance and hence should be 
classified as cluster comorbidity. Some of those statistically significant 
comorbid associations represent known causal relationships and should be 
defined as causal comorbidity.   
 
Comorbidity research 
Research on comorbidity, and accordingly research on comorbidity involving 
depression, can be divided into four broad research areas (see Figure 1): (1) 
the occurrence of  comorbidity; (2) the consequences of comorbidity for 
health, health care and society; (3) the causal mechanisms underlying the 
occurrence of comorbidity and its consequences; and (4) the study of 
interventions to prevent or reduce the occurrence of comorbidity and its 
associated burden. 
                                                     
*
 Comorbidity can be distincted from multimorbidity. In the study of multimorbidity the 
interest is on the co-occurrence of health conditions without appointing an index condition 51. 
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In general, knowledge of the occurrence of comorbidity is important for 
clinical practice, health care planning, and for generating new hypotheses for 
research 
61-62
. Clinically, data on the occurrence of comorbid relationships may 
raise awareness among health care providers of the potential presence of 
comorbidities in (specific) patient groups, which may facilitate early diagnosis 
and treatment of comorbid conditions. Information about the pattern of 
comorbidity in various patient populations can also serve as an important 
indicator of their health care needs, thereby being relevant for the planning 
and organisation of health care services. Finally, comorbidity profiles may 
form a basis for hypothesis-driven research on the causal mechanisms 
underlying the co-occurrence of health conditions. In this respect, 
identification of cluster comorbidity, i.e. when an index condition and another 
health condition occur in combination more often than expected, is of vital 
interest because concurrent comorbidity represents an index condition and 
another health condition that co-occur simply by chance, while causal 
comorbidity implies an already known causal relationship. 
A second major research area concerning comorbidity is the study of its 
associated burden on health, health care, and society 
63
. For patients, their 
relatives, and health care providers, it is important to know whether 
comorbidity adversely impacts health, for example, by means of increasing the 
likelihood of poor prognosis, functional impairment and loss of quality of life, 
and whether it negatively influences the quality of care provided. Such 
knowledge is also relevant for health care planning and organisation, together 
with data on the effect of comorbidity on health care utilization and costs. To 
get a full picture of the economic burden of comorbidity, its consequences for 
occupational functioning need to be included. Finally, the study of the 
consequences of comorbidity might generate hypotheses about the 
mechanisms that underlie the adverse impacts of comorbidity. Noteworthy, 
whether comorbidity influences health and health care may not be dependent 
on whether comorbidity represents coincidental or causal co-occurrence. 
Consequently, all three categories of comorbidity, i.e. concurrent, cluster and 
causal comorbidity, are relevant when studying the impact of comorbidity 
64
. 
Introduction 
 
 13  
Figure 1  The four main research domains of comorbidity.  Uncoloured parts 
 indicate research areas that are being addressed in the thesis 
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Unravelling the causal mechanisms underlying occurrence of comorbidity and 
its negative effects on health and health care, the third main research area 
regarding comorbidity, is vital with respect to the development and 
refinement of interventions to prevent and reduce comorbidity and its 
associated burden. As noted above, cluster comorbidity forms a useful starting 
point from which “etiologic” research can test specific hypotheses about the 
causal mechanisms that underlie the occurrence of comorbidity. Basically, a 
certain index condition and another health condition may co-occur more often 
than expected because (a) the index disease, directly or indirectly, causes or 
contributes to the development of the comorbid health condition; (b) the 
comorbid condition, directly or indirectly, causes or contributes to the 
development of the index disease; and/or (c) both the index disease and 
comorbid health condition arise from the same underlying cause or risk factor 
56; 65-67
. Indeed, with regard to research on the causal mechanisms underlying 
consequences of comorbidity the focus is not solely on cluster comorbidity, but 
also on concurrent and causal comorbidity, since these categories of 
comorbidity can have important impacts on health and health care.  
The final major research area of comorbidity is the study of the (cost-) 
effectiveness of interventions to reduce or prevent comorbidity and its 
associated burden. These studies may contribute to more (cost-)effective 
health care. 
 
The relevance of comorbidity involving depression 
In the past decade, large-scale studies have established that depression is a 
highly comorbid condition. Major depression and dysthymic disorder frequently 
co-occur with each other and with other mental disorders in the general 
population 
39; 68-69
 and the primary care population 
70-72
. According to the 
NEMESIS study, for instance, about half of Dutch persons aged 18-64 years with 
major depression in the past year also experienced an anxiety disorder in the 
same period 
73
. Depression also frequently co-exists with chronic somatic 
illnesses. Studies indicate that between 47% and 80% of primary care patients 
with current major depression, dysthymic disorder, or subthreshold depression 
also suffer from a chronic somatic condition 
71; 74
. Conversely, comorbid 
depression is common in somatically ill patients. For instance, a large-scale 
health survey of the adult Canadian population found that the annual 
prevalence of major depression in persons reporting one or more long-term 
Introduction 
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medical conditions was about 9%, more than twice the prevalence among those 
not reporting a chronic condition (4%) 
62
. Also, various population-based studies 
using a depression rating scale rather than a diagnostic instrument for major 
depression, have shown that older individuals with a chronic somatic illness 
generally have more depressive symptoms than those without a chronic illness 
75-78
. Altogether, ample evidence now exists to conclude that depression with 
comorbidity is the rule, not the exception. This is nicely exemplified by a 
recent study that examined both psychiatric as well as somatic comorbidity in 
depression instead of focusing on one “type” of comorbidity 71. It was found 
that only 12% of depressed primary care patients had no comorbidity, that is, 
had no other psychiatric disorder or chronic somatic illness at the same time.  
Comorbidity involving depression is also relevant because it is associated with 
increased personal and societal burden. Studies in the community and the 
primary health care setting have found that patients suffering from both 
depression and anxiety have more severe symptoms overall, poorer prognosis, 
higher rates of chronicity and relapse, increased suicide risk, more functional 
impairment, greater decrements in quality of life, as well as an increased 
likelihood of psychiatric hospitalization compared with patients with either 
disorder alone 
79-83
. A similar picture of increased burden emerges from 
research examining the impact of comorbidity of depression with chronic 
somatic illnesses. The course of major depression tends to be more protracted 
in the context of somatic illness 
84
. Moreover, a considerable body of evidence 
points to the adverse impact of comorbid depression in patients with chronic 
somatic illness
 57; 85
. In general, the presence of major depression and 
depressive symptoms in chronically ill patients have both been found to be 
associated with increased somatic symptom burden, additive functional 
impairment, greater loss of quality of life and decreased adherence to self-
care and treatment regimens 
67; 86-88
. Also, both major depression and 
depressive symptoms have been suggested to increase the risk of death from 
somatic conditions such as coronary heart disease and diabetes mellitus 
89-91
. 
Furthermore, comorbid depression has been associated with increased health 
care utilization and increased absence from work among chronically ill patients 
67; 92-96
. Given these observations it is not surprising that studies have found 
major depression and subthreshold depression both to be associated with 
markedly increased health care costs, which cannot be explained by the 
presence of chronic somatic conditions 
32; 97
. 
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1.2 Focus and content of the thesis 
 
Although there exists considerable evidence for its relevance, substantial 
knowledge gaps about comorbidity involving depression remain. This thesis 
addresses two sets of research questions to extend knowledge about the co-
occurrence of depression with other health conditions. The first set of 
questions pertain to the research domain of the occurrence of comorbidity 
involving depression (Part A) and the second set of questions relate to the 
research area of the health care consequences of comorbidity involving 
depression, specifically consequences for quality of care and health care 
utilization (Part B) (see Figure 1).  
 
Study data 
The studies presented in this thesis are mainly based on data collected within 
the framework of the second Dutch National Survey of General Practice 
(DNSGP-2) 
98-99
 and the National Information Network of General Practice 
(LINH) (www.linh.nl). LINH was established in 1992 and its database holds 
longitudinal data on morbidity, prescribing and referrals from a large, 
representative network of general practices located throughout the 
Netherlands. Data are extracted twice a year from the electronic medical 
records systems used by the GPs to record and store information about their 
patients. Morbidity data concern diagnoses made by GPs during consultations 
with patients as well as those made by other health care professionals after 
referral, coded by GPs according to the International Classification of Primary 
Care (ICPC-1) 
3. The LINH network served as the „backbone‟ of the DNSGP-2 
which was largely carried out in 2001. During the study period of the DNSGP-2, 
LINH data collection was temporarily expanded to include, among others, a 
socio-demographic census of the total population of approximately 385,000 
patients registered with the 104 participating practices (response rate: 77%) 
and the administration of a structured psychiatric diagnostic interview, the 
Composite International Diagnostic Interview (CIDI) 
100
, to a sample of about 
800 patients from this population (selected by a two-stage sampling 
procedure).  
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Part A. Studies on occurrence: research questions addressed 
While the occurrence of psychiatric comorbidity in depression has been well-
studied in general population samples 
39; 68-69; 73
, few large-scale population-
based studies have examined the pattern of somatic comorbidity in depression. 
Especially, the identification of chronic somatic illnesses that occur at a rate 
that exceeds chance, i.e. somatic cluster comorbities, has not often been a 
topic of research. As pointed out above, ascertaining somatic cluster 
comorbidity is relevant for clinical practice, health service planning, and 
generating hypotheses about the aetiology of comorbid relationships between 
depression and chronic somatic illnesses. It is essential to study cluster 
comorbidity in a heterogeneous population to avoid bias producing “spurious” 
cluster comorbidity 
101
. Dutch general practice provides a good opportunity to 
study the pattern of somatic cluster comorbidity in a largely unselected 
sample of depressed persons. Almost all Dutch noninstitutionalized citizens are 
registered with a GP. Moreover, in the Netherlands, GPs act as a gatekeeper to 
other health care facilities. After referral, specialists report back results to the 
patient‟s GP. GPs have therefore comprehensive knowledge about the health 
status of their patients. Chapter 2 reports on a large cross-sectional study that 
uses GPs‟ records of morbidity to answer the following research question: 
 What are the patterns of somatic and psychiatric cluster comorbidity 
 in depression, stroke, multiple sclerosis, Parkinson’s disease/ 
 parkinsonism, dementia, migraine and epilepsy?  
 
Merely determining with which chronic somatic conditions depression tends to 
co-occur at a rate that is higher than expected is valuable but not sufficient. 
Information on the temporal order of the relationship between depression and 
a chronic somatic illness is a critical indicator of possible underlying causal 
mechanisms 
57
. Causal processes that may operate include depression being a 
contributing factor to the development of the somatic illness or, conversely, 
the somatic illness being causative of or contributing to the development of 
depression 
67
. In the former case, the onset of depression generally tends to 
precede the onset of the somatic illness, while in the latter case the 
development of depression will generally occur after the onset the somatic 
disease. A theory on the causal role of somatic illness in the development of 
depression that has received considerable attention in the last decade is the 
“vascular depression hypothesis”, which postulates that cerebrovascular 
Chapter 1 
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disease may cause or exacerbate depression with late onset in life 
102-103
. 
Evidence supporting this hypothesis may derive from longitudinal 
epidemiological studies that demonstrate an association between established 
risk factors for cerebrovascular disease, such as hypertension, diabetes 
mellitus and heart disease, and the subsequent development of depression. 
The premise is that the increase in prevalence of cerebrovascular risk factors 
(CVRFs) with age contributes over time to the development of small-vessel 
brain disease, which, in turn, disrupts neurobiological functioning resulting in 
depression 
104-105
. Longitudinal research on the relationship between CVRFs and 
late-life depression is scarce, however. Chapter 3 contains a case-control 
study that further tests the vascular depression hypothesis by addressing the 
following research question: 
 Is there a relationship between cerebrovascular risk factors 
 (CVRFs) and the subsequent development of depression in older 
 general practice patients?  
 
Part A finishes with a systematic review. It is important to determine whether 
the occurrence of comorbid depression in the context of a certain index 
condition varies depending on sociodemographic and clinical variables. In this 
way, subgroups of patients with the index disease under study can be 
identified who are at greatest risk for comorbid depression. Such information 
may improve the quality of care by means of earlier diagnosis and treatment of 
comorbid depression. It could also serve as an indicator of treatment need 
which is relevant to the planning and organisation of health care services and 
give clues to the underlying mechanisms of the comorbid relationship. In 
general, however, there exist critical gaps in this type of knowledge 
85
. An 
example concerns the correlates of comorbid depression in Alzheimer‟s disease 
(AD). Although it is well-known that depression occurs frequently in patients 
with AD 
106
, it remains unclear whether the prevalence of comorbid depression 
increases, decreases or remains stable with increasing severity of AD 
107
. This 
lack of clarity is not caused by a lack of research. On the contrary, various, 
mainly cross-sectional, studies have reported on this relationship, but their  
results are equivocal. Chapter 4 describes a systematic review of these cross- 
sectional studies to address the following research question: 
Is there a relationship between severity of AD and prevalence of 
comorbid depressive symptoms and depression? 
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Part B. Studies on health care consequences: research questions addressed 
 
Consequences for quality of care 
The focus is laid on the influence of the presence of other health conditions on 
the diagnosis and management of depression in Dutch general practice. In the 
Netherlands, like various other countries, GPs have an important position in 
the care for persons with depression 
108-109
. The majority of depressed persons 
first consult their GP. Moreover, after being diagnosed as depressed, many will 
be managed exclusively in general practice, with only a minority being 
referred to mental health services 
110-111
.  
 
It is well-established that a substantial proportion of persons with depression 
are not diagnosed as such by their GP
 112-113
. A variety of factors have been 
found or hypothesized to influence diagnosis of depression in the primary care 
setting, among which are the presence of comorbid somatic and psychiatric 
disorders. Studies have suggested that being chronic somatically ill increases 
the risk of not being diagnosed as depressed. Other studies indicate that the 
presence of co-existent anxiety exerts an opposite effect and facilitates 
diagnosis of depression. However, research carried out so far investigated the 
effects of somatic and psychiatric comorbidity on depression diagnosis 
separately and did not address their combined effect, despite the fact that a 
considerable proportion of primary care patients have both types of 
comorbidity
 71
. Therefore, the study described in chapter 5 attemps to answer 
the following research question: 
 Is there an interaction effect between psychiatric and chronic 
 somatic comorbidity on diagnosis of depression by GPs? 
 
As in GPs‟ diagnosis of depression, there appears to be room for improvement 
in the adequacy of management of depression by GPs. That is, available 
evidence points to suboptimal management of depression in the primary care 
setting, meaning that too often either no treatment is initiated at all or that 
treatment provided is inadequate (e.g. because of insufficient dosing and/or 
duration of antidepressant therapy) 
113-115
. Whether this less-than-optimal 
management of depression is associated with the presence of specific chronic 
somatic illnesses has only been scarcely studied. Most primary-care based 
studies used a composite measure of chronic somatic morbidity. In chapter 6 a 
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prospective study is presented in which two research questions are being 
addressed: 
 What is the influence of specific chronic somatic conditions on the 
 initiation of any depression care in patients newly diagnosed with 
 depression by their GP?; and  
 Among those being prescribed antidepressants by their GP, what is 
 the influence of these conditions on prescription of continuous 
 antidepressant treatment?  
 
Consequences for health care utilization 
Comorbid depression among somatically ill patients is associated with a higher 
use of both outpatient and inpatient general (i.e. somatic) health care services 
67; 92-95
. There is, however, a notable lack of data on the potential influence of 
time of onset of depression on this relationship. For instance, in prospective 
studies of the association between comorbid depression and health care use of 
patients admitted to hospital for somatic illness, presence of depression was 
usually assessed in the first week of admission to a hospital 
93
. It remains 
unclear from these studies which proportion of patients were already 
depressed at the time of onset of (the complications of) their somatic illness 
leading to hospital admission and which proportion developed their depression 
afterwards, and whether this characteristic influences health care utilization. 
Knowledge on the potential role of time of onset of depression is relevant 
because it could point to possible mechanisms that underlie the increased 
health care use among hospitalized patients with comorbid depression, which 
may subsequently help to develop intervention strategies to reduce their use 
of health care services. Chapter 7 presents a study that focuses on patients 
who are already depressed when admitted to a hospital for stroke. Although 
the influence of comorbid depression on the health care use of patients 
hospitalized due to stroke has received some attention 
116-117
, no study to date  
has focused specifically on patients with pre-existing depression. The following 
research question is addressed:  
 What is the impact of having pre-existing depression at hospital 
 admission for stroke on the length of acute hospital stay and 
 discharge destination?  
This opportunity became available by linking data from the LINH database with 
data from a national longitudinal hospital database, the National Medical 
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Register (www.prismant.nl ). 
 
The final chapter, chapter 8, summarizes the study findings, and reflects on 
their relevance for further research and clinical practice, while considering the 
strengths and weaknesses of the studies. 
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Abstract 
 
Background and objective: To comprehensively examine comorbidity in 
unselected cohorts of patients with depression, stroke, multiple sclerosis (MS), 
Parkinson‟s disease/parkinsonism (PD/PKM), dementia, migraine, and epilepsy. 
Methods: This cross-sectional study used morbidity data recorded by Dutch 
general practitioners. Index disease cohort sizes ranged from 241 patients with 
MS to 6,641 patients with lifetime depression. Thirty somatic and seven 
psychiatric disease categories were examined to determine whether they were 
comorbid with the index diseases by performing comparisons with age- and 
gender-matched control cohorts. Identified comorbidities were classified as 
either „„possible‟‟ or „„highly probable‟‟ comorbidity. 
Results: An extensive range of 26 disease categories was found to be comorbid 
with lifetime depression. The comorbidity profile of stroke was also wide, 
including 21 disease categories. The comorbidity patterns of migraine and 
epilepsy comprised each 11 disease categories. Those concerning MS, PD/PKM, 
and dementia included a small number of disease categories. 
Conclusion: This study provides comprehensive knowledge of the occurrence 
of somatic and psychiatric comorbidity in general populations of patients with 
depression, stroke, MS, PD/PKM, dementia, migraine, and epilepsy. The 
implications of the findings for clinical practice and research are discussed. 
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2.1 Introduction 
 
Comorbidity, defined as any additional coexistent condition in a patient with a 
particular index disease 
1
, has been shown to be a common phenomenon, 
especially in the older population 
2-3
. The phenomenon of comorbidity is 
relevant because it has in general a negative impact on health outcomes, 
quality of life, and health care use 
4
. Knowledge about the comorbidity of 
major neurologic and psychiatric diseases like stroke, multiple sclerosis (MS), 
Parkinson‟s disease/parkinsonism (PD/PKM), epilepsy, migraine, dementia, and 
depression is limited. For each of these index diseases, relatively few studies 
have examined the occurrence of comorbidities while addressing an extensive 
range of conditions. Most studies have focused on the association between a 
neurologic/psychiatric index disease and one (e.g. stroke-depression 
5
) or a 
restricted set 
6–9 
of conditions. Furthermore, studies have mainly concentrated 
on either somatic 
10–12 
or psychiatric 
13–15 
comorbidity, with only a few 
investigating both types of comorbidity. In addition, most of the studies that 
have comprehensively examined occurrence of somatic or psychiatric 
comorbidity did not use a control group and/or were not population based 
10–26
. 
Including a control group for comparison is essential to identify comorbid 
associations beyond chance. Examining comorbidity in population-based 
samples is important to minimize the effect of referral bias. Generally, 
studying samples from secondary or tertiary care settings will probably bias 
comorbidity findings towards more severe and atypical forms of neurologic and 
psychiatric disease. The present study used general practice data from The 
Netherlands to elaborate on previous studies on comorbidity associated with 
neurologic/psychiatric index diseases. The Dutch general practice setting 
provides a good opportunity to identify comorbidity among a comprehensive 
range of somatic and psychiatric conditions for a heterogeneous cohort of 
patients with a particular index disease. In The Netherlands general 
practitioners (GPs) act as a gatekeeper to health care facilities. Patients visit 
their own GP before possible referral to specialist care. Almost all 
noninstitutionalized Dutch inhabitants are listed to a GP. By being the entry 
point of the Dutch health care system, GPs come across an almost full 
morbidity spectrum. Furthermore, after referral, specialists report back 
results, by which GPs have comprehensive information about a patient‟s health 
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status. Using morbidity information recorded by GPs, this cross-sectional study 
aimed at identifying comorbid disease categories among unselected cohorts of 
patients with seven different neurologic/psychiatric index diseases, namely 
depression, stroke, MS, PD/PKM, dementia, migraine, and epilepsy. These 
index diseases were prioritized in health research in The Netherlands because 
of their high prevalence, high disease burden, and/or high health care burden 
27
. A wide spectrum of somatic and psychiatric disease categories was 
examined. Comorbid disease categories were identified by comparing rates of 
disease categories in patients with a particular neurologic/psychiatric index 
disease with those among matched controls without that index disease. 
 
 
2.2 Methods 
 
Study setting and morbidity data 
The present study utilized morbidity data from a population of 276,921 persons 
registered with 134 GPs who worked in 75 general practices. Data were 
collected within the framework of the second Dutch National Survey of General 
Practice (2001) 
28
. The practice population was representative of the Dutch 
population in terms of age, gender, and type of health insurance. The 
morbidity data were extracted from the electronic medical records systems of 
the participating GPs and comprised: (1) diagnoses made by the GPs during 
contacts with their patients during a 1-year period, and (2) diagnoses recorded 
by the GPs on so-called „„problem lists‟‟ of relevant health problems of 
patients, including relevant past health problems. Diagnoses were coded by 
the GPs according to the International Classification of Primary Care (ICPC) 
29
 
based on the criteria of the International Classification of Health Problems in 
Primary Care 
30
. Different contacts for a same health problem during the 
contact registration were clustered into episodes of disease and a distinction 
was made between newly occurring and ongoing (prevalent) episodes. 
 
Study population 
Seven index disease cohorts of patients diagnosed with depression, stroke, MS, 
PD/PKM, dementia, migraine, and epilepsy, were established on the basis of 
morbidity data from the contact registration and problem lists. Specifically, an 
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index disease cohort consisted of patients who were diagnosed with a 
prevalent episode of that index disease according to the contact registration 
and/or who were diagnosed with that index disease according to the problem 
list. The specific ICPC codes used were: P76 (depression), K90 (stroke), N86 
(MS), N87 (PD/PKM), P70 (dementia), N89 (migraine), and N88 (epilepsy). 
Noteworthy, this „„lifetime‟‟ cohort definition did also include patients who 
were diagnosed with an index disease in the past only. The rationale for using 
a lifetime definition was that for all index diseases, except for depression, the 
cohorts include patients actually suffering from these diseases or its sequelae 
due to their persistent nature. A lifetime definition was also used for 
depression because depression has been found to have a recurrent course in 
the majority of primary care patients 
31
. Nonetheless, a substantial number of 
patients diagnosed with depression in the past only may not suffer from 
recurrent, chronic depression. Therefore, as a sensitivity analysis, we 
examined also comorbidity in a „„current‟‟ depression subcohort consisting of 
patients who were diagnosed with depression during the observation year. A 
total of 13,106 patients were selected, of which 12,422 patients were 
diagnosed with one of the index diseases under study, while 684 patients were 
diagnosed with two (5%) or more (0.2%) index diseases. The latter patients 
were included in two or more different index disease cohorts. The cohort sizes 
ranged from 241 patients with MS to 6,641 patients with lifetime depression. 
Data regarding gender and age were derived from the practice administration. 
For each neurologic/psychiatric index disease cohort, 10 control cohorts were 
randomly selected with replacement from all subjects who were not diagnosed 
with that specific index disease. Each control cohort was frequency- matched 
to the index disease cohort concerned for gender and age distribution 
(categorized into 20 age groups). 
 
Disease categories 
Thirty-seven disease categories were examined to determine whether they 
were comorbid with any of the neurologic/ psychiatric index diseases under 
study, including 30 somatic and seven psychiatric disease categories. The 
disease categories comprised a total of 213 ICPC codes (Appendix). For each 
index disease and control cohort, the occurrence of a disease category was 
determined by identifying the number of cohort members who had been 
diagnosed with (at least one of) the condition(s) included in that disease 
Chapter 2 
 
36 
category according to the contact registration and/or their problem list. 
Diagnoses from the contact registration concerned only prevalent episodes. 
 
Statistical analyses 
For each of the 37 disease categories, multilevel logistic regression analysis 
was carried out to compare the occurrence of the disease category in a cohort 
of neurologic/psychiatric patients with the occurrence among a cohort of  
control subjects. Multilevel analyses were performed because of the two-level 
structure of the data (i.e. practice level and patient level), thus allowing us to 
adjust for variation among general practices (e.g. variation regarding 
registration discipline). In addition, analyses took into account consultation 
with GP during the contact registration year (represented by a dummy 
variable: 0 vs. ≥1 contacts) to control for the opportunity to have a health 
condition diagnosed. As was often the case in the MS cohort and sometimes in 
other index disease cohorts, the number of cases in an index disease cohort 
and/or control cohort with a comorbid condition was too small for meaningful 
analysis. In these cases and when appropriate, a multilevel regression analysis 
without the covariate GP contact was carried out. Analyses were performed 
using the MLwiN software version 2.0. Statistical significance was accepted at 
the 5% level. Each analysis was repeated 10 times, each time using a different 
control cohort. In this way, the consistency of the outcomes resulting from 
using 10 different, randomly sampled control cohorts could be examined, 
thereby avoiding coincidental findings resulting from accidental abnormal 
characteristics of a control group. The choice of ten sampled control groups 
was based on other methods that try to control for random error using 
different samples, like multiple imputation 
32,33
. Associations between a 
neurologic/ psychiatric index disease and a disease category for which at least 
6 out of the 10 comparisons resulted in a statistically significant odds ratio 
(OR) were considered to indicate comorbidity. Identified comorbidities were 
classified as either highly probable comorbidity (i.e. 9 or 10 significant ORs) or 
possible comorbidity (i.e. 6 to 8 significant ORs). It should be noted that also 
statistically lower than expected prevalences of disease categories among 
patients with a particular index disease could be identified. For convenience, 
such inverse associations between an index disease and disease category were 
also termed comorbidity. To present the results in a convenient manner, an 
estimation of the average OR was calculated for each association between an 
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index disease and disease category: 
 
 
 
 
 
where βi are the regression coefficients resulting from the 10 index disease 
cohort–control cohort comparisons. In addition, an estimated 95% confidence 
interval (CI) of the average OR was calculated using an estimated average 
standard error (SE): 
 
 
 
 
 
where SEi are the SEs resulting from the 10 index disease cohort–control cohort 
comparisons. 
Noteworthy, the pooling of the individual SEs in this way is conservative, 
meaning that the estimated CIs are wider than would be the case when the 
„„true‟‟ value of the SE of the average OR is used. 
 
 
2.3 Results 
 
Table 1 presents age, gender, and GP contact characteristics of the seven 
neurologic/psychiatric index disease cohorts. Restricting the depression cohort 
to patients with current depression (n = 3,617) did not change mean age (50.6 
years; SD = 16.7 years) and slightly increased the proportion of women (69.4%). 
Also illustrated are the rates of disease categories in the different index 
disease cohorts. Table 2 shows the associations between each of the index 
diseases and the various disease categories resulting from the comparisons 
between index disease cohorts and control cohorts. Associations presented in 
bold are instances of highly probable comorbidity, and those presented in bold 
italic are instances of possible comorbidity. The associations are presented as 
estimated average ORs (hereafter referred to as ORs) with estimated 95% CIs. 
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Table 1 
Characteristics of the seven neurological/psychiatric index disease cohorts. Presented are numbers (percentages)  
 Lifetime 
depression 
cohort 
(n  = 6,641) 
 
Stroke 
cohort 
(n  = 1,701) 
 
MS 
cohort 
(n  = 241) 
Gender 
 Male 
 Female 
 
2189 (33.0) 
4452 (67.0) 
 
850 (50.0) 
851 (50.0) 
 
73 (30.3) 
168 (69.7) 
Mean age (SD) in years 50.7 (16.5) 69.4 (13.9)  49.1 (12.7) 
GP contactsa 
 0 
 ≥1 
 
380 (5.7) 
6261 (94.3) 
 
142 (8.3) 
1559 (91.7) 
 
24 (10.0)  
217 (90.0) 
Disease category (n = 37)    
 Somatic     
  Congenital 74 (1.1) 28 (1.6) 0 (0.0) 
  Allergy/allergic reaction 420 (6.3) 45 (2.6) 12 (5.0) 
  Anemia 180 (2.7) 75 (4.4) 3 (1.2) 
  Gastrointestinal 965 (14.5) 267 (15.7) 15 (6.2) 
  Liver/gall 155 (2.3) 89 (5.2) 7 (2.9) 
  Eye 337 (5.1) 216 (12.7) 8 (3.3) 
  Ear 269 (4.1) 133 (7.8) 4 (1.7) 
  Ischemic heart 411 (6.2) 376 (22.1) 2 (0.8) 
  Nonischemic heart 214 (3.2) 221 (13.0) 2 (0.8) 
  Blood pressure 1055 (15.9) 755 (44.4) 24 (10.0) 
  Stroke 149 (2.2) 1701 (100.0) 1 (0.4) 
  TIA 62 (0.9) 120 (7.1) 0 (0.0) 
  Other vascular 450 (6.8) 261 (15.3) 12 (5.0) 
  Musculoskeletal 1321 (19.9) 418 (24.6) 25 (10.4) 
  MS 12 (0.2) 1 (0.1) 241 (100.0) 
  PD/PKM 36 (0.5) 29 (1.7) 0 (0.0) 
  Epilepsy 50 (0.8) 55 (3.2) 3 (1.2) 
  Migraine 242 (3.6) 11 (0.6) 4 (1.7) 
  Other neurological 177 (2.7) 77 (4.5) 8 (3.3)  
  Respiratory 737 (11.1) 211 (12.4) 8 (3.3) 
  Skin/subcutis 798 (12.0) 213 (12.5) 25 (10.4) 
  Thyroid 271 (4.1) 76 (4.5) 4 (1.7) 
  Diabetes mellitus 422 (6.4) 337 (19.8) 4 (1.7) 
  Obesity/lipid metabolism 541 (8.1) 267 (15.7) 11 (4.6) 
  Kidney 177 (2.7) 72 (4.2) 6 (2.5) 
  Female genital 368 (5.5) 66 (3.9) 10 (4.1) 
  Male genital 87 (1.3) 57 (3.4) 3 (1.2) 
  Cancer 300 (4.5) 171 (10.1) 6 (2.5) 
  Neoplasms 313 (4.7) 92 (5.4) 7 (2.9) 
  Other chronic  332 (5.0) 106 (6.2) 9 (3.7) 
 Psychiatric     
  Substance abuse 466 (7.0) 85 (5.0) 6 (2.5) 
  Dementia 44 (0.7) 45 (2.6) 0 (0.0) 
  Schizophrenia/psychotic 136 (2.0) 15 (0.9) 2.3.1 1 (0.4) 
  Depression 6641 (100.0) 150 (8.8) 12 (5.0) 
  Anxiety 294 (4.4) 27 (1.6) 3 (1.2) 
  Other mental 348 (5.2) 21 (1.2) 4 (1.7) 
  Mental retardation 12 (0.2) 7 (0.4) 0 (0.0) 
MS, multiple sclerosis; PD/PKM, Parkinson‟s disease/ parkinsonism; SD, standard deviation; GP, general practitioner;  
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unless stated otherwise 
 
PD/PKM 
cohort 
(n  = 376) 
 
Dementia 
cohort 
(n  = 528) 
 
Migraine 
cohort 
(n  = 3,067) 
 
Epilepsy 
cohort 
(n  = 1,259) 
 
180 (47.9) 
196 (52.1) 
 
176 (33.3) 
352 (66.7) 
 
654 (21.3) 
2413 (78.7) 
 
622 (49.4) 
637 (50.6) 
73.7 (10.5) 80.8 (7.9) 43.4 (14.9) 42.3 (21.0) 
 
36 (9.6) 
340 (90.4) 
 
78 (14.8) 
450 (85.2) 
 
215 (7.0) 
2852 (93.0) 
 
166 (13.2) 
1093 (86.8) 
    
    
2 (0.5) 4 (0.8) 37 (1.2) 46 (3.7) 
9 (2.4) 10 (1.9) 257 (8.4) 76 (6.0) 
16 (4.3) 29 (5.5) 48 (1.6) 30 (2.4) 
56 (14.9) 59 (11.2) 334 (10.9) 106 (8.4) 
15 (4.0) 22 (4.2) 43 (1.4) 17 (1.4) 
39 (10.4) 62 (11.7) 79 (2.6) 56 (4.4) 
37 (9.8) 62 (11.7) 77 (2.5) 46 (3.7) 
58 (15.4) 106 (20.1) 59 (1.9) 59 (4.7) 
36 (9.6) 56 (10.6) 60 (2.0) 49 (3.9) 
89 (23.7) 132 (25.0) 322 (10.5) 125 (9.9) 
29 (7.7) 44 (8.3) 12 (0.4) 56 (4.4) 
13 (3.5) 26 (4.9) 11 (0.4) 14 (1.1) 
39 (10.4) 55 (10.4) 148 (4.8) 61 (4.8) 
86 (22.9) 123 (23.3) 475 (15.5) 158 (12.5) 
0 (0.0) 0 (0.0) 4 (0.1) 3 (0.2) 
376 (100.0) 22 (4.2) 2 (0.1) 5 (0.4) 
5 (1.3) 7 (1.3) 21 (0.7) 1259 (100.0) 
2 (0.5) 0 (0.0) 3067 (100.0) 21 (1.7) 
11 (2.9) 9 (1.7) 79 (2.6) 62 (4.9) 
43 (11.4) 58 (11.0) 230 (7.5) 105 (8.3) 
54 (14.4) 57 (10.8) 356 (11.6) 131 (10.4) 
21 (5.6) 22 (4.2) 83 (2.7) 34 (2.7) 
46 (12.2) 87 (16.5) 56 (1.8) 51 (4.1) 
29 (7.7) 31 (5.9) 168 (5.5) 85 (6.8) 
11 (2.9) 19 (3.6) 40 (1.3) 23 (1.8) 
13 (3.5) 20 (3.8) 156 (5.1) 29 (2.3) 
14 (3.7) 13 (2.5) 17 (0.6) 14 (1.1) 
32 (8.5) 54 (10.2) 87 (2.8) 49 (3.9) 
12 (3.2) 15 (2.8) 136 (4.4) 55 (4.4) 
27 (7.2) 25 (4.7) 70 (2.3) 58 (4.6) 
    
6 (1.6) 9 (1.7) 83 (2.7) 48 (3.8) 
22 (5.9) 528 (100.0) 0 (0.0) 8 (0.6) 
12 (3.2) 13 (2.5) 10 (0.3) 20 (1.6) 
37 (9.8) 47 (8.9) 244 (8.0) 51 (4.1) 
7 (1.9) 10 (1.9) 71 (2.3) 19 (1.5) 
6 (1.6) 6 (1.1) 96 (3.1) 18 (1.4) 
1 (0.3) 1 (0.4) 1 (0.4) 58 (4.6) 
TIA, transient ischemic attack. a Consultation with GP during the one-year contact registration.  
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Table 2 
Associations between the seven neurological/psychiatric index diseases and disease categories. Associations  
Disease category (n = 37) 
Lifetime 
depression 
 
Stroke 
 
MS 
   Somatic  OR (95% CI) OR (95% CI) OR (95% CI) 
   Congenital 1.21 (0.82-1.78) 2.59 (1.25-5.37) - 
   Allergy/allergic reaction 1.22 (1.03-1.44) a 1.02 (0.66-1.59) - 
   Anemia 1.55 (1.19-2.02) a 1.70 (1.15-2.53)  - 
   Gastrointestinal 1.77 (1.56-2.01) 1.34 (1.07-1.66) 0.80 (0.39-1.64) 
   Liver/gall 1.41 (1.06-1.87) a 1.91 (1.25-2.92) 3.50 (1.78-6.91) b 
   Eye 1.41 (1.15-1.72) a 1.55 (1.20-2.01) 2.05 (1.00-4.22) 
   Ear 1.44 (1.16-1.79) 1.16 (0.87-1.56) 1.16 (0.48-2.80) b 
   Ischemic heart 1.22 (1.04-1.44) a 1.67 (1.38-2.03) 0.25 (0.07-0.91) b 
   Nonischemic heart 1.11 (0.89-1.39) 2.17 (1.68-2.81) - 
   Blood pressure 1.03 (0.93-1.14) 2.39 (2.05-2.79) 0.95 (0.52-1.73) b 
   Stroke 1.96 (1.45-2.65) X - 
   TIA 1.30 (0.83-2.05) 3.50 (2.28-5.37) 2.3.2 - 
   Other vascular 1.28 (1.09-1.52) a 1.97 (1.54-2.51) 1.80 (0.92-3.54) b 
   Musculoskeletal 1.31 (1.18-1.45) 1.07 (0.89-1.28) 0.76 (0.41-1.44) 
   MS 1.24 (0.68-2.28) b - X 
   PD/PKM 2.48 (1.24-4.96) 2.54 (1.26-5.12) 2.3.3 - 
   Epilepsy 1.30 (0.83-2.05)  8.41 (3.66-19.34) - 
   Migraine 1.81 (1.44-2.29) a 0.73 (0.39-1.36) 0.81 (0.30-2.16) b 
   Other neurological 1.67 (1.27-2.19) 1.96 (1.26-3.07) - 
   Respiratory 1.46 (1.27-1.67) 1.09 (0.87-1.36) 0.61 (0.26-1.45) b 
   Skin/subcutis 1.30 (1.14-1.47) 1.25 (0.99-1.57) 1.28 (0.69-2.38) b 
   Thyroid 1.50 (1.22-1.86) a 1.43 (0.99-2.07) 0.78 (0.31-1.92) b 
   Diabetes mellitus 1.03 (0.88-1.20) 2.05 (1.68-2.51) 0.29 (0.13-0.66) b 
   Obesity/lipid metabolism 1.36 (1.17-1.59) 2.23 (1.74-2.86) 1.03 (0.56-1.91) b 
   Kidney 1.63 (1.22-2.17) a 1.76 (1.13-2.73) - 
   Female genital 1.41 (1.15-1.71) a 1.04 (0.69-1.57) 1.54 (0.91-2.62) b 
   Male genital 2.03 (1.34-3.06) a 1.24 (0.80-1.93)  - 
   Cancer 1.16 (0.96-1.40)  1.26 (0.98-1.63) 0.99 (0.41-2.38) b 
   Neoplasms 1.24 (1.01-1.51) 1.56 (1.05-2.30) 0.92 (0.49-1.71) b 
   Other chronic 1.47 (1.17-1.85) a 1.69 (1.17-2.44) 3.93 (1.64-9.39) b 
 
   Psychiatric  
   
   Substance abuse 2.78 (2.26-3.42) 1.97 (1.33-2.90) 0.62 (0.36-1.09) b 
   Dementia 2.24 (1.25-4.03) 2.00 (1.16-3.44) 2.3.4 - 
   Schizophrenia/psychotic 4.07 (2.68-6.19) 1.74 (0.94-3.24) 2.3.5 - 
   Depression X 2.39 (1.74-3.26) 1.46 (0.79-2.69) b 
   Anxiety 3.57 (2.73-4.68) 1.75 (0.94-3.24) - 
   Other mental 3.46 (2.65-4.51) 1.06 (0.66-1.69) - 
   Mental retardation 1.43 (0.82-2.49) b - 2.3.6 - 
Presented ORs and CIs are estimates (see text for the formulas used to calculate these). Empty cells refer to  
PD/PKM, Parkinson‟s disease/ parkinsonism; OR, odds ratio; CI, confidence interval; TIA, transient ischemic attack. 
a Disease categories not comorbid with current depression.   
b Model without the covariate consultation with general practitioner.  
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identified as comorbidity are presented in bold (highly probably comorbidity) or bold italic (possible comorbidity) 
 
PD/PKM 
 
Dementia 
 
Migraine 
 
Epilepsy 
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
- - 1.33 (0.77-2.28) 3.09 (1.63-5.85) 
1.15 (0.50-2.64) - 1.51 (1.21-1.88) 1.38 (0.95-2.01) 
1.17 (0.58-2.35) b 1.27 (0.71-2.27) 1.11 (0.71-1.74) 2.29 (1.17-4.51)  
1.45 (0.92-2.28) 0.93 (0.62-1.40) 1.68 (1.38-2.06) 1.19 (0.86-1.64) 
1.39 (0.80-2.40) b 1.25 (0.77-2.01) 1.15 (0.70-1.88) 1.12 (0.68-1.85) 
1.02 (0.61-1.72) 1.02 (0.67-1.56) 1.21 (0.84-1.75) 1.56 (0.98-2.48) 
1.34 (0.78-2.30) 1.47 (0.95-2.26) 1.47 (0.98-2.19) 1.61 (0.94-2.75) 
0.92 (0.61-1.39) 1.10 (0.79-1.52) 0.81 (0.55-1.18) 1.08 (0.72-1.61) 
1.09 (0.65-1.83) 1.13 (0.74-1.72) 1.22 (0.80-1.85) 1.76 (1.06-2.93)  
0.74 (0.53-1.05) 0.78 (0.59-1.03) 1.05 (0.88-1.25) 0.94 (0.71-1.23) 
3.55 (1.60-7.87) 2.03 (1.16-3.55)  0.72 (0.35-1.48) 5.84 (2.89-11.79) 
1.62 (0.79-3.31) b 1.76 (0.89-3.48) 1.27 (0.72-2.22) b - 
1.23 (0.73-2.06) 1.25 (0.80-1.96) 1.24 (0.94-1.63) 1.23 (0.81-1.87) 
1.08 (0.75-1.55) 1.01 (0.75-1.37) 1.32 (1.12-1.56) 1.07 (0.82-1.39) 
2.3.7 - 2.3.8 - - - 
X 3.84 (1.95-7.55) - - 
- 2.41 (0.91-6.38) b 1.39 (0.76-2.54) b X 
- 2.3.9 - X 1.41 (0.73-2.72) b 
1.16 (0.67-2.02) - 1.94 (1.28-2.94) 4.65 (2.33-9.29) 
0.91 (0.57-1.44) 1.12 (0.74-1.69) 1.20 (0.96-1.49) 1.15 (0.84-1.56) 
1.64 (1.02-2.62) 1.05 (0.69-1.59) 1.26 (1.05-1.51) 1.17 (0.88-1.55) 
1.84 (0.93-3.63) 1.03 (0.55-1.95) 1.17 (0.82-1.66) 1.60 (0.90-2.86) 
0.93 (0.60-1.44) 1.29 (0.92-1.82) 0.50 (0.36-0.70) 0.94 (0.63-1.42) 
1.03 (0.57-1.85) 1.25 (0.71-2.21) 1.22 (0.95-1.58) 1.41 (0.97-2.03)  
0.88 (0.45-1.71) 1.50 (0.85-2.65) b 1.34 (0.79-2.29) 1.28 (0.78-2.10)  
0.88 (0.51-1.52) 0.96 (0.55-1.69) 1.51 (1.14-2.01) 1.01 (0.59-1.74) 
1.52 (0.85-2.72) 0.97 (0.56-1.67) b 1.89 (1.04-3.42) b 1.55 (0.69-3.50) b 
0.93 (0.55-1.57) 1.14 (0.74-1.74) 1.16 (0.83-1.62) 1.64 (1.01-2.67)  
0.94 (0.55-1.61) b 0.94 (0.56-1.57) 1.50 (1.11-2.01) 2.04 (1.25-3.32) 
1.74 (0.90-3.37) 0.77 (0.45-1.30) 1.23 (0.83-1.81) 2.13 (1.30-3.50) 
 
 
 
  
0.85 (0.50-1.44) b 0.91 (0.55-1.52) b 0.86 (0.62-1.20) 1.56 (1.01-2.40)  
3.46 (1.40-8.53) X 2.3.10 - - 
- 3.52 (1.25-9.86)  0.56 (0.30-1.06) b 4.53 (1.45-14.17) 
2.98 (1.52-5.87) 2.29 (1.34-3.92) 1.85 (1.46-2.35) 1.34 (0.86-2.11) 
- 2.25 (1.20-4.23) b 1.59 (1.05-2.41) 1.64 (0.89-3.04) b 
2.21 (1.19-4.10)  1.79 (0.78-4.11) b 2.00 (1.37-2.91) 1.16 (0.65-2.07) b 
- - - - 
associations that could not be meaningfully analyzed due to a low number of cases. MS, multiple sclerosis; 
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Comorbidity in the index disease cohorts 
 
Depression 
For lifetime depression, an extensive range of 26 comorbid somatic and 
psychiatric disease categories was identified, of which 22 were classified as 
highly probable comorbidities and three as possible comorbidities. In most 
cases, ORs for the somatic comorbidities (range: 1.22–2.48) were substantially 
lower than those concerning psychiatric comorbidities (range: 2.24–4.07). The 
five highest ORs were found for schizophrenia/other psychotic disorders, 
anxiety disorders, other mental disorders, substance abuse, and PD/PKM. 
Fourteen disease categories were found to be comorbid with current 
depression, with nine classified as highly probable and five as possible 
comorbidities. Compared to the results using lifetime depression, 12 somatic 
disease categories were no longer identified as comorbidity (see Table 2, 
second column). The ORs concerning the vast majority of these categories 
decreased minimally (between 0.00–0.23), with only those regarding migraine 
(0.46) and male genital conditions decreasing to a larger extent (0.55). No 
disease category was found to be comorbid with current depression that was 
not also comorbid with lifetime depression. Also, the five comorbidities most 
strongly associated with current depression were the same as when examining 
lifetime depression. 
 
Stroke 
A broad range of 21 somatic and psychiatric disease categories was identified 
as being comorbid with stroke, with 16 categories being classified as highly 
probable comorbidities and five as possible comorbidities. The OR of the 
majority of the comorbidities was around 2.0, while the Ors concerning the 
associations between stroke and transient ischemic attack (TIA), and especially 
between stroke and epilepsy, was markedly higher. The five comorbidities with 
the highest ORs were epilepsy, TIA, congenital abnormalities, PD/PKM, and 
blood pressure problems. 
 
MS 
Three disease categories were found to be comorbid with MS, with liver/gall 
diseases classified as highly probable comorbidity and other chronic diseases 
and diabetes mellitus as possible comorbidities. Although the former two 
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disease categories were positively associated with MS, there was an inverse 
relationship between MS and diabetes mellitus. Further explorative analysis 
(data not shown) suggested that the relatively strong comorbid association of 
MS with the unspecific category other chronic diseases (i.e. OR = 3.93) was 
mainly determined by the relatively high frequency of vitamin deficiency (code 
T91) among patients with MS compared to control subjects without MS. 
Psychiatric comorbidity in the cohort of patients with MS could not be 
comprehensively examined due to too few cases regarding several  sychiatric 
disease categories. 
 
PD/PKM 
PD/PKM was found to be comorbid with four disease categories, of which 
stroke, dementia, and depression were classified as highly probable 
comorbidities and other mental disorders as possible comorbidity. The ORs of 
the comorbidities were relatively high (range: 2.21–3.55) and three of the four 
concerned psychiatric disease categories. Statistical analysis of the association 
between PD/PKM and schizophrenia/other psychotic disorders was precluded 
because of very few cases in the control groups. However, inspection of the 
frequency distributions strongly suggested a comorbid relationship (i.e. 12 
patients with PD/PKM had schizophrenia/other psychotic disorders vs. on 
average 1.2 control subjects without PD/PKM). 
 
Dementia 
Five disease categories were identified as being comorbid with dementia, of 
which PD/PKM and depression were classified as highly probable  
comorbidities, and stroke, schizophrenia/other psychotic disorders and anxiety 
disorders as possible comorbidities. The ORs of the comorbidities were 
relatively high (range: 2.03–3.84). 
 
Migraine 
Eleven comorbid disease categories were found for migraine, with eight 
classified as highly probable comorbidities and three as possible comorbidities. 
All these categories were positively associated with migraine, except for 
diabetes mellitus, which was found to be inversely related to migraine. When 
only the positive associations were taken into account, it is apparent that the 
ORs were relatively low (range: 1.26–2.00). The five comorbidities most 
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strongly positively associated with migraine were a mixture of somatic and 
psychiatric disease categories: other mental disorders, other neurologic 
disorders, depression, gastrointestinal disorders, and anxiety disorders. 
 
Epilepsy 
Eleven disease categories were identified as comorbidities of epilepsy, with six 
classified as highly probable comorbidities and five as possible comorbidities. 
The five comorbidities most strongly associated with epilepsy were stroke, 
other neurologic disorders, schizophrenia/other psychotic disorders, congenital 
abnormalities, and anemia. The ORs of the other comorbidities varied between 
1.41 and 2.13. The association between epilepsy and mental retardation could 
not be analyzed due to very few cases in the control groups. However, 
inspection of frequency distributions strongly indicated a comorbid association 
(i.e. 58 patients with epilepsy had mental retardation vs. on average 1.3 
control subjects without epilepsy). Further explorative analysis (data not 
shown) did suggest that the relatively high occurrences of carpal tunnel 
syndrome (code N93) and other diseases of the central nervous system (code 
N99) among patients with epilepsy in comparison with nonepileptic control 
subjects underlied the relatively strong comorbid association between epilepsy 
and the unspecific category other neurologic diseases (i.e. OR = 4.65). 
 
 
2.4 Discussion 
 
Strengths and weaknesses of the study 
 
Before discussing the results in more detail, strengths and weaknesses of this 
study need to be noted. A first strength is that comorbidity was examined in 
largely unselected, heterogeneous cohorts of neurologic/psychiatric patients. 
Second, a comprehensive range of potential comorbid somatic and psychiatric 
disease categories was investigated. Third, by repeating each analysis 10 times 
with different control groups, the consistency of results could be determined, 
thereby reducing the chance that coincidental comorbidities were identified. A 
final strength was that most analyses (except those regarding the MS cohort) 
took into account whether or not subjects had consulted their GP during the 
contact registration year. In this manner analyses controlled for possible 
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confounding effects of differences between patients and controls regarding the 
chance of having a health condition diagnosed. A weakness of this study 
concerns the adequacy of the GP diagnoses of the neurologic/psychiatric index 
diseases. Because all these diseases have a major impact on quality of life, a 
high rate of underdiagnosis is not expected. Furthermore, diagnoses will in 
most cases be confirmed by a specialist, except for diagnoses of depression 
and migraine, which are exclusively made by GPs in many patients. However, 
contrary to the expectation of low misclassification, studies have suggested 
considerable underdiagnosis of depression 
34
, dementia 
35
, and migraine 
36
, and 
significant overdiagnosis of stroke 
37
, PD/PKM 
38
, and epilepsy 
39
 in primary care 
settings. If underdiagnosis and overdiagnosis played a part in the results 
reported here, both sources of bias would have reduced the chances of finding 
significant associations between a particular index disease and disease 
category, either by confounding an index disease cohort with subjects who do 
not actually have an index condition (overdiagnosis) or by confounding a 
control cohort with subjects who actually have an index condition 
(underdiagnosis). A second weakness is that because of the cross-sectional 
design and the lack of onset data nothing can be said about the temporal 
association between a particular index disease and a comorbid disease 
category. Third, some disease categories under study were relatively broad 
and heterogeneous, which has the disadvantage that, on the one hand, „„true‟‟ 
comorbid associations might have been masked, and that, on the other, 
interpretation of observed comorbid associations is sometimes difficult. 
 
Range of comorbidity 
 
Our data showed that, in particular lifetime depression, and to a lesser extent, 
stroke, were associated with an extensive range of somatic and psychiatric 
disease categories. The comorbidity patterns of current depression, migraine, 
and epilepsy were less broad, while those of MS, PD/PKM, and dementia 
included only a small number of disease categories. It is possible that the 
restricted range of comorbidity associated with these latter three index 
diseases was partly due to examining relatively small cohorts, thereby limiting 
statistical power to detect „„true‟‟, but weaker comorbid associations. This 
explanation is in line with the finding that, looking at the positive associations, 
all ORs of the identified comorbidities in the MS, PD/PKM, and dementia 
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cohorts were relatively high (i.e. >2.0), while in the other larger cohorts 
several associations with ORs less than 2.0 were identified as comorbidity. An 
influence of statistical power is also indicated by the finding that, using a 
subset of the cohort of depressed patients, the comorbidity profile of current 
depression comprised considerably less somatic disease categories than the 
broad profile associated with lifetime depression, while at the same time no 
disease category was comorbid with current depression that was not also 
comorbid with lifetime depression. An additional potential explanation for the 
small number of identified comorbidities associated with dementia is that 
patients with dementia underreport symptoms 
3
. Such underreporting could 
have decreased the likelihood of having comorbid illnesses diagnosed in the 
demented patients under study, thereby lowering the opportunity to identify 
comorbidities when making comparisons with controls without dementia. We 
are not aware of other population-based studies including control group 
comparisons that have comprehensively examined comorbidity simultaneously 
in the different neurologic/ psychiatric index diseases. To the best of our 
knowledge, there are only a few population-based controlled studies that have 
focused on some of the index diseases under study, mostly examining the 
range of either somatic or psychiatric comorbidity, and not both types of 
comorbidity. Our finding of a wide spectrum of somatic comorbidity in patients 
with lifetime depression seems to contrast with that from a previous 
population-based study 
40
. Although Moldin et al. 
40
 found rates of all somatic 
conditions under study to be higher in subjects with treated lifetime major 
depression (n = 512) than in those without lifetime major depression, only a 
few associations between major depression and somatic conditions were 
statistically significant. Possibly, this study simply lacked statistical power to 
detect significant associations. Our comorbidity results concerning lifetime and 
current depression are generally in line with those of large population-based 
studies that compared subjects with and without self-reported long-term 
somatic conditions regarding the 12-month prevalence of major depression as 
assessed according to a standardized psychiatric interview 
41-42
. These studies 
found that various chronic medical conditions were associated with an 
increased prevalence of major depression. We found that patients with 
epilepsy had higher risks of a range of somatic disease categories. Other 
general population studies either did not find significant differences between 
patients with epilepsy and control subjects without epilepsy in the occurrences 
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of somatic disorders 
43
, or showed that epileptic patients, compared to 
nonepileptic controls, had increased prevalences of almost all studied broad 
somatic disease categories or specific somatic conditions 
44-45
. The negative 
findings of the former study 
43
 might be due to its investigation of a small and 
selective population, that is, 220 patients with childhood-onset epilepsy. The 
extensive pattern of somatic comorbidity observed in the latter two studies, 
which also used general practice data, might be explained by a possible bias 
towards including more severe epilepsy cases with greater morbidity. That is, 
in contrast to our study, these studies excluded patients who had not 
consulted their GP for epilepsy during the study period, thereby excluding 
patients whose seizures are well controlled. Despite various differences in 
methodology, our findings support earlier population-based controlled studies 
showing a relatively broad range of psychiatric comorbidity among patients 
with lifetime and current depression 
46
, dementia 
47
, and migraine 
48-49
. No 
broad range of psychiatric comorbidity was observed in our cohort of patients 
with epilepsy, a finding that differs from a previous general population study 
observing higher risks of a wide range psychiatric disorders in epilepsy 
patients
45
. Although, as stated above, in this study there might have been a 
bias towards patients with more severe epilepsy. 
 
Specific comorbidity 
 
Apart from differing in range, the comorbidity profiles observed in the 
different index disease cohorts also varied with respect to the specific disease 
categories they comprised. Only the comorbidity patterns associatedwith 
PD/PKMand dementia shared some similarities. That is, PD/PKM and dementia 
were observed to be comorbid with each other, irrespective of which condition 
was taken as the index condition, while both disorders were comorbid with 
stroke and depression. The majority of the identified comorbidities confirms 
previous research or clinical experience. Noteworthy, post hoc power analysis 
indicated that some established comorbidities, such as stroke–dementia and 
dementia–schizophrenia/other psychotic disorders, were most likely not 
classified as highly probable comorbidities but as possible comorbidities 
because of insufficient power. Interestingly, some index disease–disease 
category associations for which previous research has provided strong evidence 
that they represent comorbidity, were not identified as such in our study, like 
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MS–depression 50, epilepsy– depression 51, depression–cancer 52, migraine–stroke 
53
, and migraine–epilepsy 54. This may suggest that these comorbid associations 
do not exist in unselected populations. However, some of these relationships 
have been identified as comorbid in other population-based controlled 
studies
55–57
. Possible explanations for these discrepancies in findings are 
differences in study design, characteristics of the study population, and/or 
criteria and procedures used to diagnose the index disease and comorbid 
condition(s). For instance, it is possible that underdiagnosis of either the index 
disease or the comorbid condition by GPs played a role in our failure to 
confirm comorbidities. This may be particularly relevant regarding diagnosis of 
depression, because studies have indicated that underdiagnosis of depression 
by GPs is more pronounced among somatically ill patients 
58-59
. This line of 
reasoning would lead to the hypothesis that depressed patients with epilepsy, 
cancer, and MS are at special risk of being not diagnosed as depressed by 
theirGPs. Further studies are needed to evaluate this hypothesis. Also of 
interest, several specific comorbidities were identified that are not firmly 
established by earlier population- based research or that have not been 
previously investigated. These included possible comorbidities, like stroke– 
liver/gall disease, MS–diabetes mellitus (inverse association), epilepsy–
nonischemic heart disease, epilepsy–lipid metabolism disorder, epilepsy–
substance abuse disorder, as well as highly probable comorbidities such as MS–
lever/ gall disease, migraine–diabetes mellitus (inverse association) and 
migraine–female genital disease. It is beyond the scope of this study to discuss 
in detail possible underlying mechanisms for all these comorbidities. Basically, 
there are several possible explanations for a higher (or lower) than expected 
association between an index disease and comorbid condition: (1) the index 
disease and/or its treatment causes (or protects against) the development of 
the comorbid condition; (2) the comorbid condition and/or its treatment 
causes (or protects against) the development of the index disease; (3) both the 
index disease and comorbid disease arise from the same underlying cause; (4) 
the comorbid association is artificial (e.g. due to bias in the data). Further 
cross-sectional studies are required to substantiate these „„new‟‟ comorbid 
associations and, if they do, subsequent longitudinal research could elucidate 
the order of onset and mechanism(s) underlying these comorbidities.  
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Implications for clinical practice and research 
 
Our results should lead to an increased awareness among physicians of the 
comorbid conditions associated with the neurologic/psychiatric diseases under 
study, which in turn, may improve diagnosis and treatment of these 
comorbidities. Improving diagnosis and management of comorbidity is 
important because evidence is accumulating that its presence results in a 
poorer course and outcome of these neurologic/ psychiatric index diseases, as 
well as a poorer quality of life and an increased use of health services 
11,60–69
. 
As far as comorbidities are known to be caused by the index disease or its 
treatment, raised awareness of them among physicians may lead to improved 
prevention of comorbidity. Furthermore, our findings can be useful with 
respect to the planning and organisation of health services for 
neurologic/psychiatric patients. For instance, the findings that the patients 
with stroke, PD/PKM, and migraine showed in general a broad range of 
psychiatric comorbidity and that the depressed patients displayed an extensive 
spectrum of somatic comorbidity, indicate the need for a closer collaboration 
between, on the one hand, GPs and neurologists and, on the other, 
psychiatrists and psychologists. A major role for GPs in the coordination of 
care for patients with comorbidity seems appropriate, as they are in the best 
position to detect (adverse effects of) comorbidity 
70
. In addition, our results 
form a descriptive epidemiologic basis for more hypothesis-driven research on 
the comorbidity of neurologic/psychiatric disease. The identified „„new‟‟ 
comorbidities are of particular interest in this context. Further detailed 
investigation of these comorbidities could eventually provide clues to the 
etiologies of the index diseases as well as the comorbid conditions involved. 
Also, the finding that depression was comorbid with an extensive range of 
somatic and psychiatric disease categories underlines the importance of 
further research that improves our understanding of the mechanisms 
underlying the interaction between depression and (specific) somatic and 
psychiatric diseases. Furthermore, our findings provide a starting point for 
more complex future research that, when examining an association between a 
neurologic/ psychiatric index disease and a comorbid condition, takes into 
account interrelationships among comorbid conditions themselves 
9
. In sum, 
this study provides comprehensive knowledge of the occurrence of somatic and 
psychiatric comorbidity in general populations of patients with depression, 
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stroke, MS, PD/PKM, dementia, migraine, and epilepsy, which could contribute 
to efforts to improve the quality of care for these patients. 
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Appendix  
 
Disease categories and their corresponding ICPC codes 
Disease category  ICPC codes 
 
Somatic 
 Congenital  A90;e B78; B79;d,e D81; F80;c F81;c,d  
  H80;e K73; L82; N85; R89;c–e S83; T78;d,e  
                                                         T80;e U85; X83;c–e Y82;b–e Y83;c–e Y84;c–e 
 Allergy/allergic reaction  A12; R97; S98 
 Anemia/coagulative defects B80; B81; B82; B83 
 Gastrointestinal  D82; D83; D84; D85; D86; D87; D90; D92;  
                                                         D93; D94; D95; D99 
 Liver/gall  D72; D97; D98 
 Eye  F82; F83; F84; F91; F92; F93; F94; F95; F99 
 Ear  H82; H83; H84; H86; H99 
 Ischemic heart  K74; K75; K76; K77 
 Nonischemic heart  K78; K79; K80; K81; K82;d K83; K84 
 Blood pressure  K85; K86; K87; K88 
 Stroke  K90 
 TIA  K89 
 Other vascular  K91; K92; K93; K94; K95; K96; K99 
 Musculoskeletal  L83; L84; L85; L86; L87; L88; L89; L90;  
                                                         L91; L92; L95; L97; L98; L99 
 MS  N86 
 PD/PKM  N87 
 Epilepsy  N88 
 Migraine  N89 
 Other neurological  N90;e N91; N92; N93; N94; N99 
 Respiratory  R91; R93;c R95; R96; R99 
 Skin/subcutis  S86; S87; S88; S90;d,e S91; S92;d S93; S94;  
 S96; S97; S99 
 Thyroid  T15; T81; T85; T86 
 Diabetes mellitus  T87; T88;c,g T90 
 Obesity/lipid metabolism  T82; T83; T93 
 Kidney  U88; U90;a–c,e,f U95; U98;c U99 
 Female genital  X84; X85; X86; X87; X88; X89;c,d X99 
 Male genital  Y85; Y86; Y99 
 Cancer/malignant neoplasms  A79;g B72; B73;c B74;c D74; D75; D76;c  
  D77;c N74;c R84; R85; S77; T71;c–e U75;  
  U76; U77;c,f,g W72;a–e,g X75; X76; X77; Y77;  
  Y78c 
 Benign neoplasms/unspecified  
 neoplasms  B75;c,d,g D78; F74;c,e H75;c–e, K72;c–e,g  
  L71;c N75; N76;d,e R86; S78;  S79; S80;c  
  S81;c,e S82; T72; T73;c,e U78;c U79;c 
  W73;b–d X78; X79; X80; X81;c–e Y79c–e 
 Other chronic  A99; B99; T91; T92; T99 
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Disease category  ICPC codes 
 
Psychiatric 
 Subtance abuse  P15; P16;e P17; P18; P19e 
 Dementia  P70 
 Schizophrenia/psychotic  P71; P72; P73; P98 
 Anxiety  P74; P79 
 Depression  P76 
 Mental retardation  P85 
 Other mental  P75; P78; P99 
ICPC, International Classification of Primary Care; MS, multiple sclerosis; PD/PKM, 
Parkinson‟s disease/ parkinsonism; TIA, transient ischemic attack. 
a Disease not present in lifetime depression cohort and 10 matched control cohorts. 
b Idem stroke cohort. 
c Idem MS cohort. 
d Idem PD/PKM cohort. 
e Idem dementia cohort. 
f Idem migraine cohort. 
g Idem epilepsy cohort. 
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Abstract 
 
Background: This general practice-based case-control study tested the 
association between cerebrovascular risk factors (CVRFs) and the development 
of later-life depression by focusing on the impact of exposure duration to 
CVRFs and the modifying influence of age at depression onset. 
Methods: Cases were 286 patients aged ≥50 years with a first diagnosis of 
depression at age ≥50 years. Nondepressed controls (n = 832) were individually 
matched for age, gender and practice. CVRF diagnoses (hypertension, diabetes 
mellitus, cardiovascular conditions) prior to depression were determined. 
Analyses controlled for education, somatic and nondepressive psychiatric 
disease. 
Results: No CVRF variable examined was significantly associated with 
subsequent depression in the total sample. An unexpected impact of age at 
onset of depression was observed: the odds ratio associated with having any 
CVRF was smaller for patients with age at onset ≥70 years than for patients 
with onset between ages 50–59 years (p = .002) and 60–69 years (p = .067). 
Subsequent analyses excluding patients with onset at age ≥70 years revealed 
that CVRF variables, including long-term exposure to CVRFs, significantly 
increased the odds of subsequent depression with onset between ages 50 and 
69 years. 
Limitations: Reliance on GPs' records of morbidity may have resulted in bias 
towards underestimation in patients with depression onset at age ≥70 years. 
Conclusions: Our findings suggest that CVRFs play a relevant role in the 
development of depression with onset between ages 50 and 69 years, but no 
evidence was found that they contribute to the occurrence of depression with 
onset at age ≥70 years. Replication is warranted to exclude the possibility of 
bias. 
 
  Cerebrovascular risk factors-depression in older patients 
 59 
 
3.1 Introduction 
 
The vascular depression hypothesis proposes that cerebrovascular disease is an 
important aetiological factor in late-life depression 
1-2
. An implication of this 
hypothesis is the existence of an association between cerebrovascular risk 
factors (CVRFs), such as hypertension, diabetes mellitus and cardiac disease, 
and depression in later life. More specifically, Lyness et al. 
3-4
 have suggested 
that the increase in prevalence of CVRFs with age contributes over time to the 
development of small-vessel brain disease, which, in turn, disrupts 
neurobiological functioning resulting in depression. Most studies testing the 
link between CVRFs and later-life depression have been cross-sectional and 
used predominantly samples of psychiatric patients. These reports have 
yielded mixed results 
3-12
. A major limitation of these studies is their 
transversal design. Given that depression may also contribute to the 
development of CVRFs 
13-16
, it is essential to perform longitudinal studies that 
specifically address the hypothesized causal pathway of CVRFs leading to the 
development of depression. To the best of our knowledge, only two 
prospective studies have directly examined this association and their results 
are equivocal. In older primary care patients, Lyness et al. 
17
 detected no 
relationship between baseline severity of CVRFs and depression symptoms and 
diagnoses at 1-year follow-up after controlling for overall medical burden. 
Conversely, Mast et al. 
18
 investigated geriatric rehabilitation patients and 
found an association between a higher number of CVRFs at baseline and the 
manifestation of depressive symptoms at 6 and 18 months follow-up, also after 
adjusting for baseline depression scores, limitations in activities of daily living 
and general medical comorbidity. It is unclear what explains this inconsistency 
in findings, but differences in patient characteristics may play a role, as well 
as limitations within the studies. The study by Lyness et al. included patients 
who were depressed at baseline, rather than focusing exclusively on newly 
onset depression. Mast et al. examined a specific clinical sample, which was 
potentially subject to referral bias and focused on a restricted set of three 
CVRFs (i.e. hypertension, diabetes and atrial fibrillation). Both longitudinal 
studies did not examine the impact of the duration of exposure to CVRFs as 
well as the potential moderating influence of age at onset of depression. Since 
the theoretical model by Lyness et al. 
3-4
 postulates that CVRFs produce 
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depression through the development of small-vessel brain disease over time, 
exposure duration to CVRFs is an essential factor to be taken into 
consideration. In addition, age at depression onset may modify the relationship 
between CVRFs and the subsequent development of depression. Given that the 
prevalence of, and consequently exposure duration to, CVRFs generally will 
increase with age, one would expect the association between CVRFs and 
subsequent depression to be stronger in patients with an older age at 
depression onset compared with patients with a younger age at onset. The aim 
of the present case-control study was to further test the association between 
CVRFs and the subsequent development of depression in older general practice 
patients. Besides investigating the influences of having any CVRF, specific 
CVRFs and the number of CVRFs, we examined the effect of exposure duration 
to CVRFs on the development of depression in later life. In addition, the 
potential modifying influence of age at depression onset on the relationship 
between CVRFs and subsequent later-life depression was investigated.   
 
 
3.2 Methods 
 
Study setting and data  
This study was a sub-study of the second Dutch National Survey of General 
Practice 
19
 and utilized morbidity data recorded by general practitioners (GPs). 
In the Netherlands, GPs act as a gatekeeper to health care facilities. After 
referral, specialists report back results, by which GPs have comprehensive 
information about the health status of a patient. The majority of Dutch GPs 
keep electronic medical records of their patients as part of daily medical 
practice. An important element of these records, initially formulated by 
Weed
20
, are the so-called “problem lists.” A problem list contains diagnoses of 
all relevant past and current health problems of a patient, with a health 
problem defined as “anything that has required, does or may require health 
care management and has affected or could significantly affect a person's 
physical or emotional well-being” 21. The dates of establishing the diagnoses 
are also recorded. Health problems are coded by the GPs according to the 
International Classification of Primary Care (ICPC) 
22
 based on the criteria of 
the International Classification of Health Problems in Primary Care (ICHPPC-2-
Defined) 
23
. For the present study, eight practices, comprising 14 GPs, were 
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selected on the basis of their fulfillment of quality criteria relating to the 
accuracy of dates of diagnoses recorded on the problem lists, as well as the 
completeness of the registration. These practices took part in a procedure to 
increase the completeness of the problem lists concerning diagnoses of 
depressive disorder (ICPC code P76) and heart failure (code K77). This 
procedure involved running a computer search program that, by searching the 
entire electronic medical record system for markers (e.g. relevant ICPC codes, 
certain text strings, specific medication), traced potential cases of depression 
and heart failure. Subsequently, for each identified possible diagnosis of 
depression or heart failure, the GP made a decision to add the diagnosis to the 
problem list. 
 
Study population  
The population registered at the eight practices consisted of 28,307 persons in 
2001 and was representative of the Dutch population in terms of age, gender 
and type of health insurance. The practice population formed the source 
population. Cases were defined as patients aged 50 years or older in 2001 who 
were diagnosed with depressive disorder (ICPC code P76) or depressive feelings 
(code P03) for the first time at age 50 years or older according to their 
problem list. The ICHPPC-2- Defined criteria for depressive disorder correspond 
largely to those of the DSM-IV for major depression 
14
. The P03 code is used for 
patients with depressive symptomatology who do not fulfill criteria for 
depressive disorder. Cases diagnosed with stroke or transient ischaemic attack 
(TIA) and/or dementia before the date of depression diagnosis were excluded 
(n = 20) to minimize the influence of clinically overt cerebrovascular disease 
and dementia on the relationship between CVRFs and subsequent depression, 
leaving 286 cases. Controls comprised those patients who had never received a 
diagnosis of depression or depressive feelings, but who had at least one other 
diagnosis on their problem list. This latter requirement was imposed to 
minimize selectivity due to the degree of attention a GP pays to a patient. For 
each depressed case, three control patients matched on age (using 5 year age 
bands), gender and practice were randomly selected. Each matched control 
was assigned a virtual “exit date” marking the end of the observation period, 
which was identical to the date of depression diagnosis of the case with whom 
the control was matched. Controls with a diagnosis of stroke or TIA and/or 
dementia before the exit date were excluded. A small number of cases were 
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matched to less than three control patients because the number of eligible 
controls was not sufficient, resulting in 832 control patients. 
 
Cerebrovascular risk factors (CVRFs) 
The current study investigated the following wellestablished CVRFs
 24-25
: 
hypertension (ICPC codes K86 or K87), diabetes mellitus (code T90) and several 
cardiovascular conditions, including atrial fibrillation (code K78), chronic 
ischemic heart disease (code K76), angina pectoris (code K74), myocardial 
infarction (code K75), heart failure (code K77), and intermittent claudication 
(code K92). Diagnoses of hypertension, diabetes mellitus, and chronic ischemic 
heart disease made by GPs have been shown to agree well with the diagnostic 
criteria of the ICHPPC-2-Defined, with a highest false positive rate of 4% being 
observed in diabetes mellitus 
26
. For each case (control), the presence of each 
CVRF diagnosis prior to the date of depression diagnosis (assigned exit date) 
was determined, as well as the time periods between the date of each CVRF 
diagnosis and depression diagnosis date (assigned exit date). The influence of 
the following CVRF variables on the development of subsequent depression was 
examined: a basic variable “any CVRF” (i.e. any CVRF diagnosis), individual 
CVRFs (i.e. three CVRF diagnosis categories: hypertension, diabetes mellitus 
and cardiovascular conditions), the number of CVRFs (i.e. the number of 
diagnoses belonging to a different CVRF category; possible range= 0–3) and the 
duration of exposure to CVRFs. Regarding this last variable, if a case or control 
had CVRF diagnoses in more than one category, the time periods between each 
CVRF diagnosis within the category and depression diagnosis were summed 
(e.g. hypertension and diabetes mellitus diagnosed, respectively, 7.7 and 3.0 
years before depression diagnosis resulted in a total exposure duration of 10.7 
years). Subsequently, this variable was categorized into 0, >0–10, >10–20, and 
>20 years of exposure. Of note, atrial fibrillation was included in the 
cardiovascular category and not considered separately because the number of 
cases with this condition was too small for meaningful analysis. 
 
Covariates 
We took into account other factors that might influence the associations 
between the CVRF variables and subsequent depression, including attained 
educational level, other psychiatric disorder and the number of chronic 
somatic disorders present prior to the development of depression 
27
. 
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Educational level was categorized into low (none, elementary school), middle 
(high school) and high (college or university). Also, a separate category of 
missing data was created because education data were missing for a 
substantial number of cases (16.4%) and controls (18.5%). The presence of 
psychiatric disease was defined as having at least one psychiatric diagnosis 
other than depression or depressive feelings diagnosed before depression 
diagnosis date (for cases) or “exit date” (for controls), respectively. The 
following psychiatric diagnoses were taken into account: anxiety disorders, 
schizophrenia and other psychotic disorders, and a rest category of other 
mental disorders. The number of chronic somatic conditions prior to depression 
was established in a similar fashion, while considering a comprehensive range 
of conditions relating to various body systems 
28
. This variable was categorized 
into four categories, i.e. 0, 1, 2 and ≥3 conditions. 
 
Statistical analysis 
Separate conditional logistic regression analyses were performed using SPSS 
version 11.5 for Windows (www2.chass.ncsu.edu/garson/PA765/logit.htm) to 
examine the association between each of the CVRF variables and the 
subsequent development of depression in the total sample. The potential 
confounding effects of attained educational level, presence of other 
psychiatric disease and the number of chronic somatic conditions prior to 
depression were controlled for in multivariate models. Next, to examine the 
potential modifying influence of age at onset of depression, three “age at 
depression onset” groups were formed consisting, respectively, of cases with 
depression onset between ages 50 and 59 years (n = 149) and their matched 
controls (n = 439), of cases with onset between ages 60 and 69 years (n = 70) 
and their matched controls (n = 202), and of cases with onset at age 70 years 
or older (n = 67) and their matched controls (n = 191). This categorization was 
based on the most commonly employed cut-off points, i.e. 50 and 60 years of 
age, to define late-onset depression 
29
. To investigate whether there existed a 
different relationship between having any CVRF and subsequent depression for 
the three age at depression onset groups, an interaction term of any CVRF and 
age at depression onset group was added to the multivariate model. 
Interaction was tested by comparing the log likelihood of this model with that 
of the model without the interaction term (i.e. likelihood ratio test). In case of 
a significant interaction effect, the odds ratio of developing depression for 
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patients with any CVRF in each of the three age at depression onset groups 
were assessed using multivariate conditional logistic regression analysis. 
Finally, as a sensitivity analysis, all analyses were repeated while excluding 
cases that were diagnosed with depressive feelings (n = 16) and their matched 
controls (n = 48) to evaluate the effect of possible misclassification of 
depression. Also, the modifying influence of age at depression onset was 
examined using a more detailed classification of age at onset groups (i.e. onset 
between ages 50–54, 55–59, 60–64, 65–69, 70–74 years and onset at ≥75 years) 
to evaluate the influence of definition of age at onset categorization. 
Statistical significance was accepted at the 5% level. 
 
 
3.3 Results 
 
Table 1 illustrates the demographic and clinical characteristics of the 
depressed patients (n = 285) and their matched controls (n = 831). Table 2 
shows the results of the conditional logistic regression analyses examining the 
association between each of the CVRF variables and the subsequent 
development of depression. None of the CVRF variables was significantly linked 
to subsequent depression. Additionally controlling for educational level, other 
psychiatric disease and number of chronic somatic conditions only minimally 
affected the odds ratios. Next, the potential modifying influence of age at 
depression onset on the relationship between having any CVRF and subsequent 
depression was examined. Noteworthy, the proportion of cases and controls 
with any CVRF differed across the age at depression onset groups, suggesting a 
modifying role of age at depression onset. Specifically, in the groups with 
onset between ages 50 and 59 years (mean age: 61.3, SD: 6.9, 58.9% females) 
and 60 and 69 years (mean age: 70.5, SD: 5.0; 71.7% females) having any CVRF 
was more common among cases than controls (22.3% vs. 13.7% and 32.9% vs. 
27.7%, respectively). In contrast, in the group with onset at age 70 years or 
older (mean age: 80.3, SD: 5.9; 80.5% females), a lower proportion of cases 
than controls had any CVRF (35.8% vs. 46.8%).  
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Table 1  
Demographic and clinical characteristics of depressed cases and matched nondepressed 
controls  
Characteristic Depressed patients 
(n = 285) 
Control patients 
(n = 831) 
Age in 2001 (years): mean (SD), range 68.1(10.1), 51-92 67.8(10.0), 51-95 
Female gender, n (%) 191 (67.0) 557 (67.0) 
Educational level, n (%)   
High 27 (9.5) 71 (8.5) 
Middle 106 (37.2) 337 (40.6) 
Low 105 (36.8) 269 (32.4) 
Missing 47 (16.5) 154 (18.5) 
Other psychiatric disease prior to depression, n (%) 30 (10.5) 27 (3.2) 
Number of somatic diseases prior to depression, n (%)   
0 75 (26.3) 229 (27.6) 
1 67 (23.5) 223 (26.8) 
2 49 (17.2) 148 (17.8) 
≥ 3 94 (33.0) 231 (27.8) 
Any CVRF prior to depression, n (%) 80 (28.1) 205 (24.7) 
Individual CVRF prior to depression, n (%)   
Hypertension 53 (18.6) 131 (15.8) 
Diabetes 19 (6.7) 43 (5.2) 
Any cardiovascular condition 28 (9.8) 81 (9.7) 
Number of individual CVRFs prior to depression, n (%)   
1 61 (21.4) 158 (19.0) 
2 19 (6.7) 47 (5.7) 
Exposure duration to CVRFs prior to depression  
(sum of years), n (%) 
  
> 0-10 55 (19.3) 144 (17.3) 
> 10-20 9 (3.2) 30 (3.6) 
> 20 16 (5.6) 31 (3.7) 
CVRF, cerebrovascular risk factor. 
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Table 2  
Association between cerebrovascular risk factor (CVRF) variables and subsequent depression 
using separate conditional logistic regression analyses 
 Bivariate   Multivariate  
 OR (95% CI) pa  OR (95% CI) pa 
Any CVRF 1.18 (0.85-1.64) .33  1.18 (0.80-1.59) .49 
Individual CVRF      
Hypertension 1.23 (0.84-1.80) .30  1.18 (0.80-1.75) .41 
Diabetes 1.28 (0.73-2.26) .39  1.20 (0.67-2.13) .55 
Any cardiovascular condition 0.96 (0.60-1.54) .86  0.85 (0.52-1.40) .53 
Number of CVRFs 1.13 (0.88-1.44) .34  1.07 (0.83-1.38) .63 
Exposure duration to CVRFs  
(sum of years) 
     
> 0-10 1.15 (0.78-1.69) .48  1.15 (0.78-1.71) .48 
> 10-20 0.91 (0.42-1.96) .80  0.83 (0.38-1.82) .65 
> 20 1.56 (0.82-2.97) .17  1.32 (0.67-2.60) .42 
Bivariate analysis controlled for the matching variables gender, age and practice. Multivariate 
analysis additionally controlled for educational level, presence of other psychiatric disease 
and number of somatic diseases prior to depression. The reference category for exposure 
duration to CVRFs is 0 years.  
OR, odds ratio; CI, confidence interval. 
a Wald chi-square test. 
 
 
 
Table 3  
Association between having any cerebrovascular risk factor (CVRF) and subsequent depression 
in three “age at depression onset” groups using multivariate conditional logistic regression 
analysis 
 OR (95% CI) pa 
Any CVRF with age at depression onset 1.88 (1.12-3.14) .016 
50-59 years   
Any CVRF with age at depression onset 1.23 (0.64-2.35) .542 
   60-69 years   
Any CVRF with age at depression onset 0.53 (0.28-0.99) .045 
   ≥ 70 years   
Analysis controlled for educational level, presence of other psychiatric disease and number of 
somatic diseases prior to depression. The reference category is patients without CVRFs. 
OR, odds ratio; CI, confidence interval. 
a Wald chi-square test. 
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Indeed, a significant interaction between any CVRF and age at depression 
onset group (likelihood ratio test: p = .010) confirmed that the influence of 
having any CVRF differed by age at depression onset group. A subsequent 
multivariate logistic regression (Table 3) showed that, relative to patients 
without CVRFs, having any CVRF significantly increased the odds of developing 
depression in the group with onset between ages 50 and 59 years. In the group 
with onset between ages 60 and 69 years, having any CVRF also increased the 
likelihood of subsequent depression, although this relationship was not 
significant. In contrast, in the group with onset at age 70 years or older, having 
any CVRF was associated with a significantly decreased odds of developing 
depression compared to patients without CVRFs. Furthermore, the odds ratio 
associated with having any CVRF in this oldest age at depression onset group 
was significantly smaller than that observed in the group with depression onset 
between ages 50 and 59 years (p = .002) and tended to be significantly smaller 
than the odds ratio for the group with onset between ages 60 and 69 years (p = 
.067). The odds ratios associated with having any CVRF did not differ 
significantly between the two younger age at depression onset groups (p = 
.31). Using a more detailed classification of age at depression onset yielded 
essentially similar results. 
Given these results, we repeated our analyses concerning the CVRF variables 
under study while excluding the cases with an age at depression onset of 70 
years or older and their matched controls. The demographic and clinical 
characteristics of the sub-sample are shown in Table 4, and Table 5 presents 
the regression results.  
Having any CVRF significantly increased the odds of developing depression with 
onset between ages 50 and 69 years. Regarding individual CVRFs, the influence 
of having hypertension tended to be significant in both the bivariate and the 
multivariate model. Having diabetes significantly increased the likelihood of 
onset of depression between ages 50 and 69 years, while having any 
cardiovascular condition did not. Furthermore, a higher number of CVRFs was 
found to exert a significant effect. Additionally, patients who were exposed to 
CVRFs for more than 20 years were significantly more likely to have subsequent 
depression with onset between ages 50 and 69 years than patients who had no 
exposure to CVRFs. Finally, repeating all analyses after excluding cases with 
depressive feelings and their matched controls yielded basically similar results. 
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Table 4  
Demographic and clinical characteristics of depressed cases with depression onset between 
ages 50 and 69 years and matched nondepressed controls 
Characteristic Depressed 
patients 
(n = 218) 
Control  
patients 
(n = 641) 
Age in 2001 (years): mean (SD), range  64.2(7.6), 51-87 64.2(7.7), 51-90 
Female gender, n (%) 137 (62.8) 404 (63.0) 
Educational level, n (%)   
High 23 (10.6) 66 (10.3) 
Middle 91 (41.7) 282 (44.0) 
Low 66 (30.3) 176 (27.5) 
Missing 38 (17.4) 117 (18.3) 
Other psychiatric disease prior to depression, n (%) 23 (10.6) 23 (3.6) 
Number of somatic diseases prior to depression, n (%)   
0 67 (30.7) 198 (30.9) 
1 52 (23.9) 187 (29.2) 
2 34 (15.6) 116 (18.1) 
≥ 3 65 (29.8) 140 (21.8) 
Any CVRF prior to depression, n (%) 56 (25.7) 116 (18.1) 
Individual CVRF prior to depression, n (%)   
Hypertension 36 (16.5) 74 (11.5) 
Diabetes 17 (7.8) 24 (3.7) 
Any cardiovascular condition 15 (6.9) 37 (5.8) 
Number of individual CVRFs prior to depression, n (%)   
1 44 (20.2) 97 (15.1) 
2 12 (5.5) 19 (3.0) 
Exposure duration to CVRFs prior to depression  
(sum of years), n (%) 
  
> 0-10 37 (17.0) 84 (13.1) 
> 10-20 8 (3.7) 19 (3.0) 
> 20 11 (5.0) 13 (2.0) 
CVRF, cerebrovascular risk factor. 
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Table 5  
Association between cerebrovascular risk factor (CVRF) variables and subsequent depression 
with onset between ages 50 and 69 using separate conditional logistic regression analyses 
 Bivariate   Multivariate  
 OR (95% CI) pa  OR (95% CI) pa 
Any CVRF 1.61 (1.08-2.39) .019  1.56 (1.03-2.35) .034 
Individual CVRF      
Hypertension 1.59 (0.99-2.55) .057  1.57 (0.96-2.55) .071 
Diabetes 2.17 (1.12-4.18) .022  2.02 (1.03-3.96) .040 
Any cardiovascular condition 1.16 (0.62-2.19) .64  1.02 (0.53-1.98) .95 
Number of CVRFs 1.47 (1.09-1.99) .013  1.42 (1.03-1.94) .032 
Exposure duration to CVRFs  
(sum of years) 
     
> 0-10 1.45 (0.90-2.32) .12  1.42 (0.88-2.31) .15 
> 10-20 1.36 (0.57-3.26) .49  1.30 (0.53-3.17) .57 
> 20 2.80 (1.20-6.54) .018  2.64 (1.10-6.35) .031 
Bivariate analysis controlled for the matching variables gender, age and practice. Multivariate 
analysis additionally controlled for educational level, presence of other psychiatric disease 
and number of somatic diseases prior to depression. The reference category for exposure 
duration to CVRFs is 0 years.  
CVRF, cerebrovascular risk factor; OR, odds ratio; CI, confidence interval.  
a Wald chi-square test. 
 
 
 
3.4 Discussion 
 
In this general practice-based case-control study, none of the CVRF variables 
examined, including exposure duration to CVRFs, was significantly associated 
with the subsequent development of depression in later life. In addition, the 
results refuted our hypothesis that the relationship between having any CVRF 
and subsequent depression would be stronger in patients with an older age at 
depression onset compared with patients with a younger age at onset. That is, 
the odds ratio associated with having any CVRF was significantly smaller in the 
group with age at depression onset at age 70 years or older than in the group 
with onset of depression between ages 50 and 59 years and tended to be 
significantly smaller than the odds ratio observed in patients with onset of 
depression between ages 60 and 69 years. Subsequent analyses excluding the 
oldest age at depression onset group showed significant associations between 
CVRF variables, including long-term exposure duration to CVRFs, and 
subsequent depression with onset between ages 50 and 69 years. An 
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interpretation of these findings is that CVRFs play a relevant role in the 
development of depression with onset between ages 50 and 69 years, but that 
no evidence was found that CVRFs contribute to the occurrence of depression 
with onset at age 70 years or later. 
However, strengths and limitations of the reliance on morbidity data recorded 
by GPs must be considered when interpreting our findings. A strong point was 
that the data allowed us to examine the influence of exposure to CVRFs over a 
lengthy period of time, rather than merely investigating the impact of 
presence or severity of CVRFs at a given time point. Another strength was that 
a largely unselected group was studied because almost all non-institutionalized 
Dutch citizens are registered with a GP. Therefore, potential referral bias was 
minimal. Furthermore, a possible influence of recall bias concerning onset 
data was minimized because these were ascertained on the basis of dates of 
diagnosis recorded by GPs instead of based on patient recall. Relying on GPs' 
records of morbidity has also limitations.  
First, it is likely that the problem lists were not entirely complete regarding 
diagnoses of depression and CVRFs despite the implemented procedure to 
increase their completeness. Theoretically, this could have resulted in spurious 
significant results when the degree of completeness of the recorded CVRF 
diagnoses was substantially greater among cases than controls. However, we 
minimized this potential bias towards overestimation by including only controls 
who had at least one record of a health condition on their problem list. 
Second, only a limited range of CVRFs could be studied because the available 
data did not allow us to examine the influence of other risk factors (e.g. 
smoking, dyslipidemia), though not taking into consideration other CVRFs 
would most likely have attenuated a true relationship between CVRFs and 
depression rather than producing a spurious one. Third, examining diagnosis of 
depression made by GPs and not diagnosis based on a standardized assessment 
procedure may have led to a substantial misclassification of subjects who 
actually developed depression as not having had this disorder (i.e. 
underdiagnosis) and visa versa (i.e. overdiagnosis). At least, the rather low 
incidence of “depressive feelings” does suggest considerable underdiagnosis of 
subthreshold depression. If there is a true relationship between CVRFs and 
depression, misclassification of depression and/or depressive feelings would 
have resulted in an underestimation of the associations under study, though, in 
case of differential misclassification, there is also the possibility of 
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overestimating effects. For instance, underdiagnosis of depression may occur 
less frequently among patients with CVRFs because GPs have raised awareness 
of depression in these patients. However, we consider this unlikely for two 
reasons. First, as our study concerned older patients and only control patients 
were included who had been diagnosed with at least one health problem, the 
majority of the patients not suffering from CVRFs (i.e. 71%) had at least one 
somatic disease before the date of depression diagnosis (cases) or assigned 
“exit date” (controls). Given this high number together with the fact that 
these health problems in general concern conditions that require health care 
management and significantly affect a person's physical or emotional well-
being 
21
, it is likely that most patients without CVRFs were also subject to 
increased vigilance by GPs. Second, it remains to be seen whether having 
CVRFs, or more broadly having a chronic somatic illness, leads to increased 
detection of depression by GPs. In fact, studies have suggested an opposite 
effect; that is, they have found that somatically ill patients who have 
comorbid major depression have a higher risk of not being diagnosed as 
depressed by GPs than those without a somatic illness 
30-31
. A final limitation of 
our study is that only patients who were alive at the time of data collection 
were examined. There is growing evidence that depression significantly 
increases the risk of death in adults with diabetes 
32
, cardiovascular disease 
33-
34
 or hypertension 
35
. If so, differential mortality would have resulted in the 
non-participation of more cases than controls with CVRFs, which, in turn, 
would have led to an underestimation of the associations under study. 
Having addressed potential sources of bias, we cannot rule out the possibility 
that bias towards underestimation explains the “failure” to find any of the 
CVRF variables to be significantly associated with the development of later-life 
depression in our total sample. That is, it is possible that particularly in the 
oldest age at depression onset group (onset ≥70 years) a significant bias 
towards underestimation was present because (1) the rate of overdiagnosis and 
especially underdiagnosis of depression by GPs may be higher in older age 
groups than among younger age groups 
36-37
, and/or because (2) the mortality 
rate of patients with CVRFs and comorbid depression may be higher in patients 
with an older age at depression onset relative to patients with a younger age 
at depression onset 
38
. Such pronounced conservative bias in the oldest age at 
depression onset group could have masked “true” relationships between CVRFs 
and subsequent later-life depression in our total sample, which only came into 
Chapter 3 
 
72 
sight when this group was excluded from analysis. Further longitudinal 
research that circumvents the potential biases addressed above is needed to 
settle the role of CVRFs in the development of depression with onset at age 70 
years or older. Anyhow, our findings may help explain why Lyness et al.
17
 did 
not find significant associations between CVRF variables at baseline and 
subsequent depression symptoms and diagnoses at 1-year follow-up after 
controlling for overall medical burden. They examined a sample of primary 
care patients aged 60 years or older and also conducted separate analyses 
using a subset of patients with onset at age 60 years or later. However, no 
analyses were performed excluding patients with depression onset at age 70 
years or older. 
This is the first study that examined the association between duration of CVRFs 
exposure over time and the development of later-life depression. We found 
that patients who were exposed to CVRFs for more than 20 years were 
significantly more likely to develop depression with age at onset between 50 
and 69 years than patients without CVRFs. In the context of the proposed 
model of Lyness et al. 
3-4
, this suggests that a long-term exposure to CVRFs is 
required before they contribute via the development of small-vessel brain 
disease to the occurrence of depression in later life. It should be noted that 
our measure of exposure duration to CVRFs weighted each individual CVRF 
(hypertension, diabetes, cardiovascular disease) equally and also did not take 
into account treatment of CVRFs. Additionally, in case of exposure to more 
than one specific CVRF, the exposure duration to each CVRF was simply 
summed. It is possible that the association between CVRFs and subsequent 
later-life depression varies with (the exposure duration to an) individual CVRF 
and that, consequently, each individual CVRF has to be given a specific weight. 
Our findings concerning specific CVRFs suggest that diabetes and hypertension 
may play a more important role than cardiovascular conditions in the 
development of depression in later life. Only a limited number of previous 
longitudinal studies have examined the association between a specific CVRF 
and the development of depression and their results are inconsistent
 17; 39-41
. 
Also, the influence of age at depression onset was not considered in these 
studies. Further prospective studies are needed to determine whether long-
term exposure to CVRFs exerts its effect on the development of later-life 
depression regardless of type of CVRF or that specific (combinations of) CVRFs 
do matter. 
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In sum, although our findings were essentially negative using the total sample 
of older general practice patients, results of subsequent analyses excluding the 
patients with onset of depression at age 70 years or older offered support for a 
longitudinal relationship between CVRFs and subsequent depression in later 
life. Replication is needed to exclude the possibility that our findings were 
substantially influenced by biases inherent to relying on morbidity data 
recorded by GPs. Ideally, such future research should take into account several 
other variables that appear to moderate the association of CVRFs with later-
life depression, including executive functioning 
42
, severe life stress preceding 
onset of depression 
43; 28
 and physical symptoms and limitations 
44
.  
Ultimately, subgroups of patients could be identified for whom the vascular 
depression concept is particularly relevant, which, in turn, may guide 
prevention of depression in later life through modification of CVRFs. 
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Abstract 
Objectives: To gain more insight into the association between severity of 
Alzheimer‟s Disease (AD) and prevalence of comborbid depression.  
Methods: A systematic literature review based on the Cochrane methodology 
was performed. PubMed, PsychINFO and EMBASE databases were searched for 
existing studies that fulfilled predefined inclusion criteria. The studies were 
divided into: (1) those that analysed the association between severity of AD 
and prevalence of depressive symptoms (“continuous” approach) and (2) those 
that investigated the association between severity of AD and diagnosed 
depression (“categorical” approach). The quality of existing studies was rated 
and the results were synthesized with a best evidence synthesis. 
Results: Twenty-four studies fulfilled the inclusion criteria. Nineteen reported 
results for a continuous approach and seven for a categorical approach. 
Three of the four high quality studies within the continuous approach did not 
find a significant association between severity of AD and prevalence of 
depressive symptoms. None of the three high quality studies using the 
categorical approach found a significant association between the severity of 
AD and the prevalence of diagnosed depression.  
Conclusions: There is evidence for a lack of association between the severity 
of AD and the prevalence of comorbid depressive symptoms or diagnosed 
depression. Until new studies contradict this conclusion, prevention and 
intervention strategies for comorbid depression in AD should be aimed at all 
patients irrespective their disease severity.  
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4.1 Introduction 
 
According to recent studies up to 50% of patients with Alzheimer‟s Disease (AD) 
suffer from depression at least once during their disease course 
1
. Comorbid 
depression in patients with AD has been associated with decreased quality of 
life 
2
, increased need for institutionalization 
3
, greater health care utilization
4
, 
higher mortality rates 
5
 and decreasing caregiver‟s well being 6; 2. These serious 
consequences ask for the development of strategies for prevention, early 
recognition and intervention for depression in AD. Diagnostic and preventive 
services should be targeted at those at greatest risk which means that it is 
important to understand who is most likely to develop depression. In addition, 
this tells us something about the underlying causes of depression and may help 
develop preventive and intervention strategies. Within this context, it is 
important to expand knowledge regarding the relationship between severity of 
AD and comorbid depression. The results of studies that have examined this 
relationship are inconsistent 
7-9
. Explanations for these diverging results could 
be multiple, because the studies and study samples differ on many points.  
One of the differences between the existing studies is the method used to 
determine the prevalence of depression: “continuous” or “categorical”. Within 
the continuous method the number of prevalent depressive symptoms is 
determined without establishing a diagnosis of depression. According to the 
categorical method, diagnostic criteria for depression are used to determine if 
a patient suffers from comorbid depression or not. There are various other 
differences between existing studies that could possibly offer explanations for 
the diverging results:  
1. Many studies group different types of dementia together,  
2. Diagnostic procedures for AD differ between studies,  
3. The assessment instruments for the severity of AD differ,  
4. The instruments used to assess the prevalence of depression are 
multiple, also within the continuous and categorical approach and  
5. Study samples differ in many relevant aspects, such as severity of AD, 
living situation, history of depression, or use of psychotropic 
medication.  
In order to gain more insight into the relationship between the prevalence of 
depression and severity of AD we conducted a systematic literature review by 
systematically analysing the differences, similarities and methodological 
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quality of existing empirical studies. The division into studies that use a 
continuous or a categorical approach forms the main structure around which 
the results of the review are presented and discussed. 
  
 
4.2 Methods 
 
The systematic review was conducted in accordance with a predefined 
research protocol following the guidelines of the Cochrane Collaboration 
10
 
that prescribed the following steps: (1) inclusion criteria, (2) search method, 
(3) selection method, (4) data extraction, (5) assessment of methodological 
quality, (6) data synthesis. Steps 3 to 6 were performed independently by the 
first two authors (RV, JN). 
 
Inclusion criteria 
Type of research. This review included naturalistic studies that conducted 
cross-sectional analyses on the relationship between severity of AD and 
prevalence of comorbid depressive symptoms or depression.  
Patients. Studies had to involve patients who had been diagnosed with AD 
according to established diagnostic methods and criteria (e.g. NINCDS-
ADRDA
11
, ICD-10 
12
, DSM-III-R or DSM-IV 
13-14
 criteria.) 
Measurement of AD severity. Only studies using a validated measure for AD 
severity were included. Scales that just measure degree of cognitive 
impairment as a measure for the severity of AD (e.g. Minimal Mental State 
Examination (MMSE) 
15
) as well as scales that also take non-cognitive aspects of 
AD into account (e.g. Global Deterioration Scale (GDS) 
16
) were included. 
Measurement of depression. In the case of continuous studies: only studies 
using an established, validated rating scale for measuring depressive 
symptomatology were included, regardless of whether the rating scale used 
was specifically developed to assess depressive symptoms in patients with 
dementia, e.g. the Cornell Scale for Depression in Dementia (CSDD) 
17,
 or not, 
e.g. the Hamilton Depression Rating Scale (HDRS) 
18
.  In the case of categorical 
studies: those studies were included that either employed established diagnos-
tic criteria for major depressive disorder (MDD) (e.g. DSM-III-R/-IV or ICD-10 
criteria) or used an empirically validated cut-off score on a rating scale for 
depressive symptoms specifically devised for patients with dementia (e.g. 
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CSDD score >12 
19; 17
 ).  
Statistical analysis. Only studies were included that tested the relationship 
between severity of AD and prevalence of depressive symptoms or depression 
for statistical significance.  
 
Search method 
In March 2006 we searched in three international bibliographical databases, 
i.e. PubMed, PsychINFO and EMBASE, for all studies that were published in 
English until that date and potentially fulfilled all five inclusion criteria. The 
databases were searched using the following strategy that was formulated in 
PubMed and adapted to the other databases: Dementia [MESH] AND 
(Depression [MESH] OR Depressive Disorder [MESH]). All literature lists of 
possibly relevant studies were also screened for additional references.  
 
Selection method 
A first selection for inclusion was performed by the first author (RV). On the 
basis of titles and abstracts all studies that clearly did not meet one of the five 
inclusion criteria were excluded from the review. If a study appeared to meet 
the inclusion criteria or if there was any doubt, the full article was read. A 
second selection was made by two reviewers independently (RV, JN). Based on 
the full articles both reviewers checked if the studies satisfied all five criteria. 
Disagreements regarding inclusion status were resolved by discussion. In three 
cases no consensus could be met and a third reviewer (AF) was consulted.  
 
Data extraction 
After the selection procedure, the two reviewers (RV, JN) independently 
documented the following characteristics of each study: 
1. the diagnostic criteria employed to establish presence of AD; 
2. the characteristics of the study sample of patients with AD (i.e. size, 
inpatients or outpatients, socio-demographics, and, if reported, other 
relevant characteristics such as duration of AD, presence of depression 
prior to the onset of AD);  
3. the rating scale used to measure severity of AD; 
4. the rating scale used to measure depressive symptoms OR the 
diagnostic procedure used to establish presence of depression; 
5. the dependent and independent variable studied and the statistical 
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technique used to examine their relationship. If a multivariate 
technique was employed, the included covariates were also 
documented;  
6. a short description of the results (i.e. significant or non-significant 
relationship, and, if reported, descriptive statistics, test statistics, p-
value); 
7. the direction of the association (in case a significant relationship was 
found). 
The findings of the two researchers were compared and disagreements were 
resolved by discussion. The extracted data is presented for continuous and 
categorical studies in two separate tables.  
 
Assessment of quality 
After the data extraction, the quality of each included study was rated 
independently by the two researchers (RV, JN), using a set of five predefined 
criteria (box 1). Criteria one to three concerned the internal validity and four 
and five are statistical criteria. The criteria cover the key domains (1) 
comparability of subjects (between studies) (2) outcome measurement and (3) 
statistical analyses that are formulated by the U.S. Agency for Healthcare 
Research and Quality for observational studies (AHRQ)
20
. Studies were 
considered to be of “high quality” if at least three quality criteria were met. 
Several studies examined the relationship between severity of AD and 
prevalence of depressive symptoms or depression in more than one way - 
either by employing different statistical techniques or by performing the same 
analytical technique using the scores of different rating scales for measuring 
depression symptomatology and/or severity of AD. These so-called “sub-
studies” were evaluated independently.  
For each of the five quality criteria scoring positively, a (sub-)study received 
one “quality” point. The methodological quality of a (sub-)study was 
operationalized simply as the sum of all criteria scoring positively and thus 
potentially ranged from 0 to 5. There were no disagreements between the two 
researchers regarding the methodological quality ratings.  
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Box 1  
Quality criteria 
1. The diagnosis of AD is established according to the „golden standard‟, the NINCDS-
ADRDA criteria 11; 
2. Severity of AD is assessed using a clinical instrument that besides cognitive capabilities 
also takes account of functional and/or clinical factors: (a) CDR 21 or (b) GDS 16; 
3. Regarding studies that use a continuous approach, depressive symptoms are assessed 
using a rating scale specifically developed for patients with dementia. In studies with a 
categorical approach this type of rating scale should be used in combination with 
established diagnostic criteria for major depressive disorder. The following depression 
rating scales are specifically developed for demented populations: (a) the CSDD 17,     
(b) the NPI depression subscale 22, (c) the Dementia Mood Assessment Scale (DMAS) 23, 
(d) the Revised Memory and Behavior Problem Checklist (RMBPC) 24; 
4. The statistical analysis controls for the possible influence of at least two of the 
following confounders known to be associated with comorbid depression: (a) gender, 
(b) history of depression, (c) history of other psychiatric disorder, (d) current other 
psychiatric disorder, (e) current use of antidepressant or psychotropic medication, (f) 
degree of functional impairment; 
5. The sample size of patients with AD is at least as large as the median sample size of all 
included studies in the review (n = 78). 
 
 
Best evidence synthesis 
A “best evidence synthesis” 25 was conducted to determine the existing 
evidence for a relationship between severity of AD and prevalence of 
depressive symptoms and diagnosed depression. Levels of evidence were based 
on an earlier review of observational studies 
26
. Box 2 shows the principles of 
the best evidence synthesis.  
 
Box 2   
Principles of Best Evidence Synthesis 
Evidence:    
Provided by consistent outcomes in at least 75% of the studies with a quality score ≥ 3 
Insufficient evidence:    
If less than 75% of the studies with a quality score ≥ 3 have consistent outcomes OR 
If no studies received a quality score ≥ 3 
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4.3 Results 
 
Search results and selection of studies 
Figure 1 shows the results of each phase in the search method and selection of 
studies.  
 
 
Figure 1  
Results of database searches and selection methods 
Hits: 5,501 studies 
Source: 
PubMed (3 March 2006): 3,101 articles 
PsychINFOo (3 March 2006): +906 articles 
EMBASE (9 March 2006): +1,494 articles 
 
1st selection based on title/abstract  
  
 
Possibly relevant articles: 208 
2nd selection based on full article 
Included articles: 24 
Excluded articles: 5,293 
Excluded articles: 185 
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Searching the specified databases according to the strategy described above 
resulted in 5,501 hits. Of these, 208 articles were judged by the first author to 
be possibly relevant on the basis of titles and abstracts. Based on full articles 
found, the first two authors agreed that 21 studies met the four inclusion 
criteria. A screening of reference lists of all 208 articles resulted in the 
inclusion of three additional studies. Of the total of 24 included studies, 19 
reported results of analyses on the relationship between severity of AD and 
prevalence of depressive symptoms (continuous approach) and seven on the 
association between severity of AD and prevalence of diagnosed depression 
(categorical approach). Two studies used both approaches. 
 
Data extraction  
The extracted data and quality rating of each included study are presented in 
table 1 (continuous approach) and 2 (categorical approach). Studies were 
ordered by their methodological quality rating. The 19 “continuous” studies 
included 34 (sub-)studies, and the seven “categorical” studies included nine 
(sub-)studies. 
The last column of table 1 and 2 indicates whether or not a significant 
association was found between the severity of AD and the prevalence of 
comorbid depressive symptoms or diagnosed depression and, if so, the 
direction of the association. In studies with a continuous approach eight times 
a positive association was found, two times a negative association and 24 times 
no association. In studies with a categorical approach two times a negative 
association was found and seven times no association. 
 
Best Evidence Synthesis  
Only four studies within the continuous approach and three studies within the 
categorical approach were rated as being of high methodological quality. 
Three of these four “continuous” studies found no association between 
severity of AD and depressive symptoms and all three “categorical” studies 
demonstrated found no relationship between severity of AD and prevalence of 
diagnosed depression. 
Following the principles of the best evidence synthesis within both approaches 
we found scientific evidence for a lack of association between the severity of 
AD and the prevalence of depressive symptoms or diagnosed depression. 
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Table 1  
Studies on the association between severity of dementia and prevalence of depressive symptoms in patients with Alzheimer‟s 
Disease (AD) 
Study Quality Diagnostic 
criteria for 
AD 
Characteristics of AD patientsa  Severity of AD 
Piccininni  
et al., 
2005 
 
3 NINCDS-
ADRDA 
criteria for 
probable AD 
n = 50; Outpatients; Female gender: 76%; 
Age: M(SD)= 69.3(7.5), Range= 53-84; 
Education: M(SD)= 6.5(3.9)  
Duration AD (months): M(SD)= 57.7(37.3)  
Exclusion criteria: history of alcoholism or 
psychiatric disturbances prior to the onset 
of dementia; drug abuse or dependence 
(1) GDS: Mild (score: 2-3): 28%; Moderate 
(score: 4-5): 54%; Severe (score: >5): 18% 
 
(2) MMSE: M(SD)= 16.8(5.6) 
Harwood  
et al., 
2000a 
3 NINCDS-
ADRDA 
criteria for  
possible/  
probable AD 
n = 114; Outpatients; Female gender: 63% 
Age: M(SD)= 78.8(6.5), Range= 59-92; 
Education: M(SD)=11.9(3.5); Range= 2-20; 
Hispanic: 44%; Duration AD: M(SD)= 
3.4(2.5); Range= 1-11 
MMSE: M(SD)= 17.8(7.2) 
Harwood  
et al., 
1998 
3 NINCDS-
ADRDA 
criteria for 
probable AD 
n = 137; Outpatients; Female gender: 70% 
Age: M= 78.2, Range= 63-95; 
Education: M= 10.4, Range= 0-20; 
Hispanic: 50.4%;  
Duration AD: M= 4.1; Range= 0-14 
MMSE: M=15.6, Range= 0-29 
Brodaty 
and 
Luscombe, 
1996  
3 & 2c NINCDS-
ADRDA  
criteria for 
AD  
n = 208; Outpatients 
Total sample of patients with dementia  
(n = 288)d:  
Female gender: 55%;  
Age: M(SD)=71.4(7.7);  
Education: M(SD)=9.7(3.4) 
  
 
Total sample of patients with dementia d: 
(1) MMSE: M(SD)= 18.2(7.2);  
Mild (score: ≥22); Moderate (score: <22) 
  
(2) CDR:  score 0.5: 30.0%; score 1: 48.3%;  
score 2: 15.7%; score 3: 6.0%  
  
Müller- 
Thomsen 
et al ., 
2005  
2 NINCDS-
ADRDA 
criteria for  
probable AD 
n = 316f  ; Outpatients 
Patients with MMSE ≥18 (n = 157): 
Female gender: 65% 
Age: M(SD)= 72.7(8.7) 
Patients with MMSE<18 (n = 159): 
Female gender: 74% 
Age: M(SD)= 72.6(9.0) 
 
 
 
MMSE: Mild (score: ≥18): 49.7%; 
Moderate-severe (score: <18): 50.3%  
 
Mild: M(SD)= 22.3(2.8); 
Moderate-severe: M(SD)= 11.6(4.4) 
 
 
Levy  
et al., 
1998  
2 NINCDS-
ADRDA  
criteria for 
probable AD 
n = 30; Outpatients; 
Female gender: 63%; 
Age: M=74, Range= 54-85 
MMSE:  
M(SD)= 17.5(7.0) 
Bungener  
et al., 
1996  
2 NINCDS-
ADRDA  
criteria for 
possible/  
probable AD 
n = 118; Outpatients; Female gender: 64% 
Age: M(SD)= 70.1(7.8), Range= 52-86; 
Education: <6: n = 49, 7-11: n = 38,  
≥12: n = 29; 
Early-onset AD: n = 61,  
Late-onset AD: n = 55 
(1) MMSE: 
M(SD)=19.1(5.8); Range= 3-29 
 
(2) DRS:  
M(SD)= 104.8(20.5)  
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Severity of 
depressive 
symptomsb 
Statistical analysis Results Direction of 
association 
NPI depression 
subscale: 
M(SD)= 3.3(3.7) 
 
 
ANOVA: Comparison between mildly, 
moderately and severely impaired 
groups regarding NPI-depression score  
 
Mildly impaired group:  
M(SD)= 3.7(4.0);  
Moderately impaired group: M(SD)=2.7(3.1);  
Severely impaired group: M(SD)=4.7(5.0);  
Overall comparison: p = 0.35 
 
No significant 
association  
RMBPC 9-item 
depression scale:  
M(SD)= 8.4(7.8)  
Pearson correlation between RMBPC 
and MMSE scores 
r= 0.02, n.s. No significant 
association  
CSDD: M= 5.2,  
Range= 0-25;  
Mild (8-12): 9.5%;  
Moderate (>12): 
11.7% 
 
Pearson correlation between CSDD and 
MMSE scores 
r= -0.25, p < 0.01 More severe 
depressive 
symptoms in more 
severe  
AD 
HDRS (21-item 
version):  
M(SD)= 6.7(5.3)e  
 
Total sample of 
patients with 
dementiad: 
MDD (DSM-IV 
criteria): 6.3%  
(1) Spearman correlations with 
Bonferroni correction between  
(a) HDRS and MMSE scores; 
(b) HDRS and CDR scores  
 
(2) t test: comparison between mildly 
and moderately  impaired groups 
(based on MMSE) regarding HDRS scores  
(1a) significant negative correlation; (1b) n.s. 
 
(2) mildly impaired group had a significantly 
lower HDRS score  
 
  
 
(1a&2)  
More severe 
depressive 
symptoms in  
more severe AD  
 
(1b) No significant 
association 
 
(1) GDS (15-item 
version)  
(2) MADRS 
(3) CSDD 
ANOVAs: 
Comparison between mildly and 
moderately-severely impaired groups 
(based on MMSE) regarding: 
(1) GDS score 
(2) MADRS score 
(3) CSDD score 
 
A: Mildly impaired group 
B: Moderately-severely impaired group 
(1) A(n = 140): M(SD)= 4.5(3.3); B(n = 101): 
M(SD)= 4.6(2.6), n.s. 
(2) A(n = 120): M(SD)= 10.1(6.7); B(n = 76): 
M(SD)= 12.8(8.8), p < 0.10  
(3) A(n = 31): M(SD)= 6.7(5.0); B(n = 16): 
M(SD)= 8.1(5.1), n.s. 
(1-3)  
No significant 
association 
NPI depression 
subscale: 
M(SD)= 1.2(1.6) 
Spearman correlation between  
NPI-depression and MMSE scores  
Nonsignificant trend toward a negative 
correlation  
No significant 
association  
(1) HDRS (17-
item version): 
M(SD)= 8.1(4.6), 
Range= 0-22  
(2) RRS: 
M(SD)= 9.3(4.0), 
Range= 3-29 
 
MDD (DSM-III-R): 
0% 
Dysthymia (DSM-
III-R): 8.5%  
Pearson correlations between  
(1) HDRS and MMSE scores  
(2) HDRS and DRS scores  
(3) RRS and MMSE scores  
(4) RRS and DRS scores  
  
(1) n.s.  
(2) n.s. 
(3) r = -0.27, p = 0.003  
(4) r = -0.31, p < 0.001  
(1&2)  
No significant 
association  
 
(3&4)  
More severe 
depressive 
symptoms in more 
severe  
AD 
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Table 1 continued 
Study Quality Diagnostic 
criteria for 
AD 
Characteristics of AD patientsa  Severity of AD 
Haupt  
et al., 
1995  
2 ICD-10 draft 
criteria for 
mild to 
moderate 
dementia in 
AD 
n = 78; Outpatients; Female gender: 73%; 
Age: M(SD)= 74.3(7.5), Range= 57-90; 
Age at symptom onset: M(SD)= 69.4(7.3);  
Past history of depression: 0%; 
Antidepressant medication within the 2-
year study period: 32%; no patient had to 
stay on antidepressant medication for >3 
weeks  
(1) MMSE  
 
(2) CAMCOG:  
M(SD)= 36.2(24.4) 
 
(3) GDS:  
score 5: 54%; score 6: 35%; score 7: 11%  
Verhey  
et al., 
1995  
2 NINCDS-
ADRDA 
criteria for 
possible  
or probable 
AD 
n = 48; Outpatients; 
Female gender: 65%; 
Age: M(SD)= 72.9(7.6); 
Education [1(primary school) – 
7(university grade)]: 3.6(1.3); 
Duration AD: M(SD)= 3.28(2.4)  
GDS: 
M(SD)= 4.8(0.9);  
Very mild (score: 3): 8.3%;  
Mild (score: 4): 25.0%;  
Moderate (score: 5): 45.8%;  
Severe (score: 6): 20.8%;  
Very severe (score: 7): 0% 
Feher  
et al., 
1992  
2 NINCDS-
ADRDA 
criteria for 
probable AD 
n=83; Outpatients; Female gender: 49% 
Age: M(SD)= 65.6(5.7); 
Education: M(SD)= 13.3(2.8) 
Exclusion criteria: Current psychiatric 
diagnosis (DSM-III-R criteria);  
HDRS score >16  
 
MMSE: 
M(SD)= 19.4(2.9), Range= 12-23 
Gottlieb  
et al., 
1988  
2 NINCDS-
ADRDA 
criteria for 
probable AD 
n=43; Outpatients; Female gender: 67%; 
Age: M(SD)= 72.8(7.3), Range= 55-88; 
Education: M(SD)= 11.9(3.6), Range= 4-18 
Exclusion criteria: evidence of other 
psychiatric disorder; history of significant 
psychiatric disorder; requiring acute 
psychiatric intervention at the time of 
initial presentation 
GDS: 
Low (score: 3-4): 55.8%  
High (score: ≥5): 44.2% 
Weiner  
et al., 
1997  
1 NINCDS-
ADRDA 
criteria for 
AD 
 
n = 30; Outpatients 
Age: M(SD)=72.5(6.4), Range= 6-28; 
Education: M(SD)=12.6(4.0), Range= 3-20 
 
MMSEh:  
M(SD)=17.3(6.4), Range= 6-28  
Fitz and  
Teri, 1994  
1 DSM-III-R  
criteria for 
AD  
N = 91; Outpatients; 
Female gender: 55%; 
Age: Range= 46-90 
 
DRS: 
M(SD)=102(18.8), Range= 56-139;  
Mild (score: <102): 50.5%; 
Moderate (score: >103): 49.5%  
Troisi  
et al., 
1993  
1 NINCDS-
ADRDA 
criteria for 
probable AD 
n = 26; Outpatients; 
Female gender: 54%;  
Age: M(SD)= 74.0(5.5), Range= 65-84; 
Education: M(SD)=7.15(5.0), Range= 0-19 
(1) MMSE: mild-moderate (score: 16-23): 
50%; severe (score: ≤15): 50%  
 
(2) DSM-III-R: Mild: 26.9%;  
Moderate: 42.3%; Severe: 30.8%  
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Severity of  
depressive  
symptomsb 
Statistical analysis Results Direction of 
association 
DMAS mood subscale: 
M(SD)= 14(6.6), Range= 2-31 
 Correlations betweeng:  
(1) DMAS and MMSE scores 
(2) DMAS and CAMCOG scores 
  
(1) 0.02, n.s. 
(2) 0.04, n.s.  
(1&2)  
No significant 
association 
HDRS (17-item version): 
M(SD)= 9.4(9.4) 
 
MDD (DSM-III-R criteria): 6.3% 
 
Spearman correlation between HDRS and 
GDS scores  
r = 0.04, n.s.  No significant 
association 
(1) HDRS (17-item version): 
M(SD)= 4.0(3.1)  
 
(2) GDS (30-item version):  
M(SD)= 7.8(5.4)  
Correlations between: (1) HDRS and MMSE 
scores; (2) GDS and MMSE scores  
 
(3) multivariate linear regression: 
Dependent: GDS score; (a) hierarchical: 
HDRS scores were entered first; followed 
by MMSE, memory test and self-awareness 
scores (b) simultaneous entry  
(1) -0.15, n.s. 
(2) -0.15, n.s. 
(3a&b) MMSE score was not a 
significant predictor of GDS 
score, p > 0.10  
(1-3)  
No significant 
association  
 
 
(1) HDRS (17-item version) 
 
(2) SDS 
 
t tests: Comparison between low- and 
high-impaired groups (based on GDS) 
regarding  
(1) HDRS score and  
(2) SDS score  
A: High-impaired group 
B: Low-impaired group 
 
(1) A: M(SD)= 2.2(3.0),  
Range=0-10;  
B: M(SD)= 3.3(6.1),  
Range=0-28, t < 1, n.s.  
 
(2)  
A: M(SD)=39.0(8.6), 
Range=21-54;  
B: M(SD)= 36.6(8.1), 
Range=23-55, t < 1, n.s.  
(1&2)  
No significant 
association  
 
HDRS (21-item version):  
(a) Patient‟s report: M(SD)= 
5.7(3.6), Range= 1-12; (b) 
Caregiver‟s report: M(SD)= 
9.3(5.2), Range= 0-21  
Correlations between  
(1) patient‟s report HDRS and MMSE 
scores; (2) caregiver‟s report HDRS and 
MMSE scores 
(1) n.s. 
(2) n.s. 
  
(1&2)  
No significant 
association  
HDRS (17-item version) 
 
MDD (DSM-III-R criteria): 50.5% 
(1) Pearson correlation between HDRS and 
DRS scores; (2) Comparison between 
mildly and moderately impaired groups 
(based on DRS) regarding HDRS score  
(1&2) n.s.  (1&2)  
No significant 
association  
HDRS (17-item version): 
Mild-moderate (score: 10-16): 
30.8%; Marked (score: ≥17): 
7.7%  
 
MDD (DSM-III-R criteria): 23.1%  
ANOVA and PLSD  
posthoc tests:  
(1) comparison between  
mildly- moderately and severely impaired 
groups (based on MMSE) regarding HDRS 
score; (2) comparison between mildly, 
moderately and severely impaired groups 
(based on DSM-III-R) regarding HDRS score  
(1) Overall: p < 0.05; 
Posthoc: severely impaired 
group had significantly higher 
HDRS score (p < 0.05); (2) 
Overall: p = 0.01;  
Posthoc: severely impaired 
group had significantly higher 
HDRS score than mildly (p < 
0.01) and moderately 
impaired  
(p < 0.05) groups  
(1&2)  
More severe 
depressive 
symptoms in more 
severe  
AD 
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Table 1 continued 
Study Quality Diagnostic 
criteria for 
AD 
Characteristics of AD patientsa  Severity of AD 
Sultzer  
et al., 
1992  
1 NINCDS-
ADRDA 
criteria for 
probable AD 
n = 61; Outpatients (majority) and 
inpatients; 
Female gender: 5%; 
Age: M(SD)=73.0(7.8), Range= 53-88 
Education: M(SD)= 13.0(3.2), Range= 7-20 
Duration: M(SD)= 5.8(3.7), Range= 1-20 
Exclusion criteria: history of psychotic 
disorder prior to onset of dementia; 
evidence of psychoactive substance use  
MMSE: 
M(SD)= 10.0(8.5), Range= 0-28 
Fischer  
et al., 
1990  
1 NINCDS-
ADRDA 
criteria for 
probable AD 
n = 55; Inpatients; Female gender: 87%; 
Age: M(SD)=79.4(8.8), Range= 58-93; 
No patient received antidepressants at the 
time of investigation or for 2 weeks 
previously 
  
MMSE: 
M(SD)= 11.5(9.1), Range= 0-23; 
Mild (score: 16-23): 41.8%; 
Moderate (score: 6-15): 23.6%; 
Severe (score: <6): 34.5% 
 
 
Shuttle-
worth et 
al., 1987  
1 NINCDS-
ADRDA 
criteria for 
AD  
 
  
n = 22; Outpatients; Female gender: 59%; 
Age: M= 67.1; Education: M= 14.5  
 
MMSE: 
Mild (score: 20-25): 31.8%;  
Moderate (score: 15-19): 36.4%;  
Severe (score: 5-14): 31.8% 
Galynker  
et al., 
1995  
0 DSM-III-R 
criteria for 
AD 
n = 26; Outpatients; Female gender: 58%; 
Age: M(SD)=78.8(6.45), Range 63-89; 
Antipsychotic medication: 26.9%  
Benzodiazepines: 23.1% 
Antidepressants: 15.4% 
MMSE: 
M(SD)=16.8 
(7.52), Range= 1-28 
Teri and 
Wagner, 
1991  
0 DSM-III-R 
criteria for 
AD 
 
n = 75; Outpatients; Female gender: 68%; 
Age: M(SD)=74.0(7.4), Range= 46-89 
Education:  
≤12th grade: 72%, >12th grade: 28% 
 
 
(1)MMSE: M(SD)= 18.1(5.7), Range= 4-27;  
Mild (score: >21): 30.7%;  
Moderate (score: 21-16): 37.3%;  
Severe (score: <16): 32.0%  
 
(2) GDS: M(SD)=4.6(1.0), Range= 2-6 
 
CAMCOG, Cambridge Cognitive Examination; CDR, Clinical Dementia Rating Scale 27; CSDD, Cornell Scale for Depression in 
Diagnostic and Statistical Manual of Mental Disorders, third revised (DSM-III-R) or fourth (DSM-IV) edition 13-14; GDS, Geriatric 
Classification of Diseases, tenth edition (World Health Organization, 1987)12; MADRS, Montgomery and Åsperg Depression 
Neurological and Communicative Diseases and Stroke-Alzheimer‟s Disease and Related Disorders Association 11; NPI,        
Memory and Behavior Problem Checklist 24; RRS, Retardation Rating Scale 33- 34; SDS, Zung Self-Rating Depression Scale 35. 
a Data concerning education and duration of AD are presented in years, unless stated otherwise. Only psychiatric exclusion 
criteria are presented. 
b If available data on prevalence of major depression or dysthymia are also presented. 
c This study had two different quality scores because separate analyses were performed using scores on different scales to 
assess severity of AD. 
d No (further) data concerning the sample of patients with AD were reported. 
e Missing data for 6 patients, n = 202. 
f Depression scales were not performed in every patient with AD for various reasons. 
g Results concern those at baseline. 
h Missing data for 2 patients, n = 28. 
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Severity of  
depressive  
symptomsb 
Statistical analysis Results Direction of 
association 
HDRS (17-item version): 
M= 10.3, Range= 1-22 
Pearson correlation between HDRS and 
MMSE scores 
r = -0.38, p = 0.003 More severe 
depressive 
symptoms in more 
severe  
AD 
HDRS (17-item version): 
M(SD)= 12.4(5.8), Range= 2-27 
(1) Kruskal-Wallis rank test: comparison 
between mildly, moderately and severely 
impaired groups (based on MMSE) 
regarding HDRS score;  
(2) Spearman correlation between HDRS 
and MMSE scores  
(1) Mildly impaired group:  
M(SD)= 13.1(6.5); 
Moderately impaired group:  
M(SD)= 14.3(5.2);  
Severely impaired group:  
M(SD) = 9.9(3.9)  
Overall: p < 0.05  
 
(2) r = 0.27, p < 0.05 
(1&2) 
Less severe 
depressive 
symptoms in more 
severe  
AD 
 
SDS: 
M= 41.2 
 
MDD (DSM-III criteria): 41% 
 
ANOVA: comparison between mildly, 
moderately and severely impaired groups 
(based on MMSE) regarding SDS score  
Mildly impaired group:  
M= 41.4; Moderately 
impaired group: M= 41.6;  
Severely impaired group:  
M= 40.6; Overall: F= 0.98, 
d.f. = 2 and 19, n.s. 
No significant 
association  
HDRS (17-item version):  
M(SD)= 10.5(5.73), Range= 2-
24 
Pearson correlation with Bonferroni 
correction between HDRS and MMSE scores  
  
r = -0.33, n.s. No significant 
association  
HDRS (17-item version):  
(a) patient‟s report: 
M(SD)= 5.0(5.2), Range= 0-26 ;  
(b) caregiver‟s report: 
M(SD)= 7.6(6.9), Range= 0-30;  
(c) clinician‟s evaluation: 
M(SD)= 8.2(6.9), Range= 0-30  
MDD (DSM-III-R criteria): 29%  
3(source) x 3(severity of AD) repeated 
measures MANOVA:  
Dependent: HDRS score;  
Severity of AD: 
mild, moderate, severe (based on MMSE); 
Source:  
patient, caregiver or clinician 
No significant effect of  
severity of AD 
No significant 
association  
Dementia 17; df, degrees of freedom DMAS, Dementia Mood Assessment Scale 23; DRS, Mattis Dementia Rating Scale 28; DSM, 
Depression Scale 29-30; GDS, Global Deterioration Scale 16; HDRS, Hamilton Depression Rating Scale 18,31; ICD-10, International 
Scale 32; MDD, Major Depressive Disorder; MMSE, Mini-Mental State Examination 15; NINCDS-ADRDA, National Institute of 
Neuropsychiatric Inventory 22; n.s., not significant; PLSD, Fisher‟s Protected Least Significant Difference; RMBPC, Revised  
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Table 2  
Studies on the association between severity of dementia and prevalence of diagnosed depression in patients with Alzheimer‟s 
Disease (AD) 
Study Quality Diagnostic 
criteria for 
AD 
Characteristics of AD patientsa  Severity of AD 
Harwood  
et al., 
2000b 
3 NINCDS-
ADRDA 
criteria for 
possible/ 
probable AD  
n = 96; Outpatients; Female gender: 70%; 
Age: M(SD)= 74.9(6.8); 
Education: M(SD)= 9.9(5.2); 
Cuban American: 100%; 
Functional status (BDS): M(SD)= 5.8(4.2) 
Presence of delusions/hallucinations: 32.3% 
MMSE: 
M(SD)= 15.9(6.5) 
Lyketsos  
et al., 
1997  
3 NINCDS-
ADRDA 
criteria for 
probable AD 
n = 109 
Outpatients 
Female gender: 79% 
Age: M(SD)= 74.4(7.9) 
History of depressive disorder: 17.4%.  
 
 
 
(1) CDR: 
Early (score: 0.5): 9.8%;  
Mild (score: 1): 38.2%;  
Moderate (score: 2): 29.4%;  
Severe (score: 3): 21.6%  
 
(2) MMSE:  
M(SD)= 15.0(6.5), Range= 0-28 
Ballard  
et al., 
1996  
3 NINCDS-
ADRDA 
criteria for 
possible/ 
probable AD  
n = 88; Outpatients 
 
Total sample of patients with dementia  
(n = 124)c: 
Female gender: 73% ; Age: M= 79.6 
 
Exclusion criteria: fulfilment of the 
CAMDEX criteria for severe dementia  
CAMCOG: 
Total sample of patients with dementiac: 
M= 43.9  
 
  
Lopez  
et al., 
2003  
2 NINCDS-
ADRDA 
criteria for 
probable AD 
n = 1,155; Outpatients;  
Female gender: 70%; 
Education: M(SD)= 12.0(3.0); 
Duration AD: M(SD)= 4.0(2.7); 
African Americans: 6.3% ; 
BDS: M(SD)= 6.1(4.2) 
Antidepressants: 19.0% 
Sedatives, hypnotics and anxiolytics: 6.3% 
Antipsychotics: 7.7% 
(1) MMSE: M(SD)=16.9(6.1);  
Mild (score: ≥20): 37.9%; Moderate (score: 
10-19): 48.7%; Severe (score: ≤9): 13.3%  
 
(2) DRS: M(SD)= 107.4(22.9)  
 
(3) CDR: M(SD)= 1.3(6.8)  
Payne  
et al., 
1998  
2 NINCDS-
ADRDA 
criteria for 
possible  
or probable 
AD 
n = 151; Outpatients;  
Female gender: 81%; 
Age: M(SD)=78.1(7.9); 
Caucasian: 80.7%; 
Functional status (PGDRS-P):  
M(SD)= 7.5(7.5)  
MMSE: 
M(SD)=14.7 
(7.3) 
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Prevalence  
of  
depressionb 
Statistical analysis Results Direction of 
association 
Depression (CSDD score: ≥7): 
39.6% 
 
CSDD (all AD patients): 
M(SD)= 7.4(6.9), Range=  
0-28  
Multivariate logistic regression: 
Dependent: depression (0/1); 
Independent: MMSE score; 
Covariates: age, education, gender, 
marital status, functional status and 
psychosis  
OR(95% CI)= 0.9 (0.9-1.0),  
p = 0.25 
No significant 
association  
(a) MDD (DSM-IV criteria): 22%; 
(b) Minor depression (depressed 
mood, crying spells, or anhedonia 
according to CSDD and CSDD 
score: >6): 27%; (c) remaining 
patients: 51%  
 
CSDD (all AD patients):  
M(SD)= 8.0(7.2), Range= 0-28 
Chi-square test: Distribution of the 
3 depression groups across CDR 
scores  
Χ2= 5.86, d.f.= 4, p = 0.21 No significant 
association  
MDD (depressive symptoms were 
rated using the CSDD; next, 
diagnosis was made according to  
the RDC criteria): 17.0% 
 
CSDD (all AD patients):  
M= 9.2  
Bivariate logistic regression: 
Dependent: depression (0/1); 
Independent: CAMCOG score  
 
Wald chi-square test= 0.63,  
p = 0.43  
No significant 
association  
MDD (depressive symptomatolo-gy  
was rated using the BRSD, HDRS 
and BDS; next, diagnosis was 
made according to DSM-III/ -III-R/ 
-IV criteria): 17.0% 
 
HDRS (all AD patients; 17-item 
version): M(SD)= 6.4(4.4) 
Chi-square test: Comparison 
between mildly, moderately and 
severely impaired groups (based on 
MMSE) regarding frequency of MDD  
MDD: 
Mildly impaired group:  
11.5%;  
Moderately impaired group: 
10.0%; 
Severely impaired group: 
4.5%; 
Χ2= 6.03, d.f.= 2, p = 0.04 
 
 
Lower likelihood of 
depression in more 
severe AD 
Depression (CSDD score: >12): 17% 
 
CSDD (all AD patients):  
M(SD)= 6.6(6.1), Range= 0-25  
(1)  
bivariate logistic regression:  
Dependent: depression (0/1); 
Independent: MMSE score  
  
(2)  
multivariate logistic regression:  
Covariate: functional status 
(1)  
OR(95% CI)= 1.03 (0.97-1.09) 
 
(2)  
OR(95% CI)= 1.09 (1.01-1.19)  
(1)  
No significant 
association 
  
(2)  
Lower likelihood of 
depression in more 
severe AD 
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Table 2 continued 
Study Quality Diagnostic 
criteria for 
AD 
Characteristics of AD patientsa  Severity of AD 
Fitz and  
Teri, 1994 
1 DSM-III-R 
criteria for 
AD 
n = 91; Outpatients; 
Female gender: 55% 
Age: Range: 46-90 
 
 
DRS: 
M(SD)= 102(18.8), Range= 56-139;  
Mild (score: <102): 49.5%;  
Moderate (score: >103): 50.5%  
Troisi et 
al., 1993  
1 NINCDS-
ADRDA 
criteria for 
probable AD 
n = 26 
Outpatients 
Female gender: 54%  
Age: M(SD)= 74.0(5.53), Range= 65-84 
Education: M(SD)=7.15 
(5.03), Range= 0-19 
 
 
(1) MMSE: 
mild-moderate (score: 16-23): 50%;  
severe (score: ≤15): 50%  
 
(2) DSM-III-R: 
Mild: 26.9% 
Moderate: 42.3% 
Severe: 30.8%  
ADRDA, National Institute of Neurological and Communicative Diseases and Stroke-Alzheimer‟s Disease and Related Disorders 
Registry for Alzheimer‟s Disease (CERAD) 37; CAMCOG, Cambridge Cognitive Examination 34; CAMDEX, Cambridge Mental for 
Depression in Dementia 17; df, degrees of freedom; DRS, Mattis Dementia Rating Scale 28; DSM, Diagnostic and Statistical 
Depression Rating Scale 18; MDD, Major Depressive Disorder; NINCDS––MMSE, Mini-Mental State Examination 15; n.s., not 
Diagnostic Criteria 40. 
a Data concerning education and duration of AD are presented in years, unless stated otherwise. Only psychiatric exclusion 
criteria are presented. 
b If available scores on depression rating scales for the sample of patients with AD are also presented. 
c No (further) data concerning the sample of patients with AD were reported. 
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Prevalence  
of  
depressionb 
Statistical analysis Results Direction of 
association 
MDD (DSM-III-R criteria): 50.5%  Comparison between mildly and 
moderately impaired groups (based 
on DRS) regarding frequency of MDD  
MDD: 
Mildly impaired group:  
56.5%;  
Moderately impaired group: 
44.4%; n.s. 
  
No significant 
association 
MDD (DSM-III-R criteria): 23.1%  Chi-square tests: 
(1) comparison between control, 
mildly-moderately and severely 
impaired groups (based on MMSE) 
regarding frequency of MDD  
 
(2) comparison between control, 
mildly, moderately and severely 
impaired groups (based on DSM-III-R 
criteria) regarding frequency of 
MDD  
(1) MDD: 
mildly-moderately impaired 
group: 7.7%; 
severely impaired group: 38.5%;  
control group: 11.5%;  
Χ2= 5.51, d.f.= 2, p = 0.06  
 
(2) MDD: 
Mildly impaired group: 0%; 
Moderately impaired group: 
11.5%;  
Severely impaired group: 11.5%;  
Control group: 11.5%;  
Χ2= 5.11, d.f.= 3, n.s.  
  
(1&2)  
No significant 
association 
Association 11; BDS, Blessed Dementia Scale 36; BRSD, Behavioral Rating Scale for Dementia of the Consortium to Establish a 
Disorders in the Elderly Examination 34; CDR, Clinical Dementia Rating Scale 27; CI, Confidence Interval; CSDD, Cornell Scale 
Manual of Mental Disorders, third (DSM-III), third revised (DSM-III-R) or fourth (DSM-IV) edition 38, 13-14; HDRS, Hamilton 
significant; OR, Odds Ratio; PGDRS-P, Psychogeriatric Dependency Rating Scale- Physical dependency scale 39; RDC, Research  
Chapter 4 
 
96 
 
4.4 Conclusion and discussion 
 
The main conclusion of this systematic review is that, based on current 
knowledge,  evidence exists for a lack of association between the severity of 
AD and the prevalence of comorbid depressive symptoms or depression.   
Earlier non-systematic literature reviews 
e.g. 41
 often stated that no conclusions 
about the relationship between the severity of AD and the prevalence of 
comorbid depression could be drawn due to large differences between existing 
studies. In this review we used various methods to overcome this problem: in 
the first place selection criteria were formulated that make sure that (1) all 
study samples consisted of people with AD and, (2) valid assessment methods 
for depression and severity of AD were used. Secondly, selected studies were 
categorized into two groups: those that focused on the prevalence of 
depressive symptoms (continuous approach) and those that examined the 
prevalence of diagnosed depression (categorical approach). In addition the 
quality of all selected studies was rated, in order to select the studies with the 
highest validity.  
Limitations of this review are that only studies published in English were 
included and studies that did not have depression or depressive disorder as a 
keyword were not identified. We do however not consider it very likely that 
high quality studies were missed because of this. 
The finding that comorbid depressive symptomatology or diagnosed depression 
is not more prevalent in early, mild or severe AD contrasts with what is often 
theorized in physiological and psychological theories. These theories 
hypothesize that the prevalence of depression  either decreases (psychological 
theories) or increases (physiological and psychological theories) with the 
increasing severity of AD. Interactive theories 
42
 do however offer a possible 
explanation for the current findings. According to these theories the 
neurological and psychosocial factors can reinforce or diminish each other, 
depending on the specific situation of a patient. Only a longitudinal study 
could give more insight into the mechanisms underlying the aetiology of 
depression in AD.  
Following the systematic approach of this review and using current knowledge, 
such a longitudinal study should ideally meet the following criteria: (a) 
establishing diagnosis of AD according to NINCDS-ADRDA criteria 
11
; (b) 
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assessing severity of AD with a clinical instrument (e.g. CDR 
21
  or GDS 
16
); (c) 
assessing symptoms of depression with an instrument specifically developed for 
people with dementia or specifically AD (e.g. CSDD 
17
 or NPI-depression 
subscale 
22
); (d) establishing diagnosis of depression according to criteria 
specifically developed for people with AD, such as the Provisional Diagnostic 
Criteria for Depression of Alzheimer‟s Disease 41; (e) using multivariate analytic 
techniques to control for known potentially important confounders (e.g. 
gender, history of depression, current use of antidepressant or psychotropic 
medication). 
For clinical practice the conclusion of the review shows that the development 
of specific interventions for signalling, preventing and treating comorbid 
depression in the different severities of AD should continue.  
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Abstract 
 
Background: Depression is highly comorbid with both psychiatric and chronic 
somatic disease. These types of comorbidity have been shown to exert 
opposite effects on underdiagnosis of depression by general practitioners 
(GPs). However, past research has not addressed their combined effect on 
underdiagnosis of depression.  
Methods: Comorbidity data of 191 depressed primary care patients selected by 
a two-stage sampling procedure were analysed. Diagnoses of major depression 
and/or dysthymia in the last 12 months were assessed using a standardised 
psychiatric interview (CIDI) and compared with depression diagnoses registered 
by GPs in patient contacts during the same period. Presence of psychiatric and 
chronic somatic comorbidity was determined using the CIDI and contact 
registration, respectively. 
Results: Regression analysis showed a significant interaction between 
psychiatric and chronic somatic comorbidity, while taking into account the 
effects of sociodemographic variables, depression severity and number of GP 
contacts. Subsequent stratified analysis revealed that in patients without 
chronic somatic comorbidity, a lower educational level, a less severe 
depression, and less GP contacts all significantly increased the likelihood of 
being not diagnosed as depressed. In contrast, in patients with chronic somatic 
comorbidity only having no psychiatric comorbidity significantly decreased 
the likelihood of receiving a depression diagnosis.  
Conclusions: Our results indicate that there are differential effects of 
psychiatric comorbidity and other factors on underdiagnosis of depression by 
GPs among depressed patients with and those without chronic somatic 
comorbidity. Efforts to improve depression diagnosis by GPs seem to require 
different strategies for depressed patients with and those without chronic  
somatic comorbidity.  
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5.1 Introduction 
 
Major depressive disorder (MDD) is a common disorder associated with 
significant disability, poorer quality of life, increased morbidity and mortality, 
and increased use of health services 
1-2
. MDD does not occur frequently in pure 
form, but is often comorbid with other psychiatric disorders, in particular 
anxiety disorders 
3-4
, and a wide range of  long-term medical conditions, 
including endocrine, neurological, cardiac, digestive, and respiratory 
disorders, cancer, diabetes mellitus, arthritis, hypertension, and acquired 
immunodeficiency syndrome 
5-7
. 
Most depressive disorders are managed exclusively by general practitioners 
(GPs) 
8
. However, despite being one of the most prevalent disorders in primary 
care 
1
, depression is poorly recognised and diagnosed by GPs, with most studies 
reporting a rate of underdiagnosis falling in the 60% to 70% range
 9-10
. Although 
the clinical significance of this underdiagnosis has been argued 
8
, several lines 
of research underline that is worthwhile to improve the diagnosis of depression 
in primary care. First, a substantial proportion of undetected depressed 
patients have persistently poor outcomes over the course of one year
 11-12
. 
Second, there is evidence for the efficacy of both pharmacological and 
psychotherapeutic interventions for the treatment of MDD in primary care
 13-14
. 
The third and most important evidence is provided by recent systematic 
reviews of primary care trials, which have concluded that, compared with 
usual care, quality improvement efforts aimed at improving detection of 
depression can improve patients outcomes provided that those recognized 
receive adequate treatment and follow-up
 15-16
. To improve the detection rate 
of depression by GPs, it is important to have detailed knowledge about the 
barriers to the diagnosis of depression. In this respect the impact of the 
frequent presence of comorbidity on underdiagnosis of depression should be 
more thoroughly examined. 
Previous studies have shown that patients with MDD have a higher risk of being 
not diagnosed as depressed by GPs if they have additional somatic illness(es)
 17-
21
. In contrast, the co-occurrence of MDD and anxiety has been found to 
facilitate recognition of depression 
22
 or psychiatric caseness
 21, 23-25
. However, 
these studies examined the effects of psychiatric and somatic comorbidity on 
underdiagnosis of depression separately and did not address their combined 
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effect at all. Because a substantial proportion of depressed primary care 
patients is expected to have both somatic as well as psychiatric comorbidity 
6, 
26
 it is important to examine their combined effect, in particular in the context 
of their suggested opposite effects on underdiagnosis of depression. Therefore, 
the current study examines whether there is an interaction effect between 
psychiatric and chronic somatic comorbidity on GPs‟ diagnosis of depression, 
while accounting for the effects of factors that are frequently reported to be 
associated with depression diagnosis (i.e. sociodemographic factors, severity of 
depression, and number of contacts with GP). If so, then the effects of 
psychiatric comorbidity and the other factors will be studied in subgroups of 
depressed patients with and without chronic somatic comorbidity. The results 
could lead to a more precise identification of barriers to the diagnosis of 
depression and thereby contribute to improved quality of GP care and 
outcomes of MDD in primary care.        
 
   
5.2 Method 
 
Study setting 
Data collection took place within the framework of the second Dutch National 
Survey of General Practice (2001; DNSGP-2 
27
), a nationwide study of morbidity 
and interventions in general practice in the Netherlands. The DNSGP-2 was 
carried out in 104 practices comprising of 195 GPs, who served approximately 
390000 persons.  The participating GPs were representative for all GPs in the 
Netherlands regarding age, gender, region of residence and urbanisation. 
Dutch GPs are gatekeepers for secondary health care and nearly all non-
institutionalised persons are listed to a GP. Three datasets were used, i.e. 
data from (a) a health interview survey; (b) a standardised psychiatric 
interview, and (c) a contact registration. 
 
Participants  
A random sample of the practice population (n = 12,699) participated in an 
extensive health interview survey (response rate = 64.5%), spread over a whole 
year to avoid seasonal patterns. In total 1379 patients aged 18 and older had 
an indication of psychopathology as measured by two screening instruments 
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included in the health interview (see below). These patients were approached 
for follow-up psychiatric assessment using the Composite International 
Diagnostic Interview (CIDI) 
28
 , and 58.8% (n = 811) were actually assessed. CIDI 
data of 235 patients were not examined in this study because: (1) the data 
were either incomplete (n = 11) or obtained by using erroneously an earlier 
version of the CIDI (n = 6); (2) patients were diagnosed by their GP as either 
having dementia (n = 2) or a psychotic illness (n = 2) and presence of these 
disorders was not assessed using the CIDI; (3) patients had no contact with 
their GP within the time frame covered by the CIDI (n = 214). The remaining 
576 patients did not differ significantly from the eligible patients who were not 
examined (n = 803) regarding age, educational level, GHQ-, and CAGE- scores, 
though, a higher proportion was female (p < .01). Of the 576 patients those 
were included in the final study population who fulfilled the DSM-IV criteria for 
MDD and/or dysthymia according to the CIDI (n = 191).   
 
Measures 
The Dutch version of the 12-item General Health Questionnaire (GHQ-12) was 
administered as a screener for nonpsychotic psychiatric morbidity 
29
. Scores of 
≥4 (first half of 2001) or ≥3 (second half of 2001) were used as thresholds for 
follow-up psychiatric assessment. The cut-off score was lowered to enlarge the 
group of eligible patients. A three/four threshold has a high sensitivity (84.6%) 
and specificity (89.3%) in a primary care setting 
30
. Additionally, the Dutch 
version of the CAGE questionnaire was used to identify patients with alcohol 
problems 
31
. The maximum score of four positive answers was used as a 
threshold for further psychiatric assessment. Although this criterion is highly 
specific for detecting alcohol abuse/dependence in primary care patients, it 
has a low sensitivity (23%) 
32
. However, since this study examined patients with 
MDD who were already detected by the highly sensitive GHQ-12, falsely low 
prevalence rates of alcohol related disorders due to this low sensitivity were 
avoided.   
The CIDI is a fully structured interview that allows administration by trained 
lay interviewers. The Dutch version of the computerised CIDI-auto 2.1 was used 
33
. The fully specified structure does not allow judgement of the interviewer to 
intervene. Standardized probe questions establish that psychiatric symptoms 
are clinically significant and not due to medication, drugs or alcohol or to a 
physical illness or injury. After completion of the interview, computerized 
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algorithms provide diagnoses according to the DSM-IV. The presence of the 
following psychiatric disorders in the past 12 months was determined: phobic 
and other anxiety disorders, depressive disorders and dysthymic disorder, 
manic and bipolar affective disorder and disorders resulting from the use of 
alcohol. During the interview, respondents are asked about the first and last 
occurrence of psychiatric symptoms, on the basis of which the period during 
which a psychiatric disorder was present was estimated for each patient. 
During one year, all GPs electronically recorded each diagnosis made during 
their contacts with a patient, coded according to the International 
Classification of Primary Care (ICPC) 
34
. Contacts belonging to the same health 
problem were clustered into disease episodes.  
 
Definitions 
DSM-IV diagnoses obtained from the CIDI were considered as the reference 
standard. Patients were regarded to be depressed in case of a diagnosis of MDD 
and/or dysthymia (hereafter referred to as “depressed patients”). For all 
patients the diagnosis was considered positive when all diagnostic criteria (in-
clusion as well as exclusion criteria) were fulfilled, with the exception of two 
patients with dysthymic disorder for whom only inclusion criteria were met. 
A GP diagnosis of depression could be coded under depression (ICPC code P76), 
which is based on the criteria of the International Classification of Health 
Problems in Primary Care 
35
. These criteria are largely consistent with those of 
DSM-IV. In addition, depressive symptoms could also be coded under depressive 
feelings (ICPC code P03). Therefore, patients having an episode P76 and/or 
P03 were considered to be diagnosed as depressed by their GP, while patients 
without such episodes were considered to be not.  
The presence of psychiatric comorbidity was determined on the basis of the 
CIDI data and was defined as having at least one CIDI diagnosis other than 
MDD/dysthymia. Psychiatric comorbidity had to be present during at least one 
GP-patient contact. The following three categories of psychiatric comorbidity 
were formed: alcohol abuse/dependence, bipolar disorder, and anxiety 
disorder, including the five subcategories panic disorder, agoraphobia (without 
panic), social phobia, generalized anxiety disorder (GAD), and simple phobia.      
The presence of chronic somatic comorbidity was determined on the basis of 
ICPC coded diagnoses of chronic conditions recorded by GPs and defined as 
having at least one episode of chronic disease. It was ascertained that chronic 
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somatic comorbidity was present during the period of MDD and/or dysthymia. 
The following eight categories of chronic somatic comorbidity were created, 
based on the body systems involved: neurological conditions (migraine or 
regular serious headache, dizziness, Parkinson‟s disease, multiple sclerosis, 
epilepsy), musculoskeletal conditions (chronic rheumatism, rheumatic 
complaints of hips and knees, serious or persistent neck/shoulder, back, and 
hands/elbow/wrist disorder), circulatory conditions (hypertension, vascular 
disorder, myocardial infarction, other serious heart disorders, stroke), 
respiratory conditions (asthma/chronic bronchitis or chronic nonspecific lung 
disease), skin conditions (chronic eczema, psoriasis), endocrine, metabolic, 
and nutritional conditions (diabetes mellitus, hyperthyroidism, hypothyroi-
dism), digestive conditions (serious disorders of the intestine longer than three 
months, e.g. Crohn‟s disease), and a rest category (incontinence, cancer, HIV 
infection, glaucoma). 
Other explanatory variables included sociodemographic and clinical variables 
which frequently have been found to be associated with GPs‟ diagnosis of 
depression 
10, 36
. Sociodemographic data (age, gender, highest educational 
level attained) were derived from the health interview survey. Educational 
level was categorised into three classes: low (none, elementary school), 
middle (high school), and high (college or university).  Severity of depression 
was derived from the CIDI and was operationalised as the number of depressive 
symptoms with scores ranging from 5 to 9 (DSM-IV criterion A for MDD). 
Patients who had a diagnosis of dysthymia alone (n = 7) were given a score of 
four on this measure. Annual number of GP-patient contacts was categorised 
by quartiles, which resulted in the categories 1-3, 4-6, 7-10, and ≥ 11 contacts. 
 
Statistical analyses 
Rates of GPs‟ depression diagnosis in subgroups of depressed patients based on 
comorbidity characteristics were calculated to explore the relationship 
between comorbidity status and depression diagnosis. In a second explorative 
analysis, the bivariate relationships between comorbidity, sociodemographic 
(age, gender, educational level) and clinical (depression severity and GP 
contact rate) variables and depression diagnosis were examined using simple 
logistic regression analyses. Next, multivariate logistic regression analysis was 
conducted in three steps. The first model entered psychiatric comorbidity and 
chronic somatic comorbidity. In addition to the comorbidity variables, model 2 
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entered the sociodemographic and clinical variables. The final multivariate 
model included model 1 and 2 variables, plus the interaction term between 
psychiatric and chronic somatic comorbidity. In case of a significant 
interaction effect, separate multivariate analyses were carried out in patient 
subgroups stratified by presence or absence of chronic somatic comorbidity.   
Additional regression analyses were performed to explore the effects of the 
number of comorbidities (categorised into three categories: no, 1, and ≥ 2) and 
the specific comorbid disease categories. Also, a number of supplementary 
analyses were performed to test the robustness of the multivariate logistic 
regression results. First, several studies have reported an association between 
depression severity and psychiatric comorbidity, in particular anxiety 
comorbidity 
e.g. 37
. To examine a possible collinearity effect between these 
variables multivariate regression analyses were repeated without the variable 
depression severity. Second, to examine whether the possible inclusion of 
unexplained symptoms affected the results analyses were repeated after 
excluding patients with symptom diagnosis only and no somatic disease 
diagnosis. Third, to test whether lowering the GHQ-12 cut-off score influenced 
the results analyses were repeated including a dummy variable GHQ threshold. 
Finally, all analyses were repeated in multi-level models to examine whether 
the results were affected by variations among the general practices.  
Analyses were conducted using SPSS version 11.0 for Windows, except for the 
multilevel analyses, which were performed using the MLwiN software version 
1.1. Significance was accepted at the 5% level. 
 
 
5.3 Results 
 
Study population characteristics and depression diagnosis rates 
Table 1 illustrates the characteristics of the 191 depressed patients. According 
to the CIDI, 157 patients had MDD alone, seven had dysthymia alone, and 27 
had both MDD and dysthymia. Psychiatric comorbidity was present in just over 
half of the depressed patients, about the same prevalence rate as chronic 
somatic comorbidity. Anxiety disorder was by far the most common comorbid 
psychiatric disorder, with GAD being the most frequent specific anxiety 
disorder, and the most prevalent comorbid chronic somatic disease category 
was musculoskeletal, followed by the circulatory and neurological categories.  
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Table 1   
Characteristics of the depressed patients (percentages unless stated otherwise)  
 Total group 
(n = 191) 
 
 
Age (years): mean (SD) 
Gender  
   Male 
   Female 
Educational level  
   Low 
   Middle 
   High  
Depression severity: mean (SD) 
Annual number of GP contacts 
   1-3   contacts 
   4-6   contacts 
   7-10  contacts  
   ≥ 11  contacts 
No comorbidity 
Psychiatric comorbidity 
Chronic somatic comorbidity 
Psychiatric and somatic comorbidity  
Number of psychiatric comorbidities: 
   no  comorbidity 
   1    comorbidity 
    2 comorbidities 
Number of chronic somatic comorbidities: 
   no  comorbidity 
   1    comorbidity 
    2 comorbidities 
Categories of psychiatric comorbidity: 
   anxiety disorder 
   alcohol abuse/ dependence 
   bipolar disorder 
Categories of chronic somatic comorbidity: 
   musculoskeletal       
   circulatory   
   neurological      
   skin  
   endocrine/ metabolic/ nutritional   
   digestive  
   respiratory   
   rest category 
45.4  
 
27.7 
72.3 
 
38.2 
35.6 
26.2 
6.6  
 
19.4 
25.7 
28.3 
26.7 
20.4 
53.4 
51.8 
25.7 
 
46.6 
31.4 
22.0 
 
48.2 
26.2 
25.7 
 
49.2 
7.9 
1.0 
 
29.3 
16.2 
10.5 
9.4 
4.7 
3.7 
3.1 
1.6 
(14.1) 
 
 
 
 
 
 
 
(1.2) 
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About a quarter of the patients had both psychiatric and chronic somatic 
disease in addition to their depression, while two-fifths had no comorbidity.  
As shown in Table 2, fifty-five of the 191 depressed patients were diagnosed as 
depressed by GPs (ICPC code P76: n = 41; ICPC code P03: n = 11; both codes:   
n = 3), while 136 depressed patients were not diagnosed, resulting in an 
overall rate of underdiagnosis of 71.2%. 
 
 
Table 2    
Rate of GPs‟ diagnosis of depression in subgroups of depressed patients based on comorbidity 
characteristics  
 GPs‟ depression  
diagnosis rate 
All depressed patients (n = 191) 28.8% 
Subgroups by comorbidity status:  
Patients with psychiatric comorbidity (n = 102) 35.3% 
Patients without psychiatric comorbidity  (n = 89) 21.3% 
Patients with chronic somatic comorbidity (n = 99) 26.3% 
Patients without chronic somatic comorbidity (n = 92) 31.5% 
Subgroups stratified by chronic somatic comorbidity:  
Patients without chronic somatic comorbidity and  
    - with psychiatric comorbidity (n = 53) 
 
34.0% 
    - without psychiatric comorbidity (n = 39) 28.2% 
Patients with chronic somatic comorbidity and  
   - with psychiatric comorbidity (n = 49)  
 
36.7% 
 - without psychiatric comorbidity (n = 50) 16.0% 
 
Interestingly, the depression diagnosis rates in patient subgroups based on 
comorbidity characteristics suggest a possible interaction effect between 
psychiatric and chronic somatic comorbidity on depression diagnosis. That is, 
the difference in depression diagnosis rate between depressed patients with 
psychiatric comorbidity and those without psychiatric comorbidity was small in 
the subgroup of patients without chronic somatic comorbidity as compared to 
the substantial difference observed in the subgroup of patients with chronic 
somatic comorbidity.  
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Logistic regression results 
As shown in Table 3, bivariate analyses revealed that having no psychiatric 
comorbidity, having fewer contacts with a GP, and being less severely 
depressed all significantly increased the risk of underdiagnosis of depression.  
 
Table 3   
Results of bivariate logistic regression for GPs‟ depression diagnosis in depressed patients    
 
OR (95.0% CI) 
Psychiatric co-morbiditya 
Chronic somatic co-morbidityb 
Age 
Genderc 
Educational level 
Annual number of GP contacts  
Depression severity 
                    2.01 (1.05 - 3.85)d 
                    0.77 (0.41 - 1.45) 
                    0.99 (0.97 - 1.02) 
                    0.81 (0.41 - 1.60) 
                    1.31 (0.88 - 1.94)        
                    1.41 (1.08 - 1.86)d 
                    1.71 (1.24 - 2.35)e 
    OR, odds ratio; CI, confidence interval.  
      a Reference group: those without psychiatric co-morbidity. b Reference group: those without  
chronic somatic co-morbidity. c Reference group: males.  d p < .05; e p < .001 
 
The multivariate results are also presented in table 4. Shown are the main 
effects of psychiatric and chronic somatic comorbidity on depression diagnosis 
when considered jointly in the same model (model 1) and when all other 
explanatory variables were entered (model 2). As a last step, the interaction 
between the two comorbidity types was entered. Importantly, this final 
multivariate model showed a significant interaction effect between psychiatric 
and chronic somatic comorbidity on depression diagnosis. Subsequent stratified 
analysis (see table 5) revealed that psychiatric comorbidity had no significant 
effect on depression diagnosis in patients without chronic somatic comorbidity. 
Having a lower educational level, having a lower annual number of GP contacts 
and having a less severe level of depression all significantly increased the risk 
of underdiagnosis of depression in this patient subgroup. In contrast, in 
patients with chronic somatic comorbidity, psychiatric comorbidity was 
significantly associated with depression diagnosis: depressed patients with 
chronic somatic comorbidity but no psychiatric comorbidity were more likely  
to receive no depression diagnosis than those with both psychiatric and chronic 
somatic and comorbidity. None of the other variables was significantly 
associated with depression diagnosis in this patient subgroup.  
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Table 4   
Results of multivariate logistic regression for GPs‟ depression diagnosis in depressed patients    
  
Multivariate 
 Model 1                      Model 2                   Final Model 
 OR (95.0% CI)                OR (95.0% CI) OR (95.0% CI) 
Psychiatric co-morbiditya 
Chronic somatic co-morbidityb 
Psychiatric x  
   chronic somatic co-morbidity 
Age 
Genderc 
Educational level 
Annual number of GP contacts  
Depression severity 
1.98 (1.03 - 3.80)d 
0.81 (0.43 - 1.54) 
  
 
1.32 (0.63 - 2.76) 
0.65 (0.30 - 1.42) 
  
 
0.99 (0.97 - 1.02) 
0.56 (0.25 - 1.22) 
1.72 (1.07 - 2.77)d        
2.13 (1.44 - 3.18)e 
1.34 (0.99 - 1.82) 
0.55 (0.19 - 1.58) 
0.24 (0.07 - 0.78)d 
 
5.32 (1.23 - 22.98)d 
0.99 (0.96 - 1.02) 
0.57 (0.26 - 1.27) 
1.84 (1.13 - 2.98)d        
2.34 (1.54 - 3.54)e 
1.39 (1.02 - 1.90)d 
Nagelkerke R square 0.037 0.19 0.23 
    OR, odds ratio; CI, confidence interval.  
      a Reference group: those without psychiatric comorbidity. b Reference group: those without chronic  
somatic comorbidity. c Reference group: males.  d p < .05; e p < .001 
  
 
 
 Table 5  
 Results of logistic regression analysis for GPs‟ depression diagnosis in depressed patients  stratified 
by presence of chronic somatic comorbidity 
 
No chronic  
somatic comorbidity 
(n = 92) 
 
Chronic  
somatic comorbidity 
(n = 99) 
 
OR (95.0% CI) 
 
OR (95.0% CI) 
Psychiatric comorbiditya 
Age 
Genderb 
Educational level 
Annual number of GP contacts  
Depression severity  
0.33 (0.093-1.18) 
0.98 (0.94-1.03) 
0.32 (0.088-1.15) 
3.04 (1.23-7.24)c 
3.80 (1.92-7.53)d  
1.88 (1.15-3.07)c 
 2.99 (1.06-8.39)c 
0.99 (0.95-1.03) 
0.70 (0.24-2.11) 
1.39 (0.73-2.63) 
1.72 (0.95-3.11) 
1.13 (0.72-1.76) 
Nagelkerke R square 0.36  0.16 
OR, odds ratio; CI, confidence interval.  
a Reference group: those without psychiatric comorbidity. b Reference group: males.  
c p < .05; d p < .001 
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Additional multivariate analyses: number and category of comorbidity 
The number of psychiatric comorbidities exerted no significant effect in 
patients without chronic somatic comorbidity, whereas among patients with 
chronic somatic comorbidity a lower number of psychiatric comorbidities 
decreased the likelihood of receiving a depression diagnosis (OR = 2.40; 95% CI: 
1.26 to 4.59; p < .01). Again, significant effects of education, number of GP 
contacts, and depression severity were confined to patients without chronic 
somatic comorbidity. Regarding specific comorbidity categories, patients with 
a comorbid musculoskeletal condition but no comorbid GAD were more likely 
to receive no depression diagnosis than patients with both a comorbid 
musculoskeletal condition and a comorbid GAD (OR = 6.17; 95% CI: 1.39 to 
27.41; p < .05). In contrast, in patients without a comorbid musculoskeletal 
condition no effect of comorbid GAD was found. Again, only in these latter 
patients significant effects were present for education, contact rate and 
depression severity. The effects of other specific categories were not 
analysed, because patient numbers were too small for meaningful analysis. 
 
Additional multivariate analyses: robustness of findings 
Supplementary multivariate analyses underlined the robustness of the findings. 
That is, a model excluding depression severity, a model taking into account 
lowering of the GHQ-12 threshold, and a model allowing for the variation 
among practices, all yielded basically identical results. Exclusion of the 17 
patients who were diagnosed only with (possible unexplained) symptoms 
revealed also essentially the same results, except that the effect of psychiatric 
comorbidity on depression diagnosis was no longer significant among the 
patients with chronic somatic comorbidity (OR= 2.64; 95% CI: 0.92 to 7.54;  
p < .10).  
 
 
5.4 Discussion 
 
About half of our sample of patients who had depression as assessed according 
to the CIDI had either comorbid psychiatric or comorbid chronic somatic 
disease. Nearly a quarter of the depressed patients exhibited both types of 
comorbidity, and this high rate underlines the importance of studying the 
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impact of having both chronic somatic as well as psychiatric comorbidity on 
underdiagnosis of depression by GPs. Previous studies examined the effects of 
psychiatric and somatic comorbidity only separately. Our study elaborated on 
the past research and showed that there is an interaction effect between 
psychiatric and chronic somatic comorbidity on depression diagnosis. Only in 
depressed patients with a comorbid chronic somatic condition did having no 
psychiatric comorbidity increase the risk of being not diagnosed as depressed. 
Furthermore, none of the other factors under study were found to exert 
significant effects in this subgroup of patients, while in those without chronic 
somatic comorbidity, a lower educational level, a lower annual number of GP 
contacts and a less severe level of depression all increased the likelihood of 
being not diagnosed as depressed.  
It should be noted that the effect of psychiatric comorbidity in patients with 
chronic somatic comorbidity was no longer significant after excluding patients 
with only symptom diagnoses. Further research is needed to determine 
whether this was caused by reduced statistical power or that it indicates that 
the significant psychiatric comorbidity effect in our total group of patients 
with chronic somatic comorbidity is a coincidental finding. A possible 
explanation for a facilitating effect of psychiatric comorbidity on depression 
diagnosis is that GPs‟ may be better able to detect a mental problem in 
chronic medically ill patients when nondepressive psychiatric symptoms, i.e. 
symptoms more specific to anxiety and/or alcohol-related disorders, are also 
present. This higher detection rate might result in an increased likelihood of 
diagnosing depression, because GPs are probable more acquainted with 
depression than other psychiatric disorders encountered in primary care and 
therefore will interpret any mental distress as indications of depression 
21
. 
Another possible explanation is that a specific comorbidity pattern accounted 
for the facilitating effect on diagnosing depression in patients with 
concomitant chronic somatic disease. Explorative analysis suggested that 
having a comorbid GAD facilitated depression diagnosis in patients with a 
comorbid musculoskeletal condition. However, the effects of other specific 
comorbidity patterns remained unclear, because too few cases precluded 
meaningful analysis.  
The higher annual GP contact rate among depressed patients with chronic 
somatic comorbidity compared to those with no concomitant chronic somatic 
condition could explain the differential effect of contact rate in the two 
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subgroups. Because almost all depressed, chronic somatically ill patients had 
already contact with their GP on a regular basis (i.e. ≥ 4 contacts: 92%; ≥ 7 
contacts: 64%), it is probable that a higher frequency of contact will not have 
much influence on diagnosing depression. In contrast, a substantial number of 
depressed patients without somatic comorbidity consulted their GP only once 
or a few times during the last year (i.e. ≤ 3 contacts: 32%; 1-2 contacts: 22%). 
Accordingly, GPs have little opportunity to recognize depressive symptoms in 
these patients, and the likelihood of depression diagnosis will be increased in 
the non-chronically ill patients with a higher contact rate.  
One could question the clinical relevance of the finding that less severe 
depression decreased the likelihood of receiving a depression diagnosis in 
patients with no chronic somatic comorbidity. Diagnosis may not be needed in 
all patients with relatively mild forms of depression, because quite a large 
number of these patients seem to recover spontaneously without being 
detected as depressed 
38-39
. On the other hand, it has been indicated that a 
substantial number of undetected depressed primary care patients have 
persistently poor outcomes over the course of one year 
11-12
. Of concern is that 
a more severe level of depression did not facilitate diagnosis among patients 
with chronic somatic comorbidity, particularly in the context that most of 
these patients had regular contact with their GPs. It is of special importance to 
diagnose major depression in chronic medically ill patients, because its 
presence has been demonstrated to lead to amplification of chronic medical 
illness symptoms, additive functional impairment, and poorer self-care and 
adherence 
40-41
. Also, depression comorbid with chronic somatic disease may 
have poorer course and outcome than depression without comorbidity 
6; 26
. For 
these reasons, it is widely advocated that major depression must be appro-
priately and aggressively treated in patients with chronic somatic disease 
41; 40; 
42
. Indeed, appropriate treatment has been found to improve both the course 
and outcome of depression and the comorbid somatic disease as well as 
patient quality of life 
26; 43-44
.  
It should be kept in mind that the discussed results were obtained by using a 
multivariate model that included both psychiatric comorbidity and depression 
severity. In the vast majority of cases psychiatric comorbidity implied 
comorbid anxiety disorder(s), with GAD being the most prevalent specific 
comorbid anxiety disorder. As anxiety disorders in general, and GAD 
particularly, share several common symptoms with major depression, one 
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might question whether anxiety comorbidity and depression severity are 
distinct. Indeed, some researchers view them not as distinct entities, but 
rather conceptualize anxiety-depression comorbidity as an indicator of severity 
of psychopathology 
45-47
. However, we consider anxiety comorbidity and 
depression severity as related but distinct constructs. This position was based 
on reviews of research on the most common anxiety-depression comorbidity, 
i.e. major depression-GAD comorbidity, which argue against the view that GAD 
should be conceptualized as a severity marker for major depression rather 
than as an independent disorder 
48-49
. Several lines of evidence point to this 
conclusion, including reports that the symptoms of GAD form an empiric 
cluster distinct from the symptoms of major depression. Viewing psychiatric 
comorbidity and depression severity as distinct entities is supported by the 
finding that the effects of psychiatric comorbidity on depression diagnosis 
remained essentially the same after dropping depression severity from the 
multivariate model. If psychiatric comorbidity and depression severity were 
indistinguishable entities, one would expect the model excluding depression 
severity to show a significant effect of psychiatric comorbidity on depression 
diagnosis among depressed patients without chronic somatic comorbidity, 
which was not the case. Anyhow, further longitudinal research is needed to 
disentangle the concepts psychiatric comorbidity and depression severity and 
their relationship with depression diagnosis.     
Some limitations of our study must be noted. First, the generalisability of the 
findings might be restricted by the relatively high attrition rate. The 
significant difference between participant and nonparticipants regarding 
gender seemed to be of no major influence given that gender consistently did 
not exert a significant effect in our analyses. However, it cannot be ruled out 
that other differences between participants and nonparticipants could have 
affected the findings. Second, not all sections of the CIDI were administered, 
which may have confounded assessment of psychiatric comorbidity. For 
instance, the assessment of somatoform disorders was lacking, which are 
known to be common in primary care and comorbid with depression 
26
. Finally, 
only small numbers of patients had certain specific diseases, which precluded 
meaningful analysis of the effects of specific (combinations of) psychiatric and 
chronic somatic comorbidity categories.  
In conclusion, the results of our study indicate that the factors that are 
associated with   underdiagnosis of depression by GPs are different for 
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depressed patients without chronic somatic comorbidity compared to 
depressed patients with chronic somatic comorbidity. This implies that efforts 
to improve GPs‟ diagnosis of depression require different approaches for 
depressed patients with and without comorbid somatic illness. Our results 
suggest that GPs need to be more alert to symptoms of depression in the less 
well-educated, non-chronic somatically ill patients. The awareness of (the 
importance to diagnose and treat) depression in chronic somatically ill patients 
should be raised among GPs. Educating GPs in overcoming the diagnostic 
challenge of differentiating depressive symptomatology from comorbid chronic 
somatic disease and/or to refer chronic somatically ill patients to mental 
health specialists if they suspect a depression could increase the quality of 
care for these patients.   
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Abstract 
 
Background: Limited information exists on the relationship between specific 
chronic somatic conditions and care for comorbid depression in primary care 
settings. Therefore, the present prospective, general practice-based study 
examined this relationship.  
Methods: Longitudinal data on morbidity, prescribing, and referrals concerning 
991 patients newly diagnosed with depression by their general practitioner 
(GP) were analyzed. The influence of a broad range of 13 specific chronic 
somatic conditions on the initiation of any depression care as well as the 
prescription of continuous antidepressant therapy for 180 days was examined. 
Multilevel logistic regression analysis was employed to control for history of 
depression, psychiatric comorbidity, socio-demographics and inter-practice 
variation 
Results: Multilevel analysis showed that patients with pre-existing ischemic 
heart disease (72.1%) or cardiac arrhythmia (59.3%) were significantly less 
likely to have any depression care being initiated by their GP than patients 
without chronic somatic morbidity (88.0%). No other specific condition had a 
significant influence on GP initiation of any care for depression. Among the 
patients being prescribed antidepressant treatment by their GP, none of the
conditions was significantly associated with being prescribed continuous 
treatment for 180 days.   
Conclusions: Our study indicates that patients with ischemic heart disease 
or cardiac arrhythmia have a lower likelihood of GP initiation of any care for 
depression after being newly diagnosed with depression by their GP. This 
finding points to the importance of developing interventions aimed at 
supporting GPs in the adequate management of comorbid depression in heart 
disease patients to reduce the negative effects of this comorbidity.  
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6.1 Introduction  
 
Depression is known to be comorbid with a wide and diverse range of chronic 
somatic conditions, including heart disease, gastrointestinal, neurological, and 
respiratory conditions 
1-2
. In general, the presence of comorbid depression in 
chronically ill patients is associated with increased symptom burden, additive 
functional impairment, decreased quality of life, increased health-care use, as 
well as decreased self-care and adherence to treatment regimens 
3-4
. Also, 
evidence is accumulating that depression comorbid with chronic somatic 
disease may be associated with increased mortality, particularly in patients 
with heart disease and diabetes 
5-6
. Given the negative impacts of comorbid 
depression, active treatment of depression among patients with chronic 
somatic illness is recommended 
7-8
. This approach is further substantiated by 
recent evidence that depression in somatically ill patients can be treated 
effectively 
9-10
.  
Because most depressed patients are cared for in primary care settings, it is 
important to have knowledge of the primary care management of depression in 
patients with pre-existing chronic somatic disease. Most primary care based 
studies that examined the influence of having chronic somatic disease on 
depression care used a composite measure of chronic somatic morbidity and 
found conflicting results 
11-15
. Possible explanations for this discrepancy in 
findings may include differences in study settings and patient characteristics, 
focusing on different outcome measures of depression care, and considering 
different sets of specific conditions to establish a composite measure of 
chronic somatic morbidity.  
There is reason to believe that the relationship between chronic somatic 
conditions and depression management in primary care varies by type of 
condition. Having chronic somatic morbidity may influence care for depression 
in several, not mutually exclusive, ways. A pre-existing condition may impede 
depression management because it exerts a strong competing effect on 
physicians‟ limited attention and time 16, or because physicians and/or patients 
erroneously believe that there is little reason to initiate any care for 
depression because it is a “normal” consequence of having that illness 17, or 
because physicians are reluctant to prescribe antidepressant drugs because of 
potential adverse side effects or drug interactions, or to avoid polypharmacy 
18
. 
Alternatively, having a chronic somatic condition may also positively impact 
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depression management because it implicates frequent physician-patient 
contacts and thus more opportunities for depression care 
19
. It is likely that the 
relevance of each of the mechanisms described above varies by type of 
condition, and therefore differential effects of specific chronic somatic 
conditions on depression care are expected.  
However, to the best of our knowledge, only two primary care based studies 
have looked at the impacts of individual chronic somatic conditions. Bogner et 
al. 
18
 investigated the role of cardiovascular conditions and found that older 
primary care patients with heart failure had a significantly lower likelihood of 
receiving “active” management for depression (i.e. receiving 
counselling/supportive listening, referred to a mental health specialist, or 
prescribed psychotropic medication) than those without heart failure. Other 
types of cardiovascular disease were not significantly related to depression 
management. An earlier study by Dunn et al. 
20
 indirectly suggests no large 
differential effects of chronic fatigue syndrome, cancer, coronary heart 
disease, stroke, diabetes, and fibromyalgia on “adequate” duration of 
antidepressant treatment (i.e. prescribed at least 120 days of antidepressant 
therapy at an adequate daily dose within the first six months after initiation of 
therapy) in general practice patients aged 18 years or older. 
The aim of the present prospective study was to examine the influence of 
specific chronic somatic conditions on the management of newly diagnosed 
episodes of depression in general practice. Unlike previous research, this study 
considered a broad range of conditions and was not restricted to older 
patients. The following two research questions were addressed: (1) what is the 
influence of specific chronic somatic conditions on the initiation of any 
depression care in patients newly diagnosed with depression by their general 
practitioner (GP)?; and (2) among the patients being prescribed antidepressants 
by their GP, what is the influence of these specific conditions on prescription 
of continuous antidepressant treatment?  
  
 
6.2 Method   
 
Study setting  
Morbidity, drug prescription, and referral data were extracted from the 
electronic medical record systems of 103 general practitioners (GPs) working in 
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60 practices. These data were collected within the framework of the second 
Dutch National Survey of General practice (DNSGP-2) 
21
 and the National 
Information Network of General Practice (LINH) 
22
. The DNSGP-2 was a 
nationwide study of morbidity and interventions in general practice in the 
Netherlands carried out in 2001. Established in 1992, the LINH database holds 
longitudinal data on morbidity, prescribing, and referrals from participating 
general practices. The LINH data served as the “backbone” of the DNSGP-2. 
Because the 60 practices took part in the DNSGP-2 and continued participation 
in the LINH, follow-up data were available after the end of the one-year 
DNSGP-2 study period, allowing us to examine depression care provided by GPs 
during a one-year period after they have diagnosed a depression.  
Morbidity data comprised: (1) diagnoses made during contacts with a patient, 
and (2) diagnoses of all relevant health problems of a patient, including those 
developed in the past, recorded on a so-called “problem list” 23. Diagnoses 
were coded according to the International Classification of Primary Care (ICPC) 
24
 based on the criteria of the International Classification of Health Problems in 
Primary Care (ICHPC-2-Defined) 
25
. During the contact registration, GPs 
recorded whether a health problem concerned a new or ongoing problem and 
different contacts for the same health problem were clustered into episodes of 
disease. Prescription records were coded according to the Anatomical 
Therapeutic Chemical (ATC) classification system 
26
.    
 
Study population   
The total practice population registered with the 60 practices (n = 236,829) in 
2001 was representative of the Dutch population in terms of age, gender, and 
type of health care insurance.  
Potential participants were patients who were diagnosed at the age of 18 years 
or older with a new episode of depression (ICPC code P76) during the one-year 
contact registration of the DNSGP-2 (n = 1,110). The ICHPPC-2-Defined criteria 
for depression correspond largely to those of the DSM-IV for major depression 
27
. To ensure that new depressive episodes were investigated, patients were 
required to have not received a prescription for any antidepressant (ATC code 
N06A) or lithium (code N05AN01) nor were referred to a mental health 
specialist in the three months before depression diagnosis. Patients who died 
during the one-year follow-up study period (n = 26) and those who were no 
longer registered with the same practice at the end of the study period (e.g. 
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because of moving, nursing home admission; n = 83) were excluded.  
The total study population (n = 991) was utilized to answer the first research 
question concerning initiation of any depression care in the year following 
depression diagnosis. The second research question on prescription of 
continuous antidepressant therapy was examined using a subset of this 
population, namely the patients who received at least one prescription for an 
antidepressant during the study period (n = 790). To ensure that antidepressant 
treatment provided by GPs was investigated, we excluded patients who 
received a prescription for lithium and/or were referred to a mental health 
specialist during the study period (n = 93). Also, thirty patients were excluded 
because either the first antidepressant drug was prescribed 180 days or more 
after depression diagnosis or because specific prescription data were missing, 
leaving a study population of 667 patients to examine continuity of 
antidepressant treatment.    
 
Dependent variables  
Any depression care was considered to be initiated following depression 
diagnosis if the patient received at least one prescription for any 
antidepressant or lithium, and/or was referred at least once to a mental health 
professional for depression, and/or had at least one follow-up face-to-face 
contact for depression with their GP within four weeks after diagnosis. The last 
part of our definition was incorporated to ensure that patients were included 
whose depression was being managed by a GP by means of a (short-term) 
psychological intervention or a “watchful waiting” approach.  
To measure prescription of continuous antidepressant treatment a “continuous 
multiple-interval measure of medication availability” (CMA) was employed 28. 
This measure represents the sum of the days covered by all prescriptions in a 
specific period divided by the total number of days during the specified period, 
and can potentially range from 0% to values exceeding 100% (in case of 
oversupply). The number of days covered by each prescription was estimated 
by multiplying the quantity of a drug prescribed by its corresponding defined 
daily dose (DDD). The DDD is the assumed average maintenance dose per day 
for a drug used for its main indication in adults (www.whocc.no). 
Subsequently, for each patient, a CMA score for a 180-day period was 
calculated and used to define presence (CMA ≥ 80%) or absence (CMA < 80%) of 
being prescribed continuous antidepressant therapy. A 180 days period was 
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examined because clinical practice guidelines for the treatment of depression 
e.g. 29-30
, including the guideline of the Dutch College of General Practitioners 
31
, 
recommend continuing antidepressant treatment for at least six months after 
remission. A CMA cut-off score of 80% is used conventially to define a 
treatment episode as continuous or discontinuous based on prescription data 
32
.    
 
Independent variables  
The primary independent variable of interest was having a specific chronic 
somatic condition at the time of newly diagnosed depression. Diagnoses 
recorded during patient contacts as well as diagnoses recorded on the problem 
lists were used to identify patients with pre-existing specific chronic 
conditions. Thirteen conditions were studied because they are highly prevalent 
in general practice and/or known to be frequently comorbid with depression 
1-2
 
(see Appendix for a description of the included diagnoses): colon conditions, 
stomach/duodenal conditions, hypertension, cardiac arrhythmia, ischemic 
heart disease, osteoarthritis/rheumatoid arthritis, migraine, neurological 
disease, chronic lung conditions, skin conditions, diabetes mellitus, thyroid 
conditions, and cancer. Also, by considering a comprehensive range of other 
diagnoses of possible chronic somatic conditions 
2
, a broad and heterogeneous 
category of “any other chronic condition” was established. Patients were 
defined as having no chronic somatic morbidity if they were not diagnosed with 
any of the conditions considered. 
Other variables were taken into account that could potentially influence 
depression care, including history of a previous depressive episode, psychiatric 
comorbidity, and socio-demographic variables (age, gender, highest 
educational level attained) 
33
. A prior depressive episode was considered to 
have occurred when a patient had a depression diagnosis on his or her problem 
list. Presence of co-existent psychiatric morbidity at the time of depression 
diagnosis was derived from diagnoses recorded during the contact registration 
and those recorded on the problem lists. Two categories were formed: 
comorbid anxiety disorder and other psychiatric comorbidity (i.e. substance 
abuse disorder, schizophrenia/other psychotic disorder, or other mental 
disorder). Age was categorized into five groups (18-24, 25-44, 45-64, 65-74, 
and ≥75) and educational level into three (low: none/ elementary school, 
middle: high school, and high: college/ university). Also, a separate category of 
missing educational data was created because the attained level of education 
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was unknown for a substantial number of patients (23.9%).  
 
Statistical analysis  
Multi-level logistic regression analysis using MLwiN version 2.0 was carried out 
to examine the first research question on the association between specific 
chronic somatic conditions and initiation of any depression care. Multi-level 
analysis was employed because the data had a two-level hierarchical structure 
(i.e. practice level and patient level) and allowed us to adjust for variation due 
to differences between general practices. A random intercept logistic model 
was performed, yielding the odds of initiation of any depression care for each 
group of patients with a specific chronic somatic condition compared to 
patients without chronic somatic morbidity controlling for the potential 
influence of the measured covariates as well as inter-practice variation. 
Parameters were estimated using the second order predictive quasi-likelihood 
procedure with extra-binomial variation at level one 
34
.  
The second research question regarding prescription of continuous 
antidepressant therapy was addressed in a similar way. Sensitivity analyses 
were conducted to test whether the results concerning continuous prescription 
were robust to using a more (90%) or a less (70%) stringent CMA threshold 
value.  
Of note, as both initiation of any depression care and continuous 
antidepressant prescription are common outcomes, the odds ratio estimated by 
logistic regression may substantially overestimate the relative risk. To prevent 
misinterpretation of odds ratios as meaning the same thing as relative risks in 
our study, regression coefficients and their confidence intervals are presented. 
 
6.3 Results  
 
Initiation of depression care   
The study sample of 991 patients with a new episode of depression had a mean 
age of 49.0 years (SD= 16.9; Range: 18-93) at the time of depression diagnosis 
and 66.7% of the patients were female. Table 1 shows that 648 patients (65.4%) 
had pre-existing chronic somatic morbidity, with hypertension (18.8%) being 
the most prevalent specific chronic condition and migraine (3.5%) the least 
prevalent. Table 1 further presents the clinical and socio-demographic 
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Table 1  
Characteristics of patients newly diagnosed with depression by their general practitioner  
according to presence or absence of chronic somatic morbidity  
 
 
 
 
Characteristics 
Patients with  
chronic somatic 
morbidity 
(n = 648)  
n (%) 
Patients without 
chronic somatic 
morbidity 
(n = 343)  
n (%) 
Socio-demographic variables   
   Gender  
      Male 
      Female    
 
         212 (32.7) 
         436 (67.3) 
 
          118 (34.4) 
          225 (65.6) 
   Age (years): mean (SD)         52.0 (17.5)          43.1 (13.9) 
   Age groups 
      18-24 
      25-44 
      45-64 
      65-74 
      ≥ 75 
 
           28 (4.3) 
         234 (36.1) 
         213 (32.9) 
           87 (13.4) 
           86 (13.3) 
 
            25 (7.3) 
          182 (53.1) 
          105 (30.6) 
            22 (6.4) 
              9 (2.6)  
   Educational level 
      Low       
      Middle 
      High 
      Unknown 
 
         139 (21.5) 
         290 (44.8) 
           76 (11.7) 
         143 (22.1) 
 
            36 (10.5) 
          165 (48.1) 
            48 (14.0)  
            94 (27.4) 
Previous depressive episode           143 (22.1)             58 (16.9) 
Psychiatric comorbidity variables   
   Comorbid anxiety 
   Other psychiatric comorbidity 
           78 (12.0) 
         104 (16.0) 
            18 (5.2) 
            51 (14.9) 
Type of chronic somatic conditiona   
   Hypertension 
   Chronic lung 
   Skin  
   Diabetes mellitus 
   Colon 
   Stomach/duodenal    
   Neurological 
   Osteoarthritis/rheumatoid arthritis 
   Ischemic heart     
   Thyroid 
   Cancer 
   Cardiac arrhythmia 
   Migraine    
   Any other 
         122 (18.8) 
           84 (13.0) 
           81 (12.5) 
           58 (9.0) 
           55 (8.5) 
           55 (8.5) 
           46 (7.1)  
           46 (7.1) 
           43 (6.6) 
           41 (6.3) 
           28 (4.3) 
           27 (4.2) 
           23 (3.5) 
         471 (72.7) 
 
a Not mutually exclusive. 
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characteristics of the total groups of patients with and without chronic somatic 
illness.  
The unadjusted rate of initiation of any depression care in the year after 
depression diagnosis by each characteristic is shown in Table 2. Also shown are 
the unadjusted rates for the three measured “types” of depression care. 
Overall, 86.6% of the patients received any care for depression. Of these 858 
patients, 81.5% was prescribed an antidepressant or lithium, 3.3% was referred 
to a mental health professional, and 10.6% received both types of care. Forty 
patients (4.6%) were neither prescribed antidepressants nor referred but had at 
least one face-to-face contact with their GP for depression within four weeks 
after diagnosis. In 85.8% of the patients with chronic somatic morbidity 
management of depression was initiated, a slightly lower percentage than 
among the patients without chronic somatic disease (88.0%). The unadjusted 
rate of initiation of any depression care varied by type of condition, ranging 
from 59.3% for patients with cardiac arrhythmia to 92.7% for patients with a 
thyroid condition. 
From the multi-level logistic analysis we learned that, as compared to patients 
without chronic somatic illness, patients with ischemic heart disease or cardiac 
arrhythmia were significantly less likely to receive any depression care from 
their GP following a diagnosis of new depressive episode (Table 3). The odds of 
initiation of any depression care tended to be decreased for patients with 
migraine (p = .078).  
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Table 2  
Unadjusted rates of patients receiving any depression care from their general practitioner as well as the 
rates for the three types of depression care 
   Type of depression carea 
 
 
Characteristics 
Any  
depression  
care 
≥1 anti- 
depressant 
prescription 
≥1 mental 
health referral  
≥1 follow-up 
contact  
<4 weeks 
Without chronic somatic condition 
With chronic somatic condition 
88.0 
85.8 
81.3 
78.9 
13.7 
11.1 
50.4 
47.4 
Type of chronic somatic conditiona     
   Thyroid        92.7 82.9 9.8 48.8 
   Colon                    89.1 76.4 16.4 45.5 
   Stomach/duodenal                                89.1 83.6 5.5 45.5 
   Skin           87.7 84.0 11.1 51.9 
   Chronic lung                    85.7 79.8 11.9 44.0 
   Cancer                    85.7 78.6 0.0 42.9 
   Osteoarthritis/rheumatoid arthritis 84.8 76.1 0.0 45.7 
   Neurological                     82.6 78.3 4.3 50.0 
   Diabetes mellitus                            82.8 77.6 6.9 43.1 
   Hypertension                          82.0 75.4 6.6 44.3 
   Migraine                                 78.3 73.9 17.4 47.8 
   Ischemic heart                       72.1 67.4 7.0 39.5 
   Cardiac arrhythmia           59.3 59.3 7.4 29.6 
   Any other                  86.4 79.8 11.5 48.8 
Previous depressive episode       
   No    85.4 78.0 11.4 47.6 
   Yes 91.0 86.6 14.4 51.7 
Psychiatric comorbidity variables      
   Comorbid anxiety     
      No 85.9 78.8 11.8 47.5 
      Yes 92.7 88.5 13.5 57.3 
   Other psychiatric comorbidity     
      No 86.7 79.4 12.2 48.1 
      Yes 85.8 81.3 11.0 50.3 
Socio-demographic variables      
   Gender     
      Male 87.3 82.4 13.6 47.3 
      Female    86.2 78.4 11.2 49.0 
   Age groups     
      18-24  77.4 64.2 18.9 47.2 
      25-44  89.7 81.5 18.5 49.8 
      45-64   85.2 80.5 8.2 47.5 
      65-74 83.5 79.8 1.8 45.9 
      ≥ 75 86.3 77.9 1.8 49.5 
   Educational level     
      Low 89.1 81.7 7.4 50.3 
      Middle 86.8 80.9 12.5 50.1 
      High 84.7 77.4 16.1 50.8 
      Unknown 85.2 77.2 12.2 42.6 
a Not mutually exclusive. 
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Table 3  
Results of multi-level logistic regression for initiation of any depression care. Values shown in 
bold indicate significant effects 
 B 95% CI 
Type of chronic somatic condition   
   Thyroid         0.86 -0.41 to 2.14 
   Colon                     0.36 -0.58 to 1.30 
   Stomach/duodenal                                 0.47 -0.53 to 1.46 
   Skin            0.17 -0.59 to 0.92 
   Chronic lung                    -0.095 -0.80 to 0.61 
   Cancer                    -0.14 -1.35 to 1.08 
   Osteoarthritis/rheumatoid arthritis -0.084 -1.04 to 0.87 
   Neurological                     -0.095 -0.99 to 0.80 
   Diabetes mellitus                            -0.058 -0.87 to 0.75 
   Hypertension                          -0.27 -0.86 to 0.33 
   Migraine                                 -0.95 -2.00 to 0.11 
   Ischemic heart                       -1.04 -1.86 to -0.22a 
   Cardiac arrhythmia           -1.77 -2.69 to -0.86d 
   Any other                  -0.0035 -0.42 to 0.41 
Previous depressive episode     
   No    reference  
   Yes  0.88  0.29 to 1.49c 
Psychiatric comorbidity variables    
   Comorbid anxiety   
      No reference  
      Yes  0.63 -0.23 to 1.49 
   Other psychiatric comorbidity   
      No reference  
      Yes -0.098 -0.64 to 0.45 
Socio-demographic variables    
   Gender   
      Male reference  
      Female    -0.23 -0.66 to 0.21 
   Age groups   
      18-24  -1.01 -1.76 to -0.26b 
      25-44  reference  
      45-64   -0.33 -0.81 to 0.15 
      65-74 -0.51 -1.22 to 0.21 
      ≥ 75 -0.16 -1.07 to 0.75 
   Educational level   
      Low reference  
      Middle -0.55 -1.19 to 0.080 
      High -0.64 -1.42 to 0.15 
      Unknown -0.64 -1.33 to 0.054 
B, regression coefficient; CI, confidence interval.  
a p < .05; b p < .01; c p < .005; d p < .001 (determined by Wald chi-square tests) 
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Prescription of continuous antidepressant treatment  
The mean age at the time of depression diagnosis of the 667 patients being 
prescribed antidepressant therapy was 50.3 years (SD= 16.9; Range: 18-90) and 
65.7% were female. Table 4 shows the characteristics of the sample by 
presence and absence of chronic somatic morbidity. Among the 437 (65.5%) 
patients with pre-existing chronic illness, hypertension (19.0%) was the most 
common specific condition and cardiac arrhythmia (2.7%) the least common. 
Overall, 37.8% of the patients were prescribed continuous antidepressant 
therapy for 180 days. As illustrated in Table 5, the unadjusted proportion of 
patients with continuous antidepressant prescription was somewhat lower in 
the group with chronic somatic morbidity (37.1%) than in the group without 
chronic somatic morbidity (39.1%). The unadjusted rate of being prescribed 
continuous therapy for 180 days differed according to type of condition. 
Patients with cardiac arrhythmia showed the highest rate of continuous 
prescription (50.0%), whereas the lowest rate was found among patients with a 
thyroid condition (23.3%). 
Subsequent multi-level logistic regression analysis did not yield a significant 
influence of any specific chronic somatic condition on continuous prescription 
of antidepressant therapy (Table 5, last two columns). Sensitivity analyses 
using a more (90%) or a less (70%) stringent CMA cut-off score to define being 
prescribed continuous treatment revealed basically the same results as using 
the conventional threshold of 80%. Only patients with thyroid disease were 
found to be significantly less likely than patients without chronic somatic 
morbidity to have been prescribed continuous antidepressant therapy when 
using a threshold of 70% (p = .022).  
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Table 4   
Characteristics of patients newly diagnosed with depression by their  general practitioner and  
who are being prescribed antidepressant therapy according to presence or absence of  
chronic somatic morbidity  
 
 
 
 
Characteristic 
Patients with  
chronic somatic 
morbidity 
(n = 437)  
n (%) 
Patients without  
chronic somatic  
morbidity 
(n = 230)  
n (%) 
Gender  
   Male 
   Female    
 
         154 (35.2) 
         283 (64.8) 
 
  75 (32.6) 
155 (67.4) 
Age (years): mean (SD)         53.2 (17.5) 44.9 (14.1) 
Age groups 
   18-24 
   25-44 
   45-64 
   65-74 
   ≥ 75 
 
           16 (3.7) 
         149 (34.1) 
         145 (33.2) 
           65 (14.9) 
           62 (14.2) 
 
12 (5.2) 
119 (51.7) 
  73 (31.7) 
                  19 (8.3) 
   7 (10.1) 
Educational level 
   Low 
   Middle 
   High 
   Unknown 
         
         103 (23.6) 
         190 (43.5) 
           48 (11.0) 
           96 (22.0) 
 
                  26 (11.3) 
                112 (48.7) 
                  30 (13.0) 
                  62 (27.0) 
Previous depressive episode           104 (23.8)                   39 (17.0) 
Psychiatric comorbidity variables 
   Comorbid anxiety 
   Other comorbidity  
 
           56 (12.8) 
           74 (16.9) 
 
                  15 (6.5) 
                  33 (14.3) 
Type of chronic somatic conditiona  
   Hypertension 
   Skin 
   Chronic lung  
   Stomach/duodenal    
   Diabetes mellitus 
   Colon 
   Osteoarthritis/rheumatoid 
      arthritis 
   Neurological    
   Thyroid 
   Ischemic heart     
   Cancer 
   Migraine    
   Cardiac arrhythmia              
   Any other 
 
           83 (19.0) 
           58 (13.3) 
           53 (12.1) 
           44 (10.1) 
           38 (8.7) 
           36 (8.2) 
            
           34 (7.8) 
           31 (7.1) 
           30 (6.9) 
           25 (5.7) 
           21 (4.8) 
           14 (3.2) 
           12 (2.7) 
         320 (73.2) 
 
a Not mutually exclusive. 
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Table 5 
Results regarding prescription of continuous antidepressant therapy for 180 days after being newly 
diagnosed with depression. Shown are the unadjusted rates of patients being prescribed continuous 
antidepressant treatment by their general practitioner. The last two columns present the results of multi-
level logistic regression for continuous antidepressant prescription. Values shown in bold indicate significant 
effects 
 
 
Characteristic 
Unadjusted rate  
of continuous 
prescription (%) 
 
 
B 
 
 
95% CI 
Without chronic somatic condition 
With chronic somatic condition 
39.1 
37.1 
  
Type of chronic somatic conditiona    
   Cardiac arrhythmia                                          50.0  0.80 -0.47 to 2.06 
   Migraine                             42.9 -0.11 -1.36 to 1.12  
   Diabetes mellitus                    42.1  0.35 -0.40 to 1.11 
   Neurological                         41.9  0.29 -0.54 to 1.13 
   Hypertension                            39.8  0.18 -0.40 to 0.76 
   Skin                                 37.9 -0.055 -0.70 to 0.59 
   Chronic lung                    32.1 -0.22 -0.90 to 0.45 
   Stomach/duodenal                     31.8 -0.025 -0.77 to 0.72 
   Colon                                30.6 -0.29 -1.08 to 0.51 
   Osteoarthritis/rheumatoid arthritis 26.5 -0.72 -1.64 to 0.19 
   Ischemic heart                       24.0 -0.61 -1.62 to 0.40 
   Cancer           23.8 -0.45 -1.59 to 0.68 
   Thyroid                              23.3 -0.83 -1.84 to 0.17 
   Any other 40.0  0.26 -0.17 to 0.58 
Previous depressive episode      
   No    35.5 reference  
   Yes 46.2  0.73  0.26 to 1.20c 
Psychiatric comorbidity variables     
   Comorbid anxiety    
      No 37.8 reference  
      Yes 38.0  0.17 -0.41 to 0.75 
   Other psychiatric comorbidity    
      No 37.9 reference  
      Yes 37.4 -0.034 -0.54 to 0.47 
Socio-demographic variables     
   Gender    
      Male 30.6 reference  
      Female    41.6  0.58  0.19 to 0.97c 
   Age groups    
      18-24  17.9 -1.25 -2.32 to -0.19b 
      25-44  39.6 reference  
      45-64   43.1  0.22 -0.21 to 0.65 
      65-74 33.3 -0.23 -0.89 to 0.43 
      ≥ 75 27.5 -0.49 -1.26 to 0.28 
   Educational level    
      Low 34.9 reference  
      Middle 43.4  0.32 -0.22 to 0.85 
      High 43.6  0.33 -0.35 to 1.02 
      Unknown 26.6 -0.48 -1.10 to 0.14 
B, regression coefficient; CI, confidence interval. a Not mutually exclusive.  
b p < .05; c p < .005 (determined by Wald chi-square tests) 
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6.4 Discussion  
 
Principal findings The present study indicated that general practice patients 
with pre-existing ischemic heart disease or cardiac arrhythmia were less likely 
than patients without chronic somatic disease to have any depression care 
being initiated after being newly diagnosed with depression by their GP. No 
other specific chronic somatic condition impacted significantly on GP initiation 
of any depression care. Furthermore, among the patients being prescribed 
antidepressants by their GP, no specific chronic somatic condition was found to 
have a significant influence on prescription of continuous antidepressant 
treatment for 180 days.   
 
Strengths and weaknesses of the study  
Our study is the first effort to examine the relationship between specific 
chronic somatic conditions and depression management in general practice 
using a nationally representative sample of general practice patients. Unlike 
previous primary care based studies 
18; 20
, this study considered a wide range of 
specific chronic somatic conditions, both initiation of depression care as well 
as prescription of continuous antidepressant treatment, and used a study 
population that was not confined to older patients. Furthermore, besides 
controlling for several potential confounders at the level of individual patients, 
including history of depression, psychiatric comorbidity, and socio-demographic 
characteristics, we adjusted for variation at the practice level by using 
multilevel modelling.   
A number of potential limitations of our study must be considered. First, we 
relied on data from medical record systems, which may be incomplete. 
However, it is likely that the completeness of registration of antidepressant 
drug prescriptions is high because the study was carried out in computerized 
practices where prescriptions are facilitated by the computer software. 
Furthermore, to identify patients with chronic somatic morbidity, in addition 
to diagnoses recorded during patient contacts, also diagnoses recorded on 
problem lists were used, making it unlikely that a substantial number of 
patients were misclassified as having no (specific) chronic somatic morbidity. 
Secondly, the data did not allow us to take into account the severity of specific 
chronic somatic conditions. Thirdly, the number of patients with a specific 
chronic condition was sometimes low, which may have limited statistical power 
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to obtain significant results for smaller effects. Fourthly, our data did not 
include direct information on whether a psychological intervention or watchful 
waiting approach was initiated by the GP after having diagnosed depression. 
Finally, the operationalization of being prescribed continuous antidepressant 
therapy may be criticized. The time period a drug prescription was intended to 
cover was estimated by using the DDD. The DDD assigned to a drug is nearly 
always a compromise based on systematic review of the available literature 
and does not necessarily equal the dose actually prescribed. Our results 
regarding continuous prescription should not be biased if the difference 
between the DDD and actual prescribed dose did not differ substantially 
depending on presence or absence of (a specific) chronic somatic illness. 
Lastly, although a CMA threshold value of 80% is used commonly there exists no 
clear clinical or pharmacological rationale for the appropriateness of this cut-
off score 
28
. However, results using different thresholds did not differ 
substantially from those using the conventional 80% cut-off score, aside from 
the finding that patients with thyroid disease were less likely than patients 
without chronic somatic morbidity to have been prescribed continuous 
antidepressant treatment for 180 days when using the less stringent threshold 
of 70%.  
 
Clinical implications and suggestions for future research  
Our finding that general practice patients with ischemic heart disease or 
cardiac arrhythmia are less likely to have any care being initiated for newly 
diagnosed depression is clinically important because the presence of comorbid 
depression in patients with heart disease has been found to adversely impact 
various domains of functioning, quality of life, symptom burden, health-care 
utilization, self-care and adherence to medical regimens 
3-4
. Furthermore, 
there is substantial evidence that depression increases the risk of subsequent 
cardiovascular events and mortality in patients with coronary heart disease or 
post myocardial infarction (MI) patients 
5; 35
. Given the adverse effects of 
comorbid depression, an active approach to the management of depression in 
patients with heart disease is supported, all the more because a growing body 
of research indicates that concomitant depression with ischemic heart disease 
can be effectively and safely treated with selective serotonin reuptake 
inhibitors (SSRIs) 
36
. Use of SSRIs may even reduce the risk for cardiovascular 
morbidity and mortality in post MI patients 
37-38
. The beneficial influence of 
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antidepressant treatment is further substantiated by a recent naturalistic study 
demonstrating that primary care patients with ischemic heart disease and 
comorbid depression showed significant improvement in mood, social and 
emotional functioning, and disability following initiation of antidepressant 
treatment 
10
. Besides pharmacological treatment, current preliminary evidence 
suggests that psychological interventions also lead to a reduction in depression, 
although they appear to have no effect on mortality and non-fatal infarction 
39-
40
. Our data did not permit us to identify the mechanism(s) underlying the 
observed negative effect of having ischemic heart disease or cardiac 
arrhythmia on initiation of any depression care. It is possible that particularly 
heart disease exerts a strong competing effect on GPs‟ limited attention and 
time, that especially co-existent depression in heart conditions is being viewed 
as a “natural” reaction not needing active treatment or monitoring, and/or 
that particularly in heart disease potential adverse side effects or drug 
interactions have a strong negative effect on initiating antidepressant therapy. 
One may wonder whether the well-documented unfavourable cardiovascular 
profile of tricyclic antidepressants (TCAs) largely explains our findings 
36
. 
Indeed, in our study, GPs, when initiating antidepressant therapy, not often 
prescribed TCAs to their patients with ischemic heart disease (8.0%) or cardiac 
arrhythmia (8.3%). However, the relative contraindication for the use of TCAs 
in patients with heart disease does not seem to be the reason for the observed 
low rates of initiation of any depression care, since TCAs were also infrequently 
prescribed for non-chronically ill patients with newly diagnosed depression. 
Furthermore, we found not only relatively low rates of initiation of any 
antidepressant drug therapy among the patients with ischemic heart disease or 
cardiac arrhythmia, but also relatively low rates of referral and having at least 
one follow-up face-to-face contact for depression in the four weeks following 
diagnosis (see table 2). This could suggest that GPs have a relative general 
“reservation” about initiating any form of depression care in patients with 
heart conditions, including watchful waiting. Further research is required to 
understand the mechanism(s) underlying the relationship between having 
ischemic heart disease or cardiac arrhythmia and a lower likelihood of 
receiving any care for comorbid depression in general practice. 
A number of other suggestions for future research are offered by our study 
results. Apart from the negative influence of having ischemic heart disease or 
cardiac arrhythmia on initiation of any depression care, we observed no other 
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significant impact of specific chronic somatic morbidity on GP management of 
depression. However, as already stated above, the lack of other findings may 
have been due to insufficient statistical power. Further research using even 
larger samples of general practice patients is required to settle this issue. Our 
finding that initiation of any depression care as well as prescription of 
continuous antidepressant therapy varied considerably across the various 
conditions at least indicate that future studies using a composite measure of 
chronic somatic morbidity need to be aware of the possibility of obscuring 
meaningful differential effects of specific chronic conditions on depression 
management. 
In our study, we examined depression care routinely provided by GPs, and thus 
relied on their clinical diagnoses of depression and not on diagnoses based on 
DSM-IV criteria. Accordingly, the observed rates of depression management 
were determined by the probability that the GPs diagnosed depression and 
their decision to initiate some type of depression care. Not addressing 
diagnosis of depression may give an incomplete picture of the relationship 
between primary care depression management and specific chronic somatic 
conditions, because of the possibility that underdiagnosis of depression by GPs 
may vary by type of condition 
41
. Ideally, future research on this relationship 
should include a validated measure of depression to be able to take into 
consideration accuracy of GPs‟ diagnosis of depression. Also, including an 
objective measure of depression severity will allow a detailed investigation of 
the adequacy of GP management of comorbid depression. For instance, given 
the inconclusive evidence for the effectiveness of antidepressants for minor 
depression 
42
, it is interesting to know how many chronically ill patients with 
milder forms of depression are being prescribed antidepressants by their GP 
and how such treatment practice influences continuity of antidepressant 
treatment. 
Although not the primary focus of this study, it is noteworthy that 15.8% of the 
total variance in initiation of depression care and 21.5% of that in prescription 
of continuous antidepressant therapy was due to difference between practices, 
which indicates that general practice characteristics are important 
determinants of management of depression. Further study is needed to identify 
and understand GP variation.  
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6.5 Conclusion  
 
This study indicates that patients with ischemic heart disease or cardiac 
arrhythmia and who are newly diagnosed with comorbid depression by their GP 
have a lower likelihood of having any care for depression being initiated by 
their GP compared with non-chronically ill patients newly diagnosed with 
depression. This finding points to the importance of developing interventions 
targeted at supporting GPs in the adequate management of comorbid 
depression in patients with heart disease to reduce the negative impacts of 
comorbid depression and possibly improve outcomes from heart disease. To 
this end, first the mechanisms have to be ascertained that underlie the 
decreased likelihood of GP initiation of any depression care in heart disease 
patients.  
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Appendix 
 
ICPC diagnoses included in the categories of specific chronic somatic morbidity    
Chronic somatic condition  ICPC diagnoses 
Colon Diverticular disease, irritable bowel syndrome, or chronic 
enteritis/ ulcerative colitis 
Stomach/duodenal Duodenal or other peptic ulcer, or disorder of the stomach 
function 
Hypertension Uncomplicated hypertension or hypertension with involvement of 
target organs 
Cardiac arrhythmia Atrial fibrillation/ flutter, paroxysmal tachycardia, or ectopic 
beats 
Ischemic heart  Angina pectoris, acute myocardial infarction, other chronic 
ischemic heart disease, or heart failure 
Osteoarthritis/ 
rheumatoid arthritis 
Osteoarthritis of spine/ hip/ knee, other osteoarthritis, or 
rheumatoid arthritis/ allied condition 
Migraine Migraine 
Neurological conditions  Multiple sclerosis, Parkinson‟s disease/ parkinsonism, epilepsy, 
dementia, or stroke/ transient ischemic accident 
Chronic lung Chronic bronchitis, emphysema, chronic obstructive pulmonary 
disease, or asthma 
Skin Eczema or psoriasis 
Diabetes mellitus Diabetes mellitus 
Thyroid  Hyperthyroidism, hypothyroidism, or goiter 
Cancer Any malignant neoplasma  
ICPC, International Classification of Primary Care 24.  
a skin cancer was excluded because of supposed lack of chronicity.
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Abstract 
 
Background and purpose: There exists limited knowledge regarding the 
relationship between depression and healthcare utilization in stroke patients. 
The objective of this register-based study was to examine the impact of having 
pre-existing depression at the time of hospital admission for acute stroke on 
length of hospital stay (LOS) and discharge destination (DD).  
Methods: Data from a general practice database were linked to those of a 
hospital database to identify patients hospitalized for stroke and used to 
categorize these patients into three groups based on pre-existing mental 
health (MH) status at admission, i.e. those with pre-existing depression, those 
with another pre-existing MH condition and those without any pre-existing MH 
condition. Multilevel analyses controlling for several potentially important 
covariates were performed to estimate the associations under study. 
Results: Both patients with pre-existing depression (n = 41) and those with 
another pre-existing MH condition (n = 62) did not differ significantly from 
patients without any pre-existing MH condition (n = 211) regarding LOS for 
acute stroke. Among patients who survived hospitalization, those with pre-
existing depression had significantly higher odds of being discharged to an 
institution instead of their home than patients without any pre-existing MH 
condition. Having another pre-existing MH condition had no significant effect 
on DD. 
Conclusions: Having pre-existing depression at admission seems to be a 
relevant factor in determining discharge to institutional care after acute 
stroke hospitalization. Further research is needed to determine the 
mechanism(s) through which pre-existing depression decreases the chances of 
being discharged to home. 
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7.1 Introduction 
  
Poststroke depression (PSD) is common, occurring in about one third of all 
stroke survivors at some time following stroke onset 
1
, and has been associated 
with slower recovery 
2
, cognitive dysfunction 
3
 and lower quality of life 
4
. 
Given these poorer outcomes, one may expect that stroke survivors who 
develop depression have higher healthcare utilization than their nondepressed 
counterparts. However, limited information is available on this issue. Most 
studies have examined the impact of PSD on length of stay in a rehabilitation 
setting and their findings are equivocal. Some studies found an association 
between PSD and increased length of stay 
e.g. 5
, whereas other studies did not 
demonstrate such a relationship 
e.g. 6
. Recently, PSD among veterans has been 
found to be associated with more outpatient visits and an increase in the total 
length of re-hospitalization in the 1-year 
7
 as well as the 3-year 
8
 period after 
initial stroke hospitalization.  
Whereas the relationship of PSD with healthcare utilization has received some 
attention, no study to date has examined, to our knowledge, whether there 
exists a link between pre-existing depression at the time of stroke and higher 
use of healthcare services. Such a link may be expected since, considering the 
high prevalence of depression in the elderly general population 
9
, a substantial 
number of patients is likely to suffer from or have a recent history of 
depression at the time of stroke, and considering the observation that, in 
general, depression in older persons is associated with adverse health 
outcomes and increased healthcare utilization 
10
.  
The objective of this register-based study was to extend the knowledge 
regarding the relationship between depression among stroke patients and 
healthcare use by focusing on the impact of having pre-existing depression at 
hospital admission for first-ever or recurrent stroke on (1) the length of acute 
hospital stay (LOS) and (2) discharge destination (DD). Given that significant 
depressive symptomatology at admission has been associated with increased 
healthcare utilization at follow-up in the general population of older 
hospitalized patients 
11
, it was hypothesized that having pre-existing 
depression would prolong LOS for patients admitted for stroke and would 
increase the likelihood of being discharged to an institution (i.e. nursing home 
or rehabilitation centre) instead of their home among those who survived 
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acute care hospitalization. 
 
 
7.2 Methods 
 
Data sources 
For this study, data from a general practice database, i.e. the National 
Network of General Practice (LINH) 
12
, were linked to data from a hospital 
database, i.e. the National Medical Register (LMR) 
13
. Information from the 
LINH database was used to identify patients‟ pre-existing mental health (MH) 
status at hospital admission for stroke as well as to assess potential 
confounding variables (see below). LMR data were used to identify patients 
who were hospitalized for stroke and to measure LOS and DD (see below). 
The LINH database holds longitudinal data extracted from electronic medical 
records of general practitioners (GPs) on all patient contacts, including 
diagnoses and drug prescriptions. Data from a subset of 74 practices were 
used, because these practices provided additional information on morbidity, 
i.e. diagnoses recorded by GPs on so-called “problem lists” of relevant health 
problems of patients, including those developed in the past. These additional 
data were collected within the framework of the second Dutch National Survey 
of General Practice 
14
. Diagnoses are coded by GPs according to the 
International Classification of Primary Care (ICPC) 
15
 based on the criteria of 
the International Classification of Health Problems in Primary Care 
16
. 
Prescribed drugs are coded according to the Anatomical Therapeutic Chemical 
(ATC) classification system 
17
. Furthermore, the indication (i.e. ICPC-coded 
diagnosis) for a prescription is recorded.  
The longitudinal LMR database has an almost complete coverage (99%) of all 
hospital admissions in the Netherlands. Recorded data include date of 
admission, date of discharge, diagnosis at discharge, and DD. Diagnosis at 
discharge is considered the reason for hospital admission and is coded 
according to the International Classification of Diseases, Ninth Revision, 
Clinical Modification (ICD-9-CM).  
Patient records from the LINH database were linked to those from the LMR 
database by using three patient identifiers that were present in both 
databases, i.e. gender, date of birth and 4-digit postal code. A pilot study has 
shown the feasibility of this linkage procedure 
18
. 
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Study population 
First, persons 50 years of age or older registered with the 74 general practices 
on January 1, 2001 were selected (n = 68,152). Since almost all non-
institutionalized Dutch inhabitants are registered with a GP, this can be 
regarded as a general population sample of individuals aged 50 years or older. 
Persons were excluded when they had a missing value on any of the three 
linkage variables or a non-unique combination of these variables (n = 2,190). 
Next, records of the remaining 65,962 persons from the LINH database were 
linked to those from the LMR database to identify those who were admitted to 
hospital for stroke between January 1, 2001 and December 31, 2003. Stroke 
comprised hemorrhagic stroke (ICD-9-CM code 430 or 431), acute ischemic 
stroke (code 434 or 436) and transient ischemic attack (TIA; code 435). The 
linkage procedure resulted in the identification of 847 patients who were 
hospitalized for stroke, corresponding approximately to an admission rate of 4 
per 1000 persons aged 50 years or older per year. This rate compares well to 
the expected yearly hospital admission rate for stroke in the general Dutch 
population aged 50 years and older 
19-20
.  
Of the 847 identified patients, 236 were excluded because general practice 
data were not available throughout the six months preceding hospital 
admission (either because a practice ended participating in LINH or because a 
patient was no longer registered with the practice). Additionally, eight 
patients diagnosed with dementia (ICPC code P70) were excluded to minimize 
the influence of having dementia on the associations under study. These 
exclusions left 603 patients for study. 
 
Dependent variables 
LOS was calculated by subtracting the date of admission from the date of 
discharge and expressed in days. DD was treated as a dichotomous variable: 
discharge to an institutional setting (i.e. rehabilitation centre or nursing home) 
versus discharge to home (including homes for the elderly, i.e. homes specially 
designed for the elderly and their needs 
21
). 
 
Independent variables 
The 603 patients were divided into three nonoverlapping groups by pre-existing 
MH status at admission: (1) those with pre-existing depression, (2) those with a 
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pre-existing MH condition other than depression and (3) a reference group 
without any pre-existing MH condition. The heterogeneous group of patients 
with another pre-existing MH condition was formed to ensure that the 
reference group consisted of patients who had no pre-existing MH problems.  
Pre-existing depression was defined as having been diagnosed at least once 
with depression (ICPC code P76) or depressive feelings (code P03) and/or 
having received at least one prescription for any antidepressant (ATC code 
N06A) in the six months preceding admission. The ICHPPC-2-Defined criteria 
for depression correspond largely to those of the DSM-IV for major depression 
22
. The P03 code is used for patients with depressive feelings who do not fulfil 
criteria for depression. 
Patients were considered to have another pre-existing MH condition when they 
had been diagnosed at least once with a MH condition other than depression 
(i.e. a “P”-diagnosis other than P76 or P03) and/or had been prescribed at 
least once an antidepressant for a MH condition other than depression or 
another psychotropic medication (i.e. ATC codes N05, N06B, N06C or N07B) in 
the six months preceding admission. The remaining patients were defined as 
having no pre-existing MH condition. Patients identified as having both pre-
existing depression and another MH condition were classified into the group of 
patients with pre-existing depression.  
Applying these definitions, resulted in the identification of 41 (6.8%) patients 
with pre-existing depression, 132 (21.9%) patients with another pre-existing MH 
condition and 430 (71.3%) patients without any pre-existing MH condition. The 
41 patients with pre-existing depression were registered with 26 general 
practices.    
 
Covariates 
Other variables were taken into account that could potentially influence the 
relationship of pre-existing depression with LOS and DD, including age, gender, 
education, living situation before stroke (alone or living with others), year of 
hospitalization, stroke type, history of prior stroke or TIA, presence of other 
stroke risk factors and somatic comorbidity 
23-25
. Educational level was 
categorized into low (no education or elementary school), middle/high (high 
school, college or university) and missing. This last category was created 
because attained educational level was unknown for a substantial number of 
patients (17%). History of prior stroke or TIA at admission was defined as 
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having been diagnosed with stroke or TIA (ICPC code K90 or K89) in the six 
months preceding admission. Presence of other stroke risk factors 
(hypertension: code K86 or K87; diabetes mellitus: code T90; atrial fibrillation: 
code K78; any cardiovascular condition: code K74 to K77, or K92) and other 
somatic conditions was established in a similar fashion. Somatic comorbidity 
was operationalized as a count of the number of somatic conditions 
26
 other 
than the stroke risk factors examined (0, 1, 2, and ≥3 conditions). Year of 
hospitalization was included to allow for the potential influence of changes in 
the organization of hospital care of stroke patients during the study period.  
Furthermore, both death during hospitalization and DD have consistently been 
shown to significantly influence LOS 
23,27
. In general, the period of 
hospitalization is shortest for patients who die in hospital, intermediate for 
patients discharged to home and longest for patients discharged to an 
institution. Therefore, death during hospitalization and DD were included as 
covariates in the analysis concerning LOS. 
Finally, since severity of stroke has been found to be an important factor 
influencing LOS 
24-25
, LOS was included as a proxy for stroke severity in the 
analysis concerning DD.   
 
Statistical analysis 
Two steps were taken to reduce the potential confounding influence of 
variation between practices on the associations under study: (1) analyses 
included only patients with a pre-existing MH condition other than depression 
(n = 62) and those without any pre-existing MH condition (n = 211) who were 
registered with the 26 practices with whom the 41 patients with pre-existing 
depression were registered and (2) multilevel modeling was employed to 
further statistical control for potential variation between these 26 practices. 
Hospitals could not be included as higher-level units because hospital 
identifiers are not disclosed for analyses by third parties. Though, allowing for 
variation at the practice level was considered an adequate proxy for taking 
into account variation at the hospital level (e.g. variation in care for stroke 
patients, availability of a stroke unit, discharge planning) based on the 
assumption that most stroke patients who were registered with the same 
practice were admitted to the same hospital. 
The distribution of LOS was skewed. However, logarithmic transformation 
resulted in an approximately normal distribution. A two-level random-
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intercept linear regression model was used to analyze the influence of having 
pre-existing depression on the log-transformed LOS. A two-level random-
intercept logistic regression model was used to assess the relationship between 
having pre-existing depression and discharge to an institution among the stroke 
patients who survived hospitalization. The reference category was being 
discharged to home. Multilevel analyses were performed using MLwiN version 
2.0 and statistical significance was tested using the Wald statistic (P < 0.05). 
 
 
7.3 Results 
 
Patients with pre-existing depression and their general practices 
The majority of the 41 patients with pre-existing depression (80.5%) were 
diagnosed at least once with depression (n = 31) or depressive feelings (n = 2) 
in the six months preceding hospital admission. The eight remaining patients 
defined as having pre-existing depression had been prescribed at least once an 
antidepressant in this period. The vast majority of the 41 patients (90.2%) 
were prescribed antidepressant drug therapy, most frequently selective 
serotonin reuptake inhibitors (59.5%). 
The studied 26 practices were widely geographically distributed. Though, with 
regard to  urbanization level of the practice location, practices located in rural 
areas were relatively over-represented.  
 
Length of acute hospital stay (LOS) 
Table 1 presents baseline characteristics as well as LOS and DD (including 
death during hospitalization) for the three groups classified by pre-existing MH 
status. The three groups did not differ significantly with regard to LOS in 
bivariate analysis. The distribution of gender, history of prior stroke/TIA and 
diabetes mellitus differed overall significantly between the groups. Post hoc 
tests showed that relative to patients without a pre-existing MH condition, a 
higher number of patients with another pre-existing MH condition were female 
(p = .020), had a history of prior stroke/TIA (p = .010) and had diabetes 
mellitus (p = .057). Also, more patients with another pre-existing MH condition 
than those with pre-existing depression had diabetes mellitus (p = .033).     
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Table 1  
Characteristics at admission as well as length of stay (LOS) and discharge destination (DD)  
of hospitalized stroke patients grouped by pre-existing mental health (MH) status 
 Pre-existing 
depression 
(n = 41) 
Pre-existing other   
MH condition  
(n = 62) 
No pre-existing       
MH condition  
(n = 211) 
 
 
p  
Age (years):  
mean(SD), range 
 
71.1(10.1);51.6-89.5 
 
74.1(8.2);52.8-87.1 
 
72.9(9.3);51.3-92.5 
 
.28a 
   50-59 
   60-69 
   70-79 
   ≥80 
  7(17.1) 
12(29.3) 
13(31.7) 
  9(22.0) 
  4(6.5) 
15(24.2) 
26(41.9) 
17(23.6) 
  23(10.9) 
  50(23.7) 
  92(43.6) 
  46(21.8) 
.56b 
Female gender     25(61.0) 41(66.1) 103(48.8) .034b 
Educational level 
   Low       
   Middle/High 
   Unknown 
 
12(29.3) 
21(51.2) 
  8(19.5) 
 
33(53.2) 
23(37.1) 
  6(9.7) 
 
  91(43.1) 
  80(37.9) 
  40(19.0) 
 
.11b 
Living alone  10(24.4) 15(24.2)  46(21.8) .89b 
Year of hospitalization 
    2001 
    2002 
    2003 
 
  7(17.1) 
17(41.5) 
17(41.5) 
 
16(25.8) 
18(29.0) 
28(45.2) 
 
  31(14.7) 
  95(45.0) 
  85(40.3) 
 
.15b 
Stroke type 
   Acute ischemic stroke 
   Hemorrhagic stroke 
   TIA 
 
27(65.9) 
  4(9.8) 
10(24.4) 
 
39(62.9) 
16(25.8) 
  7(11.3) 
 
145(68.7) 
  37(17.5) 
  29(13.7) 
 
.13b 
History of prior stroke/TIA 
Hypertension 
Diabetes mellitus 
Atrial fibrillation 
Cardiovascular disease 
  8(19.5) 
15(36.6) 
  5(12.2) 
  3(7.3) 
  7(17.1) 
15(24.2)  
27(43.5) 
20(32.3) 
  7(11.3) 
11(20.4) 
  22(10.4) 
  80(37.9) 
  42(19.9) 
  15(7.1) 
  36(17.1) 
.015b 
.69b 
.035b 
 …c 
.99b  
Somatic diseases 
   0 
   1 
   2 
   ≥ 3 
 
16(39.0) 
12(29.3) 
  7(17.1) 
  6(14.6) 
 
21(33.9) 
15(24.2) 
13(21.0) 
13(21.0) 
 
  82(38.9) 
  73(34.6) 
  25(11.8) 
  31(14.7) 
 
.39b  
DD (including death) 
   Home  
   Institution 
   Death 
 
21(51.2) 
12(29.3) 
  8(19.5) 
   
30(48.4) 
14(22.6) 
18(29.0) 
 
132(62.6) 
  43(20.4) 
  36(17.1) 
 
.45b 
LOS (days): 
   median; IQR 
 
13.0;5.5-23.5 
 
10.5;5.8-20.5 
 
10.0;6.0-22.0 
 
.92d 
Data presented are n(%) unless stated otherwise.   
TIA, transient ischemic attack; IQR, interquartile range. 
a ANOVA; b chi-square test; c requirements for chi-square test were not met; d Kruskal-Wallis test.  
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Table 2  
Two-level linear regression model for log-transformed length of stay (LOS) among hospitalized 
stroke patients (n = 314) 
         B 95% CI p 
Pre-existing MH status    
   No pre-existing MH condition    reference   
   Pre-existing depression       0.149   -0.12–0.42      .27      
   Pre-existing other MH condition        0.103   -0.13– -0.33        .38      
DD (including death) 
   Home 
   Institution 
   Death  
 
   reference 
      0.847 
     -0.923 
  
 
   0.62–1.08      
  -1.18– -0.67      
 
 
< .001 
< .001 
Stroke type 
   Acute ischemic stroke 
   Hemorrhagic stroke 
   TIA 
 
   reference 
     -0.067 
     -0.726 
 
 
  -0.33–0.19    
  -0.99– -0.47 
 
 
   .62      
< .001 
History of prior stroke/TIA 
Hypertension 
Diabetes mellitus 
Atrial fibrillation 
Cardiovascular disease 
      0.068 
      0.145 
     -0.049 
     -0.053 
      0.005 
   0.19–0.32    
-0.034–0.33      
  -0.27–0.17    
  -0.39–0.28     
  -0.23–0.24 
   .60 
   .11      
   .66      
   .76      
   .97      
Somatic diseases  
   0 
   1 
   2 
   ≥ 3 
 
   reference 
     -0.028 
     -0.118 
     -0.119 
 
 
  -0.24–0.18      
  -0.40–0.17     
  -0.39–0.15 
 
  
   .79     
   .42     
   .39      
Age groups 
   50-59 
   60-69 
   70-79 
   ≥ 80 
 
   reference 
      0.153 
      0.389 
      0.501 
 
 
  -0.18–0.48       
 0.075–0.70      
   0.15–0.85 
 
 
   .36      
   .015    
   .0055    
Female gender         -0.142   -0.33–0.050        .15      
Educational level 
   Low 
   Middle/High 
   Unknown 
 
   reference 
     -0.186 
     -0.105 
 
 
  -0.39–0.017   
  -0.35–0.14 
 
 
   .072     
   .41      
Living with others      -0.090    0.31–0.13         .42      
Year of hospitalization 
    2001  
    2002 
    2003 
 
   reference 
     -0.075 
     -0.100 
 
 
  -0.33–0.18      
  -0.35–0.15 
 
 
   .56      
   .43      
MH, mental health; TIA, transient ischemic attack.  
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The results of the two-level regression analysis for log-transformed LOS are 
shown in Table 2. Compared to having no pre-existing MH condition at 
admission, neither having pre-existing depression nor having another pre-
existing MH condition did significantly influence duration of hospitalization, 
after controlling for the measured covariates as well as inter-practice 
variation. As expected, being admitted to a hospital because of a TIA 
(compared to being admitted because of an ischemic stroke) and dying during 
hospitalization (compared with being discharged to home) were associated 
with shorter LOS, while being sent to an institution (compared to being 
discharged to home) was related to prolonged LOS. Furthermore, patients aged 
70 years or older at admission were more likely to stay longer in hospital than 
patients aged between 50-59 years.  
 
Discharge destination (DD) 
Sixty-two (19.7%) of the stroke patients died in hospital (see Table 1). Two-
level logistic regression analysis showed that neither having pre-existing 
depression nor having another pre-existing MH condition significantly 
influenced risk of dying (data not shown). Two hundred fifty-two patients 
survived acute hospitalization for stroke. Bivariate analysis showed that the 
proportion of patients discharged to institutional care did not differ 
significantly by pre-existing MH status (pre-existing depression: 36.4%; pre-
existing other MH condition: 31.8%; no pre-existing MH condition: 24.6%; p = 
.29). Further bivariate analyses revealed similar between-group differences 
when using the total study sample (see above), with the exception that the 
difference in gender distribution was no longer significant.        
Table 3 shows the results of the two-level logistic regression analysis for DD. 
Patients with pre-existing depression had a significantly higher odds of being 
discharged to an institution than patients without any pre-existing MH 
condition, after adjusting for the measured covariates and variation between 
practices. Having another pre-existing MH condition did not exert a significant 
effect. Patients with a cardiovascular condition were significantly more likely 
to be sent to an institution compared to those without cardiovascular disease. 
Unsurprisingly, having been admitted to hospital because of TIA was associated 
with decreased odds of being discharged to institutional care, while increased 
LOS was related to higher odds of discharge to an institution. Finally, patients 
aged 80 years or older were more likely to be sent to institutional care than 
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patients aged between 50-59 years. 
 
 
Table 3   
Two-level logistic regression model for discharge to institution (vs. discharge to home)  
among stroke patients who survived initial hospitalization (n = 252) 
        OR 95% CI p  
Pre-existing MH status    
   No pre-existing MH condition    reference   
   Pre-existing depression       4.86       1.69-14.02         .0034    
   Pre-existing other MH condition        1.61       0.53-4.89         .40      
Length of hospital stay (LOS)       1.12 1.08-1.15 < .0001  
Stroke type 
   Acute ischemic stroke 
   Hemorrhagic stroke 
   TIA 
 
   reference 
      1.08 
      0.063 
 
 
0.35-3.32 
0.010-0.41 
 
 
   .89      
< .005 
History of prior stroke/TIA 
Hypertension 
Diabetes mellitus 
Atrial fibrillation 
Cardiovascular disease 
      0.69 
      0.58      
      2.02 
      0.27 
      2.57       
0.24-2.02       
0.28-1.22       
0.83-4.90    
0.048-1.52     
1.00-6.64 
   .50   
   .15      
   .12   
   .14     
   .051     
Somatic diseases  
   0 
   1 
   2 
   ≥ 3 
 
   reference 
      0.43      
      0.88      
      0.98 
 
 
0.18-1.03       
0.27-2.82       
0.31-3.07 
 
 
   .060     
   .82     
   .98     
Age groups 
   50-59 
   60-69 
   70-79 
   ≥ 80 
 
   reference 
      2.74       
      2.41       
      6.19      
 
 
0.61-12.30       
0.55-10.49        
1.34-28.62       
 
 
   .18     
   .24     
< .05   
Female gender       0.85 0.40-1.77         .66 
Educational level 
   Low 
   Middle/High 
   Unknown 
 
   reference 
      0.89      
      0.67 
 
 
0.39-2.03       
0.23-1.95   
 
 
   .79      
   .46    
Living with others       1.14 0.45-2.93     .78     
Year of hospitalization 
    2001  
    2002 
    2003 
 
   reference 
      1.12       
      1.48     
 
 
0.40-3.13       
0.55-3.93 
 
 
   .83      
   .44      
MH, mental health; TIA, transient ischemic attack; OR, odds ratio. 
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7.4 Discussion 
 
The present register-based study indicated that having pre-existing depression 
at the time of hospital admission for a new or recurrent stroke did not 
influence LOS. Though, among patients who survived hospitalization for acute 
stroke, we found that patients who were already depressed at admission were 
more likely to be discharged to an institution instead of their home than those 
without any pre-existing MH condition, after controlling for the influence of 
several potentially confounding factors including socio-demographic variables, 
living alone or not, stroke type, history of prior stroke or TIA and somatic 
comorbidity. This is an important finding because it indicates that having pre-
existing depression may be a relevant factor in determining discharge to 
institutional care rather than to home after acute stroke hospitalization. As far 
as we are aware no previous studies have examined the impact of  pre-existing 
MH status at hospital admission for stroke on use of healthcare services.  
Some potential limitations of our study should be acknowledged. First, the 
generalizability of our findings to the general population of patients 
hospitalized for stroke may be limited due to the exclusion of 28% of eligible 
patients. However, these patients did not differ from those that were included 
regarding gender, age, and educational level. Moreover, it is highly unlikely 
that the reason for excluding these patients, namely unavailability of general 
practice medical records, would have been associated with having pre-existing 
depression at admission. Another feature that may have limited the 
generalizability is that the final study population, and especially the group of 
patients with pre-existing depression, was rather small. Nevertheless, the 
studied patients were registered with 26 different practices that were 
geographically located throughout the Netherlands. Though, practices located 
in rural areas were somewhat over-represented. Second, using  medical 
records of GPs to identify patients who were depressed at the time of 
admission for stroke has some drawbacks. Research has shown substantial 
underdiagnosis of depression in Dutch general practice 
28
. In comparison, the 
rate of overdiagnosis seems to be considerably lower 
29
. Importantly however, 
misclassification of cases due to overdiagnosis or underdiagnosis of depression 
would most likely have attenuated a true relationship between pre-existing 
depression and a higher likelihood of being discharged to institutional care 
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after stroke hospitalization rather than have produced a spurious one. In 
addition, by using GP records no standardized assessment of severity of 
depression was available, nor was information concerning possible initiated 
psychological treatments for depression. A third limitation is that the influence 
of potentially important unmeasured factors could not be taken into account. 
Our study lacks a detailed assessment of stroke severity, which is an important 
factor in determining both LOS and DD 
23,25
. Though, LOS was included as a 
proxy for stroke severity in the analysis concerning discharge destination. 
Other unmeasured factors including subtype of ischemic stroke, functional 
status, cognitive functioning and availability of social support may have had 
modifying or confounding effects on the associations under study. In particular, 
poorer social support networks, functional and cognitive impairment are linked 
with depression in the elderly, probably in a complex and reciprocal manner 
10
, 
and each of these factors has been found to reduce the chances of discharge to 
home after acute stroke hospitalization 
23, 30-31
. 
Bearing these limitations in mind, an obvious question that comes up is how 
the observed association between having pre-existing depression at hospital 
admission for stroke and increased likelihood of institutionalization can be 
explained. Possibly, this finding reflects a heightened level of dependency at 
discharge among patients with pre-existing depression. Their depressive 
symptoms, such as having pessimistic expectations, being demotivated, having 
less energy and diminished concentration, could reduce their ability to adapt 
to the impairments caused by stroke and thereby lead to slowed recovery 
during hospitalization 
32
. The possibility of a relationship between antecedent 
depression and increased stroke severity could offer another explanation. The 
emerging body of evidence that suggests a role of depressive symptoms in the 
development of stroke does leave open the possibility of such a relationship 
33
. 
Finally, having pre-existing depression at admission may contribute to a higher 
level of dependency at discharge through its potential associations with 
unmeasured factors such as functional disability, cognitive dysfunction and 
poor social support.  
Evidently, further studies are needed to confirm our results and to better 
understand the mechanism(s) through which having pre-existing depression 
increases the likelihood of discharge to institutional care among patients 
hospitalized for acute stroke. Identification of the underlying mechanism(s) is 
essential to determine whether there exist opportunities to improve outcomes 
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for stroke patients with pre-existing depression and to reduce their frequency 
of discharge to an institution. Possible targets for intervention may include the 
routine assessment of pre-existing levels of depression at hospital admission 
for acute stroke and the optimization of depression management during 
hospitalization for stroke when necessary. GPs regularly miss depression in 
older persons, and when they do, often provide inadequate treatment 
10
. A 
further potential intervention strategy might be to intensify the level of care 
and support provided in the home situation for stroke patients with pre-
existing depression, for instance, by supporting informal caregivers and/or 
increasing the degree of home healthcare. Our study complements findings of 
two prior studies using administrative databases indicating a relationship 
between PSD and long-term healthcare utilization after acute hospitalization 
1-
2
. Altogether, these findings indicate the need for further studies specifically 
designed to disentangle the relationships between a past history of depression, 
pre-existing depression at the time of stroke, PSD and acute as well as long-
term healthcare utilization.   
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8 General discussion 
 
 
This thesis addressed some identified gaps in the knowledge about the 
occurrence of comorbidity involving depression and its health care 
consequences. In this closing section first the main findings of the thesis will 
be presented, followed by reflections on the merits and disadvantages of using 
data from general practice records, while finishing with a discussion of the 
relevance and implications of the findings for future research and clinical 
practice. 
 
 
8.1 Principal findings 
 
Part A. Studies on occurrence 
Part A started with a cross-sectional study that addressed the following 
research question (chapter 2): 
What are the patterns of somatic and psychiatric cluster comorbidity in 
depression, stroke, multiple sclerosis, Parkinson’s disease/ 
parkinsonism, dementia, migraine and epilepsy?  
Of the 30 categories of somatic illness studied, a broad and diverse set of 21 
categories were identified as possible or highly probable instances of somatic 
cluster comorbidity in a large group of general practice patients with a 
lifetime GP diagnosis of depression.
*
  This finding indicates that patients who 
have (had) depression are generally more likely to have a somatic illness than 
those who never had a depression. Noteworthy, when analyses were restricted 
to the subgroup of patients with a current GP diagnosis of depression, 12 of 
the 21 somatic disease categories were no longer identified as (possible or 
highly probable) cluster comorbidity. This was interpreted to reflect reduced 
statistical power due to the smaller size of this subgroup.  
 
                                                     
*
 Being of most interest to this thesis, summary of findings is limited to those concerning 
somatic    cluster comorbidity in depression. 
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Part A continued with a case-control study that attempted to answer the 
following research question (chapter 3): 
Is there a relationship between cerebrovascular risk factors (CVRFs) and 
the subsequent development of depression in older general practice 
patients?  
In this study, CVRFs included diagnoses of hypertension, diabetes mellitus, and 
cardiovascular disease. None of the CVRF variables examined (i.e. any CVRF, 
individual CVRF, number of CVRFs, and exposure duration to CVRFs) was found 
to be significantly associated with the subsequent onset of depression in a 
sample of older general practice patients. However, several of the CVRF 
variables under study were associated with a significantly increased odds of 
developing depression with onset between ages 50 and 69 years. It was 
suggested that these findings could indicate that CVRFs play a relevant role in 
the development of depression with onset between ages 50 and 69 years, but 
that no evidence was found that CVRFs contribute to the occurrence of 
depression with onset at age 70 years or later. These results should be 
considered preliminary given the possibility of bias inherent in using morbidity 
data recorded by GPs. 
 
Part A finished with a systematic review in which the following research 
question was examined (chapter 4): 
Is there a relationship between severity of Alzheimer’s disease (AD) and 
prevalence of comorbid depressive symptoms and depression? 
A search strategy identified twenty-four studies that fulfilled pre-defined 
inclusion criteria. Of these, 19 reported findings on the relationship between 
severity of AD and prevalence of depressive symptoms and seven on the 
association of AD severity with frequency of diagnosed depression. Four of the 
19 studies on the former association were rated as being of high quality, and 
three of these found no significant association. Three of the seven studies on 
the latter relationship were rated as being of high quality, and none of these 
reported a significant result. It was concluded that no evidence exists for a 
relationship between severity of AD and prevalence of comorbid depressive 
symptoms or depression.  
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Part B. Studies on health care consequences 
 
Consequences for quality of care 
The first study presented in Part B set out to answer the following research 
question (chapter 5): 
Is there an interaction effect between psychiatric and chronic somatic 
comorbidity on GPs’ diagnosis of depression? 
It was shown that approximately half of a group of patients with major 
depression and/or dysthymic disorder established according to a structured 
diagnostic interview, the Composite International Diagnostic Interview (CIDI) 
1
, 
had either comorbid psychiatric (as indicated by the CIDI) or comorbid chronic 
somatic disease (as indicated by GP records). Almost a quarter of them had 
both types of comorbidity. About 65% of the patients with psychiatric 
comorbidity were not diagnosed as being depressed by their GP, as reflected 
by having no GP record of a diagnosis of depression or depressive feelings. The 
rate of underdiagnosis of depression was somewhat higher among those with 
comorbid chronic somatic illness (74%). Multivariate analysis demonstrated an 
interaction effect between somatic and psychiatric comorbidity on GPs‟ 
diagnosis of depression. Further analysis showed that - among the patients 
without chronic somatic comorbidity - a lower educational level, less severe 
depression, and fewer GP contacts all were independently associated with a 
decreased likelihood of  being diagnosed as depressed. Among the chronic 
somatically ill patients only having no comorbid psychiatric disorder was 
associated with a  decreased likelihood of receiving a depression diagnosis. It 
was concluded that the factors associated with underdiagnosis of depression by 
GPs differ depending on whether or not depressed patients have a chronic 
somatic illness. 
 
Next a prospective study was described in which two research questions were 
examined (chapter 6): 
What is the influence of specific chronic somatic conditions on the 
initiation of any depression care in patients newly diagnosed with 
depression by their GP?; and  
Among those being prescribed antidepressants by their GP, what is the 
influence of these conditions on prescription of continuous 
antidepressant treatment? 
Chapter 8 
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Any depression care was initiated in 86% of the patients with chronic somatic 
illness. A comparable percentage was observed among the non-chronically ill 
patients (88%). Rate of initiation of any depression care varied by type of 
condition, ranging from 59% in patients with cardiac arrhythmia to 93% among 
those with a thyroid condition. Multivariate analysis showed that, compared to 
patients without chronic somatic illness, patients with pre-existing ischaemic 
heart disease or cardiac arrhythmia had a significantly lower likelihood of 
having any depression care being initiated after being newly diagnosed with 
depression by their GP. None of the other 12 chronic somatic conditions under 
study was found to significantly impact the initiation of any depression care. 
The proportion of patients with continuous prescription after initiating 
antidepressant therapy was comparable among the groups with and without 
chronic somatic illness (resp. 37% and 39%). The rate of continuous 
prescription differed according to the type of the comorbid condition. Patients 
with cardiac arrhythmia showed the highest rate (50%), while the lowest rate 
was observed among those with a thyroid condition (23%). Multivariate analysis 
demonstrated that none of the chronic somatic conditions significantly 
influenced the prescription of continuous antidepressant treatment. These 
findings were interpreted as pointing to the relevance of supporting GPs in the 
management of comorbid depression in patients with heart disease to reduce 
its negative impact.  
 
Consequences for health care utilization 
Part B finished with a prospective study that investigated the following 
research question (chapter 7): 
What is the impact of having pre-existing depression at hospital 
admission for stroke on the length of acute hospital stay and discharge 
destination?  
It was found that having pre-existing depression at the time of hospital 
admission for a new or recurrent stroke did not significantly affect length of 
acute hospital stay. It was further shown that among the survivors of 
hospitalization for acute stroke, the patients who were already depressed at 
admission had a significantly greater likelihood of being discharged to an 
institution instead of their home than those without any pre-existing mental 
health condition. Having a pre-existing mental health condition other than 
depression did neither influence length of acute hospital stay nor discharge 
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destination. These findings were interpreted as indicating that having pre-
existing depression is a possibly important factor in determining discharge to 
institutional care after hospitalization for acute stroke. 
 
 
8.2 Strengths and limitations of using general practice records  
 
As has been discussed to some extent in the preceding chapters, using data 
from general practice records for studying occurrence of comorbidity involving 
depression and its health care consequences has its strengths and limitations. 
These will be considered below.  
 
Strengths 
Morbidity data that are continuously collected within a large, representative 
network of general practices, such as the National Information Network of 
General Practice (LINH) (www.linh.nl), have a combination of characteristics 
that makes them, in principle, very useful for research into the occurrence of 
comorbidity involving depression. Firstly, at least in countries such as the 
Netherlands, in which virtually all inhabitants are listed in a general practice 
and where GPs fulfil a gatekeeper‟s role towards the access to medically 
specialized care, the data represent the morbidity of a largely unselected 
population. It is essential to study associations between depression and other 
health conditions in an unselected population sample to preclude the 
identification of spurious cluster comorbidity due to selection bias 
2
. Secondly, 
data on a large  number of persons are available. This is important because the 
study of the occurrence of comorbidity involving depression may require very 
large samples, especially when the focus lies on specific associations between 
depression and other, less common health conditions. For instance, the large 
sample examined in the study presented in chapter 2 allowed the investigation 
of the association of lifetime depression with disorders with a relatively low 
prevalence in the general population, such as multiple sclerosis and 
Parkinson‟s disease. Thirdly, the morbidity data reflect GP-defined health 
problems rather than being based on self-report. Fourthly, morbidity 
information from general practice is relatively comprehensive. GPs, as 
generalists, see a broad spectrum of somatic and mental health problems. 
They record diagnoses made by themselves, complemented with records of 
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diagnoses made by other health care professionals after referral. By 
comparison, large-scale population health surveys usually focus on (selected) 
somatic and/or psychiatric morbidity and rely fully on self-report. The 
resulting datasets may therefore have limited value for the study of 
comorbidity between depression and somatic illnesses. For instance, 
psychiatric morbidity surveys obviously collect extensive data about mental 
disorders, but usually only basic, self-reported information on (a restricted set 
of) chronic somatic conditions. A fifth strong point is that morbidity data that 
are continuously collected within a general practice network allows 
prospective or retrospective research to be conducted that spans long periods 
of time (of which the case-control study described in chapter 3 is an example) 
3
. Such research is vital to enhance our knowledge of the (time of) occurrence 
and the longitudinal pattern of depression during the course of another health 
condition, and vice versa. Other datasets usually cover a restricted time 
window.  
The value of data collected in the primary setting for the study of the health 
care consequences of comorbidity involving depression is obvious. GPs in 
various countries play a key role in the diagnosis and management of persons 
with depression and in their referral to other health care professionals. 
Therefore, an important part of the research on the impact of comorbidity on 
the quality of depression care must be undertaken within the primary care 
setting. The same holds true for research on the relationship between 
comorbidity involving depression and health service utilization. Moreover, 
because opportunities exist to link datasets from general practice networks 
with data from patient based registers from other care settings, research on 
the health care use of general practice patients in relation to comorbidity 
involving depression can be extended to cover use of services in these settings 
(of which the study described in chapter 7 is an example).   
 
Limitations 
There are a number of limitations inherent to using data from general practice 
records that hamper research into the occurrence of comorbidity involving 
depression. A first limitation is the reliance on GP-diagnosed depression. 
Several studies, including our own presented in chapter 5, have consistently 
shown that a considerable number of persons with major depression according 
to DSM-IV criteria are not diagnosed as being depressed by their GP 
4-6
. 
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Overdiagnosis of depression appears to occur less often in Dutch general 
practice 
7-8
. Misclassification of depressed individuals as nondepressed and vice 
versa due to missed and incorrect diagnosis may lead to a biased estimation of 
the rates of comorbidity involving depression (i.e. concurrent comorbidity). 
Regarding research into cluster comorbidity, of which the studies presented in 
chapters 2 and 3 are examples, such misclassification will probably lead to an 
underestimation of the comorbid associations under study. However, the 
possibility of differential misclassification cannot be ruled out, which could 
result in overestimated effects and thereby increase the chance of finding 
instances of spurious cluster comorbidity. With regard to the findings of 
chapters 2 and 3, which concentrated on associations between depression and 
somatic conditions, it is to some extent reassuring that research, including our 
own, has indicated that the rate of underdiagnosis of depression by GPs 
generally tends to be higher among chronically ill patients 
5; 9-10
.  
A second limitation is that not all diagnoses made by GPs and other health care 
professionals after referral will be completely and fully correctly recorded in 
the patient‟s electronic medical record. This may lead to misclassification of 
depression and thereby bias both rates of comorbidity and strength of 
comorbid associations. Again, differential misclassification cannot be 
excluded. It may be possible that the quality of recording of depression 
diagnosis depends on whether persons have other (specific) health conditions 
problems. It is difficult to assess the quality of diagnosis recording because 
“gold” standards to determine completeness and accuracy are lacking 11-12. 
Anyhow, within the LINH network measures are being taken to facilitate coding 
of diagnosis. Moreover, the extent of agreement regarding diagnostic coding 
between GPs participating in the second Dutch National Survey of General 
Practice and GPs highly experienced in coding was found to be reasonably high 
13
. Research into the occurrence of comorbidity involving depression may also 
be hampered by deficiencies in the recording of other data types. For 
instance, the study described in chapter 3 could only use a subset of patients‟ 
health history data because in a considerable number of participating practices 
electronic medical records included incomplete information about dates of 
diagnosis. Recently, an instrument was developed in the Netherlands that gives 
an indication of the quality of data included in electronic medical records 
14
. 
Implementation of such an instrument may improve quality of recording.  
A third limitation is that the accuracy of diagnoses of health problems and the 
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quality with which this information and other relevant data are recorded in an 
electronic patient record system may differ between participating GPs and 
practices 
15
. However, there are analytical techniques available to control for 
this variation among GPs and practices, such as multilevel analysis.  
Fourthly, a general practice database usually provides relatively crude 
measures of morbidity. The GPs participating in the LINH network use the 
ICPC-1 
16
 to record health problems. This classification system offers no 
measure of the type and severity of depression according to standard 
psychiatric criteria. This is relevant because the occurrence of comorbidity 
involving depression may differ depending on these characteristics. The ICPC-1 
provides diagnostic criteria from the International Classification of Health 
Problems in Primary Care (ICHPPC-2-Defined 
17
). Given that the ICHPPC-2-
Defined criteria for depressive disorder (ICPC code P76) are less strict than the 
DSM-IV criteria for major depression (e.g. a lower number of symptoms is 
required; no clinical significance criterion), it is likely that a proportion of the 
persons who are diagnosed as being depressed by their GP suffer from a 
dysthymic disorder or subthreshold depression 
8
. Furthermore, it is unclear 
how the symptom diagnosis depressive feelings (ICPC code P03) relates to a 
diagnosis of subthreshold depression as defined by psychiatric criteria. Coding 
morbidity according to the ICPC does also provide relatively crude measures of 
other health conditions. A limited number of classes for diagnoses is offered by 
the classification system and assessment of the severity of a particular health 
condition is not included 
18-19
. These characteristics preclude more in-depth 
research into the occurrence of comorbidity involving depression that 
considers the influence of specific types and severities of health conditions. 
Noteworthy, the second edition of the ICPC includes an extension to assess 
severity of a health condition and it appears to be feasible for GPs to routinely 
code this information 
19
.  
A final limitation is that within a general practice database generally no or 
restricted information is available about other characteristics that could 
confound or modify associations between depression and other health 
conditions. For instance, research on the relationship between somatic illness 
and the subsequent development of depression, of which the study described 
in chapter 4 is an example, would ideally take into account the influence of 
psychological and social risk factors for depression, such as personality 
disorder, stressful life events, and poor social support 
20-21
.     
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All above-mentioned limitations regarding the value of general practice 
records for research on the occurrence of comorbidity involving depression are 
also broadly relevant to studies on its health care consequences. In some 
cases, though, reliance on GP diagnosis of depression is not a shortcoming but 
a prerequisite in this research area. For instance, if the focus lies on the 
influence of the presence of other health conditions on the care for depression 
in general practice, as in the study described in chapter 6, patients who are 
diagnosed as depressed by their GPs are the study population of interest, 
irrespective of whether or not they meet standard psychiatric criteria for 
depression. Moreover, inter-practice or inter-GP variation needs not 
necessarily be treated as a factor whose influence has to be controlled for in 
analysis, but may also be a variable of interest. For instance, it is possible that 
GPs with certain characteristics have particular difficulties with diagnosing or 
managing depression in the context of (a specific) somatic illness.  
  
 
8.3 Directions for future research  
 
Implications of the studies on occurrence  
Although addressing different research topics, all three studies presented in 
Part A point to the need for well-designed longitudinal research to better 
describe the occurrence of comorbidity between depression and other health 
conditions and to better understand its underlying mechanisms. Based on the 
study findings some (interrelated) research objectives for future longitudinal 
research could be formulated specifically regarding comorbidity of depression 
and somatic illness.  
 
Gain more insight into the specificity of cluster comorbidity between 
depression and somatic illness 
The finding of the study presented in chapter 2 that lifetime and (to a lesser 
extent) current depression are cross-sectionally associated with a wide and 
diverse range of chronic somatic conditions in a largely unselected population 
corroborates the findings of two recent large-scale population-based studies 
22-
23
. The consistent finding of extensive cross-sectional cluster comorbidity 
stresses the relevance of gaining a better understanding of the comorbid 
relationships between depression and chronic somatic illnesses. In particular, 
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it does raise the question of how specific these associations are. Is depression 
largely non-specifically associated with a wide and diverse set of chronic 
somatic conditions or are specific chronic somatic conditions uniquely linked to 
depression? Such knowledge is important as an indicator for the pathways that 
may underlie links between depression and somatic illnesses 
24-27
. To shed more 
light on this issue longitudinal research using unselected populations is needed 
that evaluates whether any association between depression and a specific 
chronic somatic illness is maintained after taking the influence of other 
coexisting somatic disorders into account. A longitudinal design is required to 
disentangle the bidirectional relationship that is likely to exist between 
depression and various chronic somatic illnesses 
28
. Recently, a population-
based longitudinal study examined the risk of depression in the 8-year period 
after the onset of cancer, diabetes, hypertension, heart disease, arthritis, 
chronic lung disease, or stroke 
29
. Unlike most prior research, this study took 
into account the co-occurrence between the specific chronic conditions. It was 
found that the risk of depression over time varied by chronic condition, which 
suggests that there does not merely exist a general association between any 
chronic somatic condition (no matter which one) and risk of depression. 
Though, to clarify the specificity of comorbidity between depression and 
chronic somatic illness future longitudinal research also needs to consider the 
influence of mental disorders that are known to co-occur commonly with 
depression 
23
. In particular, depression and anxiety disorders are closely 
related to each other, and anxiety disorders have also been shown to be 
associated with a range of chronic somatic conditions 
30-31
. Given that most 
research performed to date has not taken the comorbidity of depression with 
anxiety and other mental disorders into account, it remains unclear whether 
depression‟s association with chronic somatic conditions is independent of 
other co-existing mental disorders. 
 
Gain more insight into the interplay between having a chronic health 
condition and other risk factors in the onset of depression 
The case-control study presented in chapter 3 provided some support for a role 
of cerebrovascul
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the association between CVRFs and depression in later life 
32
. Well-designed, 
prospective research over a long follow-up period is required before more 
definite conclusions can be drawn regarding this relationship. Such research 
should take into account the various other biological, psychological, and social 
risk factors for later-life depression that have been reported in the literature 
20-21
 and determine their possible interplay with CVRFs in the onset of 
depression in older people. It has been proposed, for instance, that the 
presence of non-biological factors might be conditional to trigger depression in 
patients predisposed to it by cerebrovascular disturbance 
33-35
. The question 
regarding the interaction with other risk factors for depression is generally 
relevant to any research into the role of a chronic health condition in the 
development of depression 
36
. Yet, risk factors for depression are not often 
studied simultaneously 
37
. Future longitudinal studies on the association 
between a chronic health condition and onset of depression should be designed 
taking a broad range of risk factors into account to allow investigation of 
interaction with possible other biological, psychological and social 
determinants of depression.   
 
Gain more insight into the course of depression in the context of a chronic 
health condition and its determinants 
The systematic review described in chapter 4 suggests that, on the basis of 
published cross-sectional data, severity of dementia is not an important 
correlate of depression or depressive symptoms in Alzheimer‟s disease (AD). 
Evidently, though, prospective longitudinal studies with follow-up of patients 
who are in the early stages of AD can determine more definitely how the 
occurrence of depression and depressive symptoms relates to the various 
stages of severity of AD. To date, however, such studies have scarcely been 
performed 
38
. The need for prospective research that examines the long-term 
course of comorbid depression and its determinants pertains not specifically to 
patients with AD, but generally to patients with any long-term health condition 
28
. Given the heterogeneous nature of depression 
39
, it is important that such 
research determines if relevant subtypes of  depression can be distinguished in 
the context of a particular chronic health condition. Recent studies of 
subtypes of depression following myocardial infarction (MI) offer potential 
insights in this respect. Firstly, incident post-MI depression, i.e. depression 
that develops for the very first time after MI, and non-incident post-MI 
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depression, i.e. depression that is preceded by or is a continuation of previous 
episodes of depression present before the occurrence of MI, appear to 
constitute meaningful subtypes of post-MI depression. Specifically, this 
subtyping describes subgroups of patients with post-MI depression that differ in 
pre-MI characteristics, severity of the MI, cardiovascular prognosis and 
response to psychiatric treatment 
40-42
. Secondly, other studies indicate that 
distinct courses of depressive symptoms can be distinguished in post-MI 
patients 
43-44
.  
 
Implications of the studies on health care consequences 
 
Gain more insight into the mechanisms underlying suboptimal diagnosis and 
management of depression in the context of somatic illness 
The study presented in chapter 5 found a low rate of depression diagnosis by 
Dutch GPs among depressed patients with chronic somatic illness, which is 
especially noteworthy in view of the fact that the vast majority of these 
patients had regular contact with their GP. This is a worrisome finding given 
the evidence that depression negatively affects the course and outcome of 
somatic illnesses 
45; 28
, and vice versa 
46
. Further research is needed to uncover 
the mechanisms that underlie underdiagnosis of depression in chronically ill 
patients. In our study different factors were found to affect diagnosis of 
depression by Dutch GPs in depressed patients with and without chronic 
somatic illness. However, a limited set of variables was considered and much 
of the variance was left unexplained. Future research should take into account 
the various other patient-related, GP-related, and health system-related 
factors that have been reported to hinder depression diagnosis in the general 
population of depressed general practice patients 
47-49
, and determine whether 
or not they apply to the subpopulation of depressed patients with a chronic 
somatic condition. Moreover, such future studies should ideally be large 
enough to allow investigation of the influence of characteristics of chronic 
somatic disorders (e.g. type and severity of somatic illness), characteristics of 
depression (e.g. depression subtypes), and common co-existent mental 
disorders (e.g. anxiety, somatisation) on the likelihood of depression diagnosis 
by GPs. 
The study described in chapter 6 indicates that patients newly diagnosed with 
depression are generally not managed differently by their GP depending on 
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whether or not they have a chronic somatic condition. Though, patients with 
pre-existing ischaemic heart disease or cardiac arrhythmia appear to be an 
exception: they were found to have a lower likelihood of any care for 
depression being initiated than those without chronic somatic illness. Further 
research is needed to replicate and elaborate on these findings. Given the 
adverse effects of comorbid depression in patients with ischaemic heart 
disease and available effective treatment strategies 
50-51
, it is important to 
understand the  reasons why Dutch GPs are less likely to initiate depression 
care in patients with heart disease. Apart from pointing to the potential 
special case of patients with heart disease, the findings of our study also 
suggest that, once initiated, management of comorbid depression is less-than-
optimal in the total group of patients with chronic somatic illness. For 
instance, a high rate of initiation of antidepressant treatment was observed 
among chronically ill patients with newly diagnosed depression (79%), while 
the rate of prescription of continuous therapy was found to be low (37%). To 
date, only a small number of studies in primary care settings have addressed 
the quality of depression treatment in patients with chronic somatic illness, 
and they used rather crude indicators for adequate depression treatment, i.e. 
treatment according to clinical guidelines 
52-54
. Future research should more 
thoroughly examine the adequacy of pharmacological and psychological 
treatment initiated for depression in the context of specific chronic somatic 
illnesses and identify the mechanisms that underlie the occurrence of 
suboptimal depression treatment.   
In this thesis the focus was laid on the influence of comorbidity on the care for 
depression in general practice, as Dutch GPs play a central role both in the 
diagnosis and management of depression 
55
. Though, underdiagnosis and 
undertreatment of depression have also been found to be widespread among 
patients hospitalized for somatic illness 
e.g.
 
56-57
. Future research should also 
focus on identifying the barriers to diagnosis and treatment of comorbid 
depression in the general hospital setting, and determine how these barriers 
relate to those in the primary care setting.  
 
Gain more insight into the mechanisms underlying the association between 
comorbid depression and increased health care utilization among persons with 
somatic illness   
The study presented in chapter 7 found evidence suggesting that depression 
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already present at the time of stroke plays a relevant role in determining 
discharge to institutional care after acute stroke hospitalization. Coupled with 
earlier findings of a relationship between post-stroke depression (PSD) and 
increased health care utilization among stroke survivors in the years following 
hospitalization 
58-59
, this finding highlights the necessity that future 
longitudinal research uncovers the mechanisms by which depression exerts its 
effects on health care utilization after stroke, with a specific focus on the role 
of time of onset of depression.  
This research issue is also relevant for patients with other somatic illnesses 
leading to hospital admission. Studies have found associations between 
comorbid depression and increased health care use in both the general 
population and various subpopulations of hospitalized patients, but the specific 
reason(s) for these links remain largely unclear 
60-62
. Moreover, most previous 
research did not differentiate between patients for whom depression 
represented a first-ever depressive episode, those for whom depression was a 
continuation of a depression already present at the time of admission, and 
those for whom depression represented a recurrence of depression 
63
. As 
mentioned before, such subtyping allows to identify subgroups of patients with 
depression after myocardial infarction (MI) that differ in pre-MI characteristics, 
severity of the MI, cardiovascular prognosis, and response to psychiatric 
treatment 
40-42
. Further longitudinal research is needed to determine whether 
these, and other possibly relevant subtypes of depression differ in their effects 
of increasing use of health care services among patients hospitalized for 
somatic illness and whether the mechanisms through which they exert their 
influence are different. Such research should also clarify whether the associ-
ation between comorbid depression and increased health care use and its 
underlying mechanisms are generalizable to any somatic illness leading to hos-
pital admission or only to specific somatic illnesses requiring hospitalization. 
Finally, these research questions need to be answered in the outpatient 
population as well. For instance, research in the primary care setting has 
consistently demonstrated that comorbid depression is associated with 
increased use of health services in patients with chronic somatic illness 
64-67; 45
. 
 
Gain more insight into the (cost-)effectiveness of interventions for depression 
comorbid with somatic illness 
Given the findings of suboptimal diagnosis and management of depression 
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comorbid with chronic somatic illness in Dutch general practice, future 
research needs to develop and evaluate strategies to improve quality of care 
for comorbid depression in chronically ill patients. An appealing strategy to 
improve the diagnosis of comorbid depression is to routinely screen for 
depression in patients with chronic somatic illness. Although routine screening 
for depression in chronically ill patients has been recommended in a number of 
guidelines 
e.g. 68-69
, its effectiveness in improving diagnosis, management and 
outcomes of depression has scarcely been investigated 
70
. Research is needed 
in this area. Studies in depressed patients in the primary care setting indicate 
that screening works best when embedded within multifaceted disease 
management programs for depression, thereby helping to ensure that adequate 
treatment and follow-up is provided 
71-72
. These multifaceted organisational 
interventions, also termed “collaborative care” interventions, have been 
shown to be effective in improving short- and long-term outcomes in 
depression in the primary care setting, at least in the US and UK 
73-75
. Trials in 
primary care in the US indicate that collaborative care may also be effective in 
improving depression care and outcomes in depressed patients with diabetes 
mellitus 
76-77
, those with arthritis 
78
, and those with multiple chronic somatic 
conditions 
79
. However, effects on outcomes related to the somatic illnesses 
under study were inconsistent or not investigated. Recently, evidence was 
found that collaborative care for patients with diabetes mellitus and comorbid 
depression significantly reduces outpatient health services costs 
80
. Further 
research is needed to evaluate whether collaborative care is (cost-)effective in 
patients with (multiple) chronic somatic illness(es) in general practice in the 
Dutch health care setting 
81
, which intervention components are essential, and 
how such interventions can be further elaborated to also lead to improved 
outcomes of chronic somatic illnesses. Furthermore, such research needs to 
determine how disease management for depression can best be incorporated 
into the present-day care for chronic somatic illness in Dutch general practice, 
including integration within existing disease management programs for chronic 
somatic disorders.  
The questions regarding the (cost-)effectiveness of complex organisational 
interventions to improve care for comorbid depression in the primary care 
setting are also relevant to the general hospital setting. As mentioned 
previously, there appears to be substantial room for improvement in the 
diagnosis and management of comorbid depression among patients hospitalized 
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for somatic illness 
e.g.
 
56-57
. Interestingly, however, most studies performed to 
date have not demonstrated clear beneficial effects of enhanced depression 
care programs in the general hospital setting 
82-86
.  
Finally, besides research that evaluates organisational strategies to improve 
quality of care for comorbid depression, more studies are needed that examine 
the effectiveness of pharmacologic and psychological treatments for 
depression in the context of chronic somatic illness. Although a growing body 
of evidence indicates that depression comorbid with chronic somatic illness 
can be effectively treated 
28; 46; 87
 more research is needed in this area, also to 
determine whether outcomes of somatic illnesses can be positively influenced. 
 
 
8.4 Relevance and implications for Dutch general practice 
 
Findings of this thesis point to less-than-optimal diagnosis and management of 
comorbid depression in patients with chronic somatic illness in general 
practice in the Netherlands. This underscores the need for educational 
initiatives to increase the awareness of GPs and other health professionals 
working in Dutch general practice about the commonness of comorbid 
depression in chronically ill patients, its negative impact on the course and 
outcomes of chronic somatic illnesses, and the options for its diagnosis and 
management. In this respect, clinical guidelines on somatic illnesses need to 
be amended to include existing knowledge about comorbidity with depression. 
Current practice guidelines of the Dutch College of General Practitioners as 
well as current Dutch multidisciplinary guidelines concerning somatic illnesses 
generally devote little or no attention to psychiatric comorbidity 
88
.  
It is unlikely, however, that educational efforts and introducing adjusted 
clinical guidelines will be sufficient to lead to better care for comorbid 
depression in chronically ill patients. Reviews of strategies to enhance quality 
of depression care in the primary care population have indicated that 
organizational restructuring is an essential component for improving care and 
outcomes 
48; 73
. As mentioned before, the collaborative care model has been 
demonstrated to be effective in the primary care setting in the US and UK 
74-75
, 
and recent US studies have suggested that this multifaceted organisational 
intervention may also result in better outcomes in the subpopulation of chronic 
somatically ill patients 
76-79
. Collaborative care introduces several changes in 
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the way care for depression is organized and delivered in primary care, among 
which are the use of a care manager to coordinate and monitor care, the 
availability of a mental health specialist who provides supervision and 
consultation, screening for depression, the formulation of a personalized 
treatment plan, a stepped-care model of treatment, and systematic follow-up 
89
. These redesigns can be considered starting-points to improve present-day 
care of chronically ill patients with comorbid depression in the primary care 
setting.   
In the Dutch health care setting there are a number of potential candidates 
who may take on the role of care manager, including primary care psycho-
logists, social workers, community psychiatric nurses, and mental health care 
practice nurses (a new function which was introduced just recently in Dutch 
general practice) 
90
. These persons have a mental health background, which 
appears to be conducive to the effectiveness of collaborative care 
91
. However, 
with regard to chronically ill patients, practice nurses or specialized nurses 
could be involved as well. They usually have already regular contacts with 
chronically ill patients. Moreover, they play an important role in existing 
disease management programs for chronic somatic illnesses (e.g. 
www.diabeteszorgbeter.nl), and could therefore provide together with GPs the 
necessary link between disease management programs that are currently 
focused on a single somatic or mental disorder. The consultant psychiatrist 
would be a likely candidate to fulfil the role of supervising mental health 
specialist. Adequate medical and pharmacological knowledge and experience is 
a prerequisite to ascertain the diagnosis of depression in chronically ill 
patients and to formulate a treatment and management plan 
92
. An important 
element of collaborative care is a close liaison between the patient, the care 
manager, the GP, and the supervising mental health specialist. Continued 
efforts are therefore needed to strengthen existing multidisciplinary 
relationships and to develop new ones in practices where they are not present 
yet. Collaboration between the different health care providers may be 
fostered by using technology, such as, for instance, a computerized tracking 
system which enables them to monitor patient progress and communicate with 
each other 
93
. Routine screening for depression in a person with a chronic 
somatic condition can be performed during the regular contacts with his or her 
GP, practice nurse or specialized  nurse. Short screening instruments exist that 
have shown there value in detecting depression in the context of medical 
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illness 
94
.  A positive screening result needs to be followed up by diagnostic 
assessment and, when necessary, by evidence-based, stepped-care treatment 
for depression in the context of somatic illness. Both a screening instrument 
and evidence-based treatment algorithms for comorbid depression could be 
incorporated into the electronic medical record systems used in Dutch general 
practice.  
Evidently, whether the above-mentioned suggested reorganizations will 
actually improve quality of care and outcomes for patients with chronic 
somatic illness and comorbid depression needs to be evaluated in practice. 
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Summary 
 
 
Depression and comorbidity. General practice-based studies 
on occurrence and health care consequences. 
 
 
Introduction (chapter 1) 
 
Depression often co-occurs with other mental and somatic disorders in one 
patient. This comorbidity is associated with increased personal and societal 
burden. Depression comorbid with another mental disorder is more severe and 
has a poorer prognosis than depression alone. The course of depression also 
tends to be more protracted in the context of somatic illness. The other way 
around, there is ample evidence that depression negatively affects the course 
and outcome of chronic somatic disorders. From a societal viewpoint, 
comorbidity involving depression is important given its association with 
increased use of health care services and increased absence from work.  
Although its relevance is clear, substantial knowledge gaps about comorbidity 
involving depression remain. In this thesis two sets of research questions were 
examined to extend knowledge about: (a) the occurrence of comorbidity 
involving depression; and (b) the health care consequences of comorbidity 
involving depression, specifically consequences for quality of care and health 
care utilization. The studies are mainly based on general practice data 
collected within the framework of the second Dutch National Survey of General 
Practice (DNSGP-2) and the National Information Network of General Practice 
(LINH). 
 
 
Part A. Studies on occurrence 
 
Knowledge on somatic cluster comorbidity, i.e. somatic illness that occurs at a 
higher rate than expected by chance, among depressive patients in the general 
population is limited. Dutch general practice provides a good opportunity to 
study the pattern of somatic cluster comorbidity in a largely unselected 
sample of depressed persons. Chapter 2 reports on a cross-sectional study that 
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used medical  records of general practitioners (GPs) to address the following 
research question: 
What are the patterns of somatic and psychiatric cluster comorbidity in 
depression, stroke, multiple sclerosis, Parkinson’s disease/ parkinsonism, 
dementia, migraine and epilepsy? 
Of the 30 categories of somatic illness studied, a broad and diverse set of 21 
categories were identified as possible or highly probable instances of somatic 
cluster comorbidity in a large group of general practice patients with a 
lifetime GP diagnosis of depression.
*
 This finding indicates that patients who 
have (had) depression are generally more likely to have a somatic illness than 
those who never had a depression. Noteworthy, when analyses were restricted 
to the subgroup of patients with a current GP diagnosis of depression, 12 of 
the 21 somatic disease categories were no longer identified as (possible or 
highly probable) cluster comorbidity. This was interpreted to reflect reduced 
statistical power due to the smaller size of this subgroup.  
 
Part A continued with a case-control study that examined the association 
between cerebrovascular risk factors (CVRFs) and the subsequent development 
of depression in later life. There is little research on this relationship. 
Demonstrating the existence of such a link would lend support for the vascular 
depression hypothesis of late-life depression, which postulates that 
cerebrovascular disease may cause or exacerbate depression with late onset in 
life. The following research question was addressed in chapter 3: 
Is there a relationship between CVRFs and the subsequent development of 
depression in older general practice patients?  
In this study, CVRFs included diagnoses of hypertension, diabetes mellitus, and 
cardiovascular disease. None of the CVRF variables examined (i.e. any CVRF, 
individual CVRF, number of CVRFs, and exposure duration to CVRFs) was found 
to be significantly associated with the subsequent onset of depression in a 
sample of older general practice patients. However, several of the CVRF 
variables under study were associated with a significantly increased odds of 
developing depression with onset between ages 50 and 69 years. It was 
suggested that these findings could indicate that CVRFs play a relevant role in 
the development of depression with onset between ages 50 and 69 years, but 
                                                     
*
 Being of most interest to this thesis, summary of findings is limited to those concerning 
somatic cluster comorbidity in depression. 
 Summary     
 193 
that no evidence was found that CVRFs contribute to the occurrence of 
depression with onset at age 70 years or later. These results should be 
considered preliminary given the possibility of bias inherent in using morbidity 
data recorded by GPs. 
 
Part A finished with a systematic review. The various cross-sectional studies 
performed to date that have examined the relationship between severity of 
Alzheimer‟s disease (AD) and prevalence of comorbid depressive symptoms or 
depression have yielded inconsistent results. Chapter 4 describes a systematic 
review of these cross-sectional studies to address the following research 
question:  
Is there a relationship between severity of AD and prevalence of comorbid 
depressive symptoms and depression? 
A search strategy identified twenty-four studies that fulfilled pre-defined 
inclusion criteria. Of these, 19 reported findings on the relationship between 
severity of AD and prevalence of depressive symptoms and seven on the 
association of AD severity with frequency of diagnosed depression. Four of the 
19 studies on the former association were rated as being of high quality, and 
three of these found no significant association. Three of the seven studies on 
the latter relationship were rated as being of high quality, and none of these 
reported a significant result. It was concluded that no evidence exists for a 
relationship between severity of AD and prevalence of comorbid depressive 
symptoms or depression.   
 
 
Part B. Studies on health care consequences 
 
Consequences for quality of care 
The focus was laid on the influence of comorbidity on the care for depression 
in general practice in the Netherlands, as Dutch GPs play a central role both in 
the diagnosis and management of depression.  
 
Given that previous studies have suggested opposite effects of psychiatric and 
somatic comorbidity on underdiagnosis of depression by GPs, the study 
described in chapter 5 set out to answer the following research question: 
Is there an interaction effect between psychiatric and chronic somatic 
 194 
comorbidity on GPs’ diagnosis of depression? 
It was shown that approximately half of a group of patients with major 
depression and/or dysthymic disorder established according to a structured 
diagnostic interview had either comorbid psychiatric (as indicated by the 
interview) or comorbid chronic somatic disease (as indicated by GP records). 
Almost a quarter of them had both types of comorbidity. About 65% of the 
patients with psychiatric comorbidity were not diagnosed as being depressed 
by their GP, as reflected by having no GP record of a diagnosis of depression or 
depressive feelings. The rate of underdiagnosis of depression was somewhat 
higher among those with comorbid chronic somatic illness (74%). Multivariate 
analysis demonstrated an interaction effect between somatic and psychiatric 
comorbidity on GPs‟ diagnosis of depression. Further analysis showed that - 
among the patients without chronic somatic comorbidity - a lower educational 
level, less severe depression, and fewer GP contacts all were independently 
associated with a decreased likelihood of being diagnosed as depressed. Among 
the chronic somatically ill patients only having no comorbid psychiatric 
disorder was associated with a  decreased likelihood of receiving a depression 
diagnosis. It was concluded that the factors associated with underdiagnosis of 
depression by GPs differ depending on whether or not depressed patients have 
a chronic somatic illness. 
 
There is limited information on whether having a specific chronic somatic 
condition influences the care for depression in general practice. Chapter 6 
presents a prospective study in which two research questions were addressed: 
What is the influence of specific chronic somatic conditions on the 
initiation of any depression care in patients newly diagnosed with 
depression by their GP?; and  
Among those being prescribed antidepressants by their GP, what is the 
influence of these conditions on prescription of continuous antidepressant 
treatment? 
Any depression care was initiated in 86% of the patients with chronic somatic 
illness. A comparable percentage was observed among the non-chronically ill 
patients (88%). Rate of initiation of any depression care varied by type of 
condition, ranging from 59% in patients with cardiac arrhythmia to 93% among 
those with a thyroid condition. Multivariate analysis showed that patients with 
pre-existing ischaemic heart disease or cardiac arrhythmia had a significantly 
 Summary     
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lower likelihood of having any depression care being initiated after being 
newly diagnosed with depression by their GP than patients without chronic 
somatic illness. None of the other 12 chronic somatic conditions under study 
was found to significantly impact the initiation of any depression care. The 
proportion of patients with continuous prescription after initiating 
antidepressant therapy was comparable among the groups with and without 
chronic somatic illness (resp. 37% and 39%). The rate of continuous 
prescription differed according to the type of the comorbid condition. Patients 
with cardiac arrhythmia showed the highest rate (50%), while the lowest rate 
was observed among those with a thyroid condition (23%). Multivariate analysis 
demonstrated that none of the chronic somatic conditions significantly 
influenced the prescription of continuous antidepressant treatment. These 
findings were interpreted as pointing to the relevance of supporting GPs in the 
management of comorbid depression in patients with heart disease to reduce 
its negative impact.  
  
Consequences for health care utilization 
Although a number of studies have addressed the impact of depression on use 
of health care services by patients who suffered a stroke, none of them has 
specifically focussed on the influence of already existing depression. Part B 
finished with a prospective study that attempted to answer the following 
research question (chapter 7): 
What is the impact of having pre-existing depression at hospital admission 
for stroke on the length of acute hospital stay and discharge destination?  
It was found that having pre-existing depression at the time of hospital 
admission for a new or recurrent stroke did not significantly affect length of 
acute hospital stay. It was further shown that among the survivors of 
hospitalization for acute stroke, the patients who were already depressed at 
admission had a significantly greater likelihood of being discharged to an 
institution instead of their home than those without any pre-existing mental 
health condition. Having a pre-existing mental health condition other than 
depression did neither influence length of acute hospital stay nor discharge 
destination. These findings were interpreted as indicating that having pre-
existing depression is a possibly important factor in determining discharge to 
institutional care after hospitalization for acute stroke. 
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General discussion (chapter 8) 
 
Strengths and limitations of using general practice records  
The studies showed that using data from general practice records for studying 
the occurrence of comorbidity involving depression and its health care 
consequences has its strengths and limitations.  
 
Strengths include: 
 Data represent a largely unselected population, at least in countries 
where GPs act as a gatekeeper to other health care facilities; 
 Data on a large number of persons are available;  
 Morbidity data reflect doctor-defined health problems rather than 
being based on self-report; 
 Morbidity information is relatively comprehensive given that GPs come 
across a broad spectrum of somatic and mental health problems; 
 Data are continuously collected, which allows prospective or 
retrospective research to be conducted that spans long periods of 
time; 
 Opportunities exist to link datasets from general practice networks 
with data from patient based registers from other care settings;  
 In various countries GPs play a important role in the diagnosis and 
management of persons with depression and in their referral to other 
health care professionals. 
 
Potential limitations include: 
 Reliance on GP-diagnosed depression including its inherent variability; 
 Suboptimal recording of morbidity in terms of completeness and 
accuracy;  
 Variation between GPs and practices regarding quality of recording;  
 Low specificity of diagnoses recorded, by which no information is 
available on the type and severity of depression and other health 
problems;  
 No or restricted information is available about important potential 
confounders or effect modifiers, such as psychological and social risk 
factors for depression.  
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Directions for future research  
 
Research on occurrence 
Based on the findings in Part A, it was concluded that there exists a need for 
well-designed longitudinal research to better describe the occurrence of 
comorbidity between depression and other health conditions and to better 
understand its underlying mechanisms. Three more specific research 
objectives were suggested regarding comorbidity between depression and 
somatic illness:   
 Gain more insight into the specificity of cluster comorbidity between 
depression and somatic illness; 
 Gain more insight into the interplay between having a chronic health 
condition and other risk factors in the onset of depression;  
 Gain more insight into the course of depression in the context of a 
chronic health condition and its determinants.  
 
Research on health care consequences 
Three objectives for future research were proposed based on the findings in 
Part B: 
 Gain more insight into the mechanisms that underlie suboptimal 
diagnosis and management of depression in the context of somatic 
illness;  
 Gain more insight into the mechanisms underlying the association 
between comorbid depression and increased health care utilization 
among persons with somatic illness;   
 Gain more insight into the (cost-)effectiveness of interventions for 
depression comorbid with somatic illness. 
 
Relevance and implications for Dutch general practice 
Study findings indicate that the diagnosis and management of comorbid 
depression in patients with chronic somatic illness is less-than-optimal in 
general practice in the Netherlands. This finding is of concern given the 
commonness of comorbidity between depression and chronic somatic illness 
and the evidence that depression negatively affects the course and outcome of 
somatic illnesses, and vice versa. Some suggestions are given to improve care 
for chronic somatically ill patients with comorbid depression in general 
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practice, such as regular screening for depression, stepped-care treatment, 
the availability of a care manager and supervision by a mental health 
specialist.  
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Samenvatting 
 
 
Depressie en comorbiditeit. Studies in de huisartsenpraktijk 
naar voorkomen en gevolgen voor de zorg. 
 
 
Inleiding (hoofdstuk 1) 
 
Een depressie komt vaak tegelijkertijd voor met een chronische lichamelijke 
ziekte of een andere psychische stoornis. Deze comorbiditeit bij depressie 
heeft belangrijke gevolgen voor zowel de individuele patiënt als voor de 
samenleving als geheel. Een depressie die samengaat met een andere 
psychische stoornis is over het algemeen ernstiger en heeft een minder goed 
beloop. Een slechtere prognose van depressie wordt ook gezien wanneer er 
sprake is van een chronische lichamelijke aandoening. Andersom bekeken zijn 
er sterke aanwijzingen dat depressie het beloop van chronische lichamelijke 
ziekten ongunstig beïnvloedt. Maatschappelijk gezien is comorbiditeit bij 
depressie van belang gezien de samenhang met meer gebruik van 
zorgvoorzieningen en meer werkverzuim.   
Hoewel de relevantie van comorbiditeit bij depressie duidelijk is, bestaan er 
nog tal van leemtes in de kennis op dit gebied. In dit proefschrift worden twee 
sets van onderzoeksvragen beantwoord om meer kennis te verkrijgen over: (a) 
het voorkomen van comorbiditeit bij depressie; en (b) de gevolgen van 
comorbiditeit bij depressie voor de kwaliteit van zorg en het zorggebruik. Voor 
de studies is gebruik gemaakt van gegevens uit huisartsenpraktijken die 
verzameld zijn in het kader van de Tweede Nationale Studie naar ziekten en 
verrichtingen in de huisartsenpraktijk (NS2) en het Landelijk Informatie 
Netwerk Huisartsenzorg (LINH). 
 
 
Deel A. Studies naar voorkomen 
 
De kennis over het voorkomen van lichamelijke cluster comorbiditeit, oftewel 
lichamelijke ziekten die vaker voorkomen dan op basis van toeval verwacht 
wordt bij personen met een depressie in de algemene bevolking is beperkt. In 
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Nederland biedt de huisartsenpraktijk een goede mogelijkheid om het patroon 
van lichamelijke cluster comorbiditeit in een goeddeels ongeselecteerde groep 
van personen met een depressie te onderzoeken. In hoofdstuk 2 wordt een 
cross-sectionele studie beschreven waarin gebruik gemaakt is van door 
huisartsen geregistreerde morbiditeitgegevens om de volgende 
onderzoeksvraag te beantwoorden: 
Wat zijn de patronen van lichamelijke en psychische cluster comorbiditeit 
bij depressie, beroerte, multiple sclerose, ziekte van Parkinson/ 
Parkinsonisme, dementie, migraine en epilepsie? 
Uit de analyses van een grote groep van personen die depressief zijn of zijn 
geweest volgens hun huisarts, bleken 21 van de 30 onderzochte lichamelijke 
ziektecategorieën naar voren te komen als mogelijke of zeer waarschijnlijke 
lichamelijke cluster comorbiditeit.
*
 Deze bevinding geeft aan dat personen die 
een depressie hebben of ooit gehad hebben over het algemeen vaker een 
lichamelijke aandoening hebben dan degenen die nooit depressief zijn 
geweest. Wanneer de analyses beperkt werden tot de subgroep van personen 
met een huidige depressie, bleken 12 van de 21 ziektecategorieën niet meer 
als lichamelijke cluster comorbiditeit naar voren komen. Dit is mogelijk te 
verklaren door een lagere statistische power vanwege de kleinere omvang van 
deze subgroep.  
 
Deel A vervolgt met een patiënt-controle-onderzoek waarin het verband 
onderzocht is tussen het hebben van risicofactoren voor cerebrovasculaire 
ziekte (CVRF‟s) en het ontwikkelen van een depressie later in het leven. Hier is 
tot dusverre weinig onderzoek naar gedaan. Indien dit verband zou bestaan, 
ondersteunt dit de “vasculaire depressie” hypothese. Deze hypothese 
veronderstelt dat cerebrovasculaire ziekte depressie op oudere leeftijd kan 
veroorzaken of verergeren. In hoofdstuk 3 is gepoogd de volgende 
onderzoeksvraag te beantwoorden: 
Bestaat er een relatie tussen het hebben van CVRF’s en het ontwikkelen 
van een depressie bij oudere patiënten in de huisartsenpraktijk?    
CVRF‟s omvatten in deze studie de diagnoses hypertensie, diabetes mellitus en 
cardiovasculaire ziekte. Het bleek dat in de onderzochte groep van oudere 
huisartspatiënten (≥50 jaar) het hebben van een CVRF (ongeacht welke) niet 
                                                     
*
 Gezien de focus van het proefschrift worden hier alleen de resultaten met betrekking tot 
lichamelijke cluster comorbiditeit bij depressie besproken . 
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samenhing met het ontstaan van een depressie op latere leeftijd. Ook het 
hebben van een specifieke CVRF, het aantal CVRF‟s en de duur van de 
aanwezigheid van CVRF‟s bleken niet van invloed. Wel werd gevonden dat een 
aantal van de bestudeerde CVRF-variabelen samenhing met een verhoogde 
kans op het krijgen van een depressie op de leeftijd tussen 50 en 69 jaar. Dit 
suggereert dat CVRF‟s een rol spelen bij het ontwikkelen van een depressie in 
deze leeftijdsperiode, maar dat er geen aanwijzingen zijn dat CVRF‟s 
bijdragen aan het ontstaan van een depressie op 70-jarige leeftijd of later. 
Deze bevindingen moeten echter als voorlopig beschouwd worden omdat het 
mogelijk is dat de resultaten vertekend zijn door gebruik te maken door 
huisarts geregistreerde morbiditeitgegevens.  
 
Deel A eindigt met een systematische review. In de loop der tijd zijn er 
verscheidene cross-sectionele studies gepubliceerd die de relatie tussen de 
ernst van de ziekte van Alzheimer (AD) en het voorkomen van comorbide 
depressie of depressieve symptomen hebben onderzocht. Deze studies laten 
echter inconsistente resultaten zien. Hoofdstuk 4 presenteert een 
systematische review van de studies om de volgende onderzoeksvraag te 
beantwoorden: 
Bestaat er een relatie tussen de ernst van AD en de prevalentie van 
comorbide depressie en depressieve symptomen? 
Een zoekstrategie vond 24 studies die voldeden aan vooraf gestelde 
inclusiecriteria. Negentien studies beschreven bevindingen omtrent de relatie 
tussen de ernst van AD en de prevalentie van comorbide depressieve 
symptomen. Slechts vier van de 19 studies werden als kwalitatief goed 
beoordeeld, en van deze vier studies vonden drie geen verband. De relatie 
tussen de ernst van AD en het voorkomen van depressie werd door zeven 
studies onderzocht. Drie werden als kwalitatief goed beoordeeld, maar in geen 
van deze studies werd een verband gevonden. Op basis hiervan is 
geconcludeerd dat er geen bewijs bestaat voor een relatie tussen de ernst van 
AD en de prevalentie van comorbide depressie en depressieve symptomen.  
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Deel B. Studies naar gevolgen voor de zorg 
 
Gevolgen voor de kwaliteit van zorg  
Nederlandse huisartsen spelen een centrale rol in de diagnose en behandeling 
van depressie. Om deze reden is in dit proefschrift de focus gelegd bij de 
invloed van comorbiditeit op de huisartsgeneeskundige zorg voor depressie.  
Bevindingen uit eerdere studies geven aan dat psychische en lichamelijke 
comorbiditeit tegengestelde effecten hebben op de kans dat een depressie 
niet gediagnosticeerd wordt door een huisarts. Daarom stond in hoofdstuk 5 de 
volgende onderzoeksvraag centraal: 
Bestaat er een interactie-effect tussen psychische en lichamelijke 
comorbiditeit op de kans dat een depressie gediagnosticeerd wordt door 
een huisarts?  
Ongeveer de helft van een groep personen met een depressieve en/of 
dysthyme stoornis zoals vastgesteld via een gestructureerd psychiatrisch 
diagnostisch interview bleek ofwel een comorbide psychische stoornis (bepaald 
middels het psychiatrisch interview) ofwel een comorbide chronische 
lichamelijke aandoening (bepaald aan de hand van door huisartsen 
geregistreerde morbiditeitgegevens) te hebben. Bijna een kwart had beide 
typen comorbiditeit. Ongeveer 65% van de depressieve personen met 
psychische comorbiditeit waren niet als depressief gediagnosticeerd door hun 
huisarts, blijkend uit het ontbreken van een geregistreerde diagnose depressie 
of depressieve gevoelens. De mate van onderdiagnostiek van depressie was 
hoger onder degenen met een comorbide chronische lichamelijke aandoening 
(74%). Multivariate analyse toonde een interactie-effect aan tussen psychische 
en lichamelijke comorbiditeit op de kans dat een depressie gediagnosticeerd 
werd door de huisartsen. Verdere analyses gaven aan dat – onder de personen 
zonder chronische lichamelijke comorbiditeit – een lager opleidingsniveau, een 
minder ernstige depressie, en minder contact met de huisarts, onafhankelijk 
samenhingen met een kleinere kans op het krijgen van de diagnose depressie. 
Onder de chronisch lichamelijk zieke, depressieve personen was alleen het niet 
hebben van een comorbide psychische stoornis gerelateerd aan een minder 
grote kans op de diagnose depressie. Op basis van deze bevindingen is 
geconcludeerd dat de factoren die samenhangen met de onderdiagnostiek van 
depressie in de huisartsenpraktijk verschillen, afhankelijk van of depressieve 
personen wel of niet chronisch lichamelijk ziek zijn.  
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Er is weinig informatie over de invloed van specifieke chronische lichamelijke 
aandoeningen op de zorg voor depressie in de huisartsenpraktijk. Hoofdstuk 6 
presenteert een prospectieve studie die ingaat op twee onderzoeksvragen: 
Wat is de invloed van specifieke chronische lichamelijke aandoeningen op 
het beginnen van enige vorm van depressiebehandeling bij personen die 
door hun huisarts nieuw gediagnosticeerd zijn met depressie?; en 
Wat is – onder degenen die antidepressiva voorgeschreven kregen door hun 
huisarts – de invloed van deze aandoeningen op het voorschrijven van een 
continue behandeling met antidepressiva gedurende zes maanden?    
Bij 86% van de personen met een chronische lichamelijke aandoening werd 
begonnen met enige vorm van behandeling voor de nieuw gediagnosticeerde 
depressie. Dit gebeurde bij een vergelijkbaar percentage van de niet-chronisch 
zieke personen (88%). Het percentage personen bij wie een vorm van 
depressiezorg gestart werd verschilde per type aandoening, variërend van 59% 
van de personen met een hartritmestoornis tot 93% van degenen met een 
schildklieraandoening. Multivariate analyse liet zien dat personen met een 
ischemische hartaandoening of hartritmestoornis een kleinere kans hadden dan 
niet-chronisch zieke personen dat er enige vorm van depressiebehandeling 
geïnitieerd werd na nieuw gediagnosticeerd te zijn met depressie. Geen van de 
andere 12 bestudeerde chronische lichamelijke aandoeningen had invloed op 
de kans dat depressiebehandeling gestart werd. Het percentage personen dat 
gedurende zes maanden op continue basis antidepressiva kreeg voorgeschreven 
was vergelijkbaar in de groep chronisch lichamelijk zieke personen en de groep 
niet-chronisch zieken (resp. 37% en 39%). De mate van continu voorschrijven 
varieerde per type chronische aandoening. Bij personen met een 
hartritmestoornis werd het hoogste percentage (50%) gevonden, terwijl het 
laagste percentage (23%) gevonden werd onder degenen met een 
schildklieraandoening. Multivariate analyse toonde aan dat geen van de 
specifieke chronische lichamelijke aandoeningen de kans op het continu 
voorschrijven van antidepressiva beïnvloedde. De bevindingen van deze studie 
wijzen op het belang om huisartsen te ondersteunen in het adequaat 
behandelen van comorbide depressie bij personen met een hartaandoening om 
de negatieve gevolgen van de depressie te verminderen.  
 
 
 204 
Gevolgen voor het zorggebruik 
Een aantal eerdere studies heeft de invloed onderzocht van depressie op het 
gebruik van zorgvoorzieningen door personen die een beroerte hebben 
doorgemaakt. Echter, dit onderzoek heeft zich niet specifiek gericht op het 
effect van een al bestaande depressie op zorggebruik. Deel B (hoofdstuk 7) van 
dit proefschrift eindigt met een prospectieve studie waarin getracht is de 
volgende onderzoeksvraag te beantwoorden: 
Wat is de invloed van het reeds hebben van een depressie ten tijde van 
een ziekenhuisopname vanwege een beroerte op de duur van de opname 
en de ontslagbestemming?   
Een reeds bestaande depressie bleek geen effect te hebben op de duur van de 
ziekenhuisopname vanwege een eerste of recidief beroerte. Verder werd er 
gevonden dat – onder de personen die de beroerte overleefden – degenen die 
al depressief waren een grotere kans hadden om opgenomen te worden in een 
verpleeghuis of revalidatiecentrum dan degenen die niet reeds depressief 
waren. Het hebben van een ander psychisch probleem dan depressie ten tijde 
van de ziekenhuisopname had geen invloed op zowel opnameduur als 
ontslagbestemming. De bevindingen suggereren dat een reeds bestaande 
depressie een mogelijk belangrijke factor is bij het bepalen of een patiënt wel 
of niet naar huis kan na een ziekenhuisopname vanwege een beroerte.    
 
 
Algemene discussie (hoofdstuk 8) 
 
Voor- en nadelen van gegevens uit de huisartsenpraktijk 
De studies in dit proefschrift laten zien dat het gebruiken van door huisarts 
geregistreerde gegevens voor het bestuderen van het voorkomen en de 
gevolgen van comorbiditeit bij depressie voor- en nadelen heeft. 
Voordelen van gegevens uit huisartsenpraktijken zijn onder andere: 
 Gegevens hebben betrekking op een grotendeels ongeselecteerde 
populatie, althans in landen zoals Nederland waarin de huisarts 
fungeert als poortwachter van de gezondheidszorg; 
 Gegevens hebben betrekking op een groot aantal personen; 
 Morbiditeitgegevens zijn niet gebaseerd op zelfrapportage, maar 
hebben betrekking op gezondheidsproblemen die gediagnosticeerd zijn 
door artsen; 
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 Morbiditeitgegevens zijn omvangrijk in die zin dat de huisarts als 
generalist te maken heeft met een breed spectrum van lichamelijke 
en psychische gezondheidsproblemen; 
 Gegevens worden op continue basis geregistreerd wat retro- en 
prospectief onderzoek over lange tijdsperioden mogelijk maakt; 
 Er bestaan mogelijkheden om door huisarts geregistreerde gegevens te 
koppelen aan geregistreerde gegevens uit andere zorgsettingen; 
 In diverse landen, waaronder Nederland, speelt de huisarts een 
belangrijke rol in de diagnose, behandeling en verwijzing van personen 
met een depressie. 
 
Nadelen van gegevens uit huisartsenpraktijken zijn onder andere: 
 Het baseren van onderzoek op depressie zoals gediagnosticeerd door 
de huisarts en de daarmee samenhangende variabiliteit; 
 Het niet optimaal registreren van morbiditeitgegevens in termen van 
compleetheid en accuraatheid; 
 Variatie tussen huisartsen en huisartsenpraktijken wat betreft de 
kwaliteit van registratie; 
 Het globale karakter van de geregistreerde diagnoses, waardoor er 
geen informatie aanwezig is over het type en de ernst van een 
depressie en van andere gezondheidsproblemen; 
 Het niet of beperkt beschikbaar zijn van gegevens over mogelijk 
belangrijke vertekenende factoren variabelen of effect-modificatoren 
zoals psychologische en sociale risicofactoren voor het ontwikkelen 
van depressie.  
 
 
Aanbevelingen voor toekomstig onderzoek 
 
Onderzoek naar voorkomen 
Op basis van de bevindingen van Deel A van dit proefschrift wordt algemeen 
gesteld dat er behoefte is aan goed opgezet longitudinaal onderzoek zodat een 
beter inzicht verkregen wordt in het voorkomen en de onderliggende 
mechanismen van comorbiditeit van depressie en andere 
gezondheidsproblemen. Er worden drie meer specifieke doelen voor 
toekomstig onderzoek geformuleerd met betrekking tot comorbiditeit van 
 206 
depressie en lichamelijke ziekte:  
 Het verkrijgen van meer inzicht in de specificiteit van cluster 
comorbiditeit tussen depressie en lichamelijke ziekte; 
 Het verkrijgen van meer inzicht in de wisselwerking tussen het 
hebben van een chronische lichamelijke aandoening en andere 
risicofactoren voor het ontstaan van een depressie; 
 Het verkrijgen van meer inzicht in het beloop van depressie bij 
personen met een chronische lichamelijke aandoening en de 
determinanten hiervan.    
 
Onderzoek naar gevolgen voor de kwaliteit van zorg en het zorggebruik 
Er wordt een drietal aanbevelingen voor toekomstig onderzoek gedaan op basis 
van de bevindingen in deel B van dit proefschrift: 
 Het verkrijgen van meer inzicht in de mechanismen die ten grondslag 
liggen aan de suboptimale diagnostiek en behandeling van depressie 
bij personen met een chronische lichamelijke aandoening; 
 Het verkrijgen van meer inzicht in de onderliggende mechanismen van 
de relatie tussen comorbide depressie en meer zorggebruik bij 
lichamelijk zieke personen; 
 Het verkrijgen van meer inzicht in de (kosten-)effectiviteit van 
interventies voor comorbide depressie bij lichamelijke aandoeningen.  
 
 
Relevantie en aanbevelingen voor de huisartsgeneeskundige zorg 
De bevindingen in dit proefschrift geven aan dat de diagnostiek en behandeling 
van comorbide depressie bij chronisch lichamelijk zieke personen niet altijd 
optimaal verloopt in de huisartsenpraktijk in Nederland. Dit is een zorgelijke 
constatering omdat deze vorm van comorbiditeit vaak voorkomt. Verder zijn er 
sterke aanwijzingen dat depressie het beloop van een chronisch lichamelijke 
aandoening ongunstig beïnvloedt en vice versa. Er worden een aantal 
suggesties gedaan die de diagnostiek en behandeling van comorbide depressie 
bij chronisch zieken in de huisartsenpraktijk kunnen verbeteren, zoals onder 
andere het geregeld screenen op depressie, het opstellen van een persoonlijk 
behandelplan, een getrapte zorg benadering voor depressie, het aanstellen van 
een “care manager” en het consulteren van specialisten op het gebied van 
diagnostiek en behandeling van (comorbide) depressie.  
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